ACTEL CORP
10-K, 1998-03-31
PRINTED CIRCUIT BOARDS
Previous: HYSEQ INC, 10-K405, 1998-03-31
Next: SUGEN INC, 10-K405, 1998-03-31




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                     --------------------------------------

                                    FORM 10-K

(Mark One)

X    ANNUAL REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES  EXCHANGE
     ACT OF 1934

For the fiscal year ended December 28, 1997

                                       OR

     TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934

Commission file number 0-21970

                     --------------------------------------

                                ACTEL CORPORATION
             (Exact name of Registrant as specified in its charter)

               California                               77-0097724
    (State or other jurisdiction of                  (I.R.S. Employer
     incorporation or organization)                Identification No.)

         955 East Arques Avenue
         Sunnyvale, California                          94086-4533
(Address of principal executive offices)                (Zip Code)

                                 (408) 739-1010
              (Registrant's telephone number, including area code)

                     --------------------------------------

               Securities registered pursuant to Section 12 (b) of
                                    the Act:
                                      None

           Securities registered pursuant to Section 12(g) of the Act:
                          Common Stock, $.001 par value
                                (Title of class)

                     --------------------------------------

     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant  was required to file such  reports) and (2) has been subject to such
filing requirements for the past 90 days.    Yes  X         No

     Indicate by check mark if disclosure of delinquent  filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's  knowledge,  in definitive proxy or information  statements
incorporated  by reference in Part III of this Annual Report on Form 10-K or any
amendment to this Annual Report on Form 10-K.          X

     The aggregate  market value of the voting stock held by  non-affiliates  of
the  Registrant,  based upon the  closing  price for shares of the  Registrant's
Common Stock on March 27, 1998, as reported by the National Market System of the
National  Association of Securities  Dealers  Automated  Quotation  System,  was
approximately  $203,525,747.  In calculating such aggregate market value, shares
of Common Stock owned of record or beneficially by all officers,  directors, and
persons  known to the  Registrant  to own more than five percent of any class of
the  Registrant's  voting  securities were excluded  because such persons may be
deemed to be affiliates.  The  Registrant  disclaims the existence of control or
any admission thereof for any other purpose.

     Number  of  shares  of  Common  Stock  outstanding  as of March  27,  1998:
21,246,215.


                     --------------------------------------

                       DOCUMENTS INCORPORATED BY REFERENCE

         The following documents are incorporated by reference in Parts II, III,
and IV of this Annual Report on Form 10-K: (i) portions of  Registrant's  annual
report to security holders for the fiscal year ended December 28, 1997 (Parts II
and IV),  and (ii)  portions  of  Registrant's  proxy  statement  for its annual
meeting of shareholders to be held on May 22, 1998 (Part III).

<PAGE>


                                     PART I

ITEM 1.  BUSINESS

Overview

     Actel  designs,  develops,  and  markets  field  programmable  gate  arrays
("FPGAs") and associated  development system software and programming  hardware.
FPGAs  are  used  by  designers   of   communications,   computer,   industrial,
military/aerospace, and other electronic systems to differentiate their products
and get them to market  faster.  The  Company is the  leading  supplier of FPGAs
based on  antifuse  switching  elements,  which  are  smaller  than  alternative
switching  elements (such as static random access memories ("SRAMs") or erasable
programmable read only memories ("EPROMs")), permitting reduced circuit size and
cost and increased design efficiencies. Actel shipped its first products in 1988
and  thousands  of  its  development  systems  are in the  hands  of  customers,
including  Allen   Bradley/Rockwell,   AST  Computer,   Alcatel,  Bay  Networks,
Cabletron,  DSC  Communications,   Hughes  Aircraft,   Lockheed-Martin,   Lucent
Technologies,  and Siemens. The Company has foundry relationships with Chartered
Semiconductor  Manufacturing Pte Ltd ("Chartered  Semiconductor")  in Singapore,
Lockheed-Martin  Federal Systems Company  ("Lockheed-Martin  FSC") in the United
States,  Matsushita  Electronics  Company  and  Matsushita  Electrical  Industry
Company Ltd.  (collectively,  "Matsushita")  in Japan,  and Winbond  Electronics
Corp. ("Winbond") in Taiwan, permitting Actel to focus its resources on its core
strengths of designing, developing, and marketing FPGAs.

     The Company's FPGAs  currently are based on two  proprietary  technologies:
the Actel  antifuse  and a circuit  architecture  that  takes  advantage  of the
Company's  antifuse.  The principal  advantages of the antifuse over alternative
switching elements are smaller size and lower electrical resistance. The smaller
size of the antifuse generally permits Actel to make programmable  circuits that
are smaller, and hence less costly, than circuits of comparable  performance and
capacity  made  under   comparable   design  rules  using   alternative   switch
technologies.   Similarly,   for  circuits  of  comparable   size  and  capacity
manufactured under comparable design rules, the antifuse  facilitates the design
of circuits with a greater number of switches,  which,  in combination  with the
lower electrical resistance of the antifuse, tends to enhance flexibility and/or
performance.   In  addition,   the  Company  believes  that  its  antifuse-based
architecture is better suited for the high-level  logic synthesis tools that are
increasingly   employed  to  design  higher   capacity   devices  than  existing
architectures using other types of switching elements.

     Actel  believes that the demand for higher  capacity  devices will increase
faster than that for programmable devices as a whole.  Accordingly,  the Company
is focusing its attention on the transition to higher  capacity  devices and the
associated high-level design  methodologies.  Actel's strategy is to provide the
best FPGA  solutions by giving logic  designers the capability and confidence to
successfully  move up to higher level designs.  The Company is implementing this
strategy  by  enhancing  the  functionality,  usability,  and  accessibility  of
high-level design tools for its antifuse-based  architecture;  by increasing its
support for high-level design methodologies; and by developing a new, SRAM-based
architecture  that Actel believes will be better suited for use with  high-level
design tools than existing non-antifuse architectures.

     The Company's  product line currently  consists of seven families of FPGAs,
Designer  Series  Development  System and  CoreHDL  software,  Silicon  Explorer
debugging and diagnostic  tools, and Activator device  programmers.  To meet the
diverse customer requirements in the broad FPGA market, each member of a product
family  generally  is  offered  in a variety  of speed  grades,  package  types,
reliability screenings, and ambient temperature tolerances.  Designers typically
use popular  third-party  software  for circuit  design and then  translate  the
design  into a  programmed  FPGA using  Actel's  proprietary,  highly  automated
software   (Designer   Series   Development   System)  and  device   programmers
(Activator).  CoreHDL  blocks or "cores" that can be used to reduce  development
time by being "dropped into" designs, and Silicon Explorer can be used to reduce
design-verification  time by enabling the user to monitor the functionality of a
programmed FPGA in "real time."

     During 1997, Actel introduced a number of new silicon products.  In January
1997, the Company  announced the immediate  availability  of the world's highest
capacity  antifuse-based  FPGA, the 30,000-gate  A32300DX.  In April 1997, Actel
expanded its 3.3-volt product line to include  additional  members of its 1200XL
and 3200DX FPGA  families.  Most  significantly,  in October  1997,  the Company
introduced its new MX family of antifuse FPGAs, which is expected to feature six
devices ranging from 2,000 to 36,000 logic gates. At introduction, the MX family
was  believed  to be the world's  fastest  FPGA  family.  The MX family is being
marketed as a  single-chip  alternative  to ASICs and offered at pricing  levels
that are intended to be attractive to high-volume users of FPGAs.

     In  April  1997,  the  Company  introduced  its  Silicon  Explorer  desktop
debugging and diagnostic tool. Silicon Explorer permits designers to monitor and
hence debug the internal  operation of an Actel FPGA while running within a real
system at system speeds, a capability that is unique to Actel.

     During the course of 1997, the Company's  Designer Series software products
were  significantly  enhanced in terms of both functionality and support for the
various new silicon products. In addition, notable improvements were made in the
packaging of the software to enhance both its usability and  accessibility.  For
example,  the  requirement  for a licensing  security  block in order to run the
software was removed in June 1997. More significantly, certain software packages
were offered free of charge and made available for downloading  from Actel's web
site.

     Actel  markets its  products  through a worldwide,  multi-tiered  sales and
distribution  network.  The North American network includes six sales management
offices, seven technical sales offices, 21 manufacturers'  representative firms,
and three major  industrial  distributors.  The European  network includes sales
management  offices in  England,  France,  Italy,  and  Germany,  as well as two
Pan-European distributors and five regional distributors.  In Japan, the Company
has a sales  management  and technical  office and markets its products  through
three  distributors.  In Korea, the Company has a sales management and technical
office  and  markets  its  products  through  one  distributor.  Six  additional
distributors serve the remaining international markets in which Actel offers its
products.

     The Company was  incorporated  in  California  in 1985.  Actel's  principal
facilities  and  executive  offices  are  located  at 955  East  Arques  Avenue,
Sunnyvale,  California  94086-4533,  and its telephone number at that address is
(408) 739-1010. The Company's World Wide Web address is http://www.actel.com. As
used in this Annual Report on Form 10-K,  "Actel" and the  "Company"  mean Actel
Corporation and its  consolidated  subsidiaries.  "Actel" and the Actel logo are
registered  trademarks  of the  Company.  This  Annual  Report on Form 10-K also
includes  unregistered  trademarks  of the Company and  trademarks  of companies
other than Actel.

Industry Background

     The three  principal  types of  integrated  circuits  used in most  digital
electronic   systems   are   microprocessor,   memory,   and   logic   circuits.
Microprocessors  are used for control and computing  tasks;  memory  devices are
used to store program instructions and data; and logic devices are used to adapt
these  processing  and storage  capabilities  to a specific  application.  Logic
circuits are found in virtually every electronic system.

     The logic design of competing  electronic systems is often a principal area
of  differentiation.  Unlike the  microprocessor  and memory markets,  which are
dominated  by a  relatively  few  standard  designs,  the logic market is highly
fragmented  and  includes,  among  many  other  segments,  low-density  standard
transistor-transistor  logic circuits ("TTLs") and  custom-designed  ASICs. TTLs
are  standard  logic  circuits  that  can  be  purchased  "off  the  shelf"  and
interconnected  on a  printed  circuit  board,  but they  tend to  limit  system
performance  and increase  system size and cost  compared  with logic  functions
integrated at the circuit  (rather than the board) level.  ASICs are  customized
circuits  that offer  electronic  system  manufacturers  the  benefits of higher
levels of circuit integration: improved system performance, reduced system size,
and lower system cost.

     ASICs include  conventional  gate arrays and  programmable  logic circuits.
Conventional  gate arrays are customized to perform desired logical functions at
the time the device is  manufactured.  Since they are "hard  wired" at the wafer
foundry,  conventional  gate arrays are  subject to the time and  expense  risks
associated   with  any  development   cycle  involving  a  foundry.   Typically,
conventional gate arrays are first delivered in production  volumes months after
the successful production of acceptable  prototypes.  In addition,  conventional
gate arrays cannot be modified after they are manufactured,  which subjects them
to the risk of inventory  obsolescence and constrains the system  manufacturer's
ability to change the logic design.  Programmable  logic circuits,  on the other
hand,  are  manufactured  as standard  devices and  customized "in the field" by
electronic system manufacturers using computer-aided  engineering ("CAE") design
and programming systems. Programmable logic circuits are being used by a growing
number of  electronic  system  manufacturers  as a solution to their  increasing
demands  for   differentiation,   rapid  time  to  market,   and   manufacturing
flexibility.  While  conventional  gate array designs are generally more complex
than  programmable  logic circuit designs,  the average capacity (or "gates" per
circuit) of both  conventional  gate arrays and programmable  logic circuits has
increased over time.  This indicates that long-term  growth in sales within each
market segment has increased faster for circuits with higher capacities.

     Programmable logic circuits include programmable logic devices ("PLDs") and
FPGAs. The market for complex PLDs ("CPLDs") and FPGAs has grown rapidly because
they generally offer greater  capacity,  lower total cost per usable logic gate,
and lower power consumption than TTLs and simple PLDs, and faster time to market
and lower development  costs than conventional gate arrays.  For many electronic
system manufacturers, the time-to-market and manufacturing-flexibility  benefits
of CPLDs and FPGAs outweigh their price premium over conventional gate arrays of
comparable  capacity.  This is particularly  true with respect to communications
applications.

     Electronic system  manufacturers  customize  programmable logic circuits to
perform the desired logical  functions by using CAE systems to define a device's
function  and then a device  programmer  to  change  the  state of the  device's
programming elements (such as antifuses or memory cells) through the application
of an electrical signal. Most CPLDs currently are programmed with EPROM or other
"floating  gate"  technologies.  Many FPGAs  currently are programmed  with SRAM
technology.   FPGAs  based  on  antifuse   programming   elements  are  one-time
programmable, meaning they will retain their circuit configurations permanently,
even in the  absence of  electrical  power.  FPGAs and CPLDs  based on EPROM- or
SRAM-controlled programming elements are reprogrammable.

     The  principal  limitation on the wider use of CPLDs and FPGAs has been the
difficulty in developing devices with price and performance  factors approaching
those of  conventional  gate  arrays.  Programming  elements  based on  existing
reprogrammable  architectures  occupy  relatively large amounts of area within a
circuit, which tends to increase the overall size and, in turn, the cost of each
circuit.  In  addition,  the size of  programming  elements  based  on  existing
reprogrammable architectures tends to limit the number of interconnect points in
a circuit,  which, in combination with the relatively high electrical resistance
of such programming elements,  tends to limit to limit design flexibility and/or
circuit performance.

     Before an FPGA can be  programmed  there  are  various  steps  that must be
accomplished  by a  designer  using CAE design  software.  These  steps  include
defining  the  function of the FPGA,  verifying  the design,  and laying out the
circuit.  Traditionally,  logic  functions  have been  defined  using  schematic
capture  tools,  which  essentially  permit the  designer to construct a circuit
diagram on the computer.  As FPGA designers have begun to design higher capacity
circuits, the time required to create schematic diagrams using schematic capture
tools  has  become   prohibitive.   To  address  this  problem,   designers  are
increasingly turning to hardware description  languages ("HDLs"),  also known as
high-level description ("HLD"). VHDL and Verilog are the most common HDLs, which
permit the designer to describe the circuit  functions at an abstract  level and
to verify the performance of logic functions at that level.  The HDL can then be
fed into logic synthesis  software that  automatically  converts the abstract or
high-level  description  to  a  gate-level  representation  equivalent  to  that
produced by schematic  capture tools.  After a gate-level  representation of the
logic  function has been created and  verified,  it must be  translated or "laid
out" onto the generic logic modules of the FPGA. This is achieved by placing the
logic gates and routing their interconnections,  a process referred to as "place
and route." As designers have begun to design higher capacity circuits, the need
for  automatic  (instead  of  manual)  place and  route  capability  has  become
increasingly important.  This transition to the use of HDLs presents a challenge
to the  designer  to learn new design  methods and to use new design  tools.  In
addition,  not all  programmable  logic circuit  architectures  are equally well
suited for use with logic synthesis and place and route tools.

Actel Strategy

     Actel  believes that the demand for higher  capacity  devices will increase
faster than that for programmable devices as a whole.  Accordingly,  the Company
is focusing its attention on the transition to higher  capacity  devices and the
associated high-level design  methodologies.  Actel's strategy is to provide the
best FPGA  solutions by giving logic  designers the capability and confidence to
successfully  move up to higher level designs.  The Company is implementing this
strategy  by  enhancing  the  functionality,  usability,  and  accessibility  of
high-level design tools for its antifuse-based  architecture;  by increasing its
support for high-level design methodologies; and by developing a new, SRAM-based
architecture  that Actel believes will be better suited for use with  high-level
design tools than existing reprogrammable architectures.

Technology

     Actel's FPGAs  currently  are based on two  proprietary  technologies:  the
Actel antifuse and a circuit  architecture that takes advantage of the Company's
antifuse.  The  antifuse is a  two-terminal  switch  that is open  before  being
programmed.  In contrast to a conventional  fuse, the  application of sufficient
voltage to an antifuse causes the switch to close permanently,  allowing current
to pass. Actel is the leading supplier of FPGAs based on antifuses.

     Antifuse

     Actel  believes  that  it  was  first  to  achieve  volume   production  of
antifuse-based  FPGAs.  The  patented  antifuse  structure  used by Actel in its
current  product  families  consists of a "sandwich" of silicon  oxide,  silicon
nitride,  and silicon oxide  ("ONO").  This  structure is similar to that of ONO
capacitors  employed in the volume  manufacture  of many dynamic  random  access
memory (DRAM) circuits.  Actel has continued to develop antifuse  technology and
plans to introduce a family of FPGAs during 1998 based on a new "metal-to-metal"
fuse  structure  that further  enhances the benefits of the antifuse,  which the
Company believes include the following:

          Small Size

          Antifuses are smaller than  alternative  switching  elements  (such as
     those utilizing SRAM and EPROM elements),  so antifuse-based  circuits tend
     to  be  smaller,  and  hence  less  costly,  than  circuits  of  comparable
     performance and capacity  manufactured  under comparable  design rules with
     alternative switching elements.  Similarly, for circuits of comparable size
     and capacity  manufactured  under  comparable  design  rules,  the antifuse
     facilitates the design of circuits with a greater number of switches, which
     tends to enhance flexibility and/or performance.

          Low Resistance

          Antifuses   typically   exhibit  lower   electrical   resistance  than
     alternative  switching elements.  Lower electrical resistance also tends to
     enhance circuit performance.

          High Reliability

          The  Company  has  performed  extensive  reliability  testing  on  its
     antifuses over many years with excellent  results.  The negligible  rate of
     individual  antifuse  failure  permits  antifuses to be used in substantial
     numbers  without  degrading  overall  circuit  reliability,  which  in turn
     permits the small size and low resistance  attributes of the antifuse to be
     fully exploited.

          Nonvolatility

          After an  antifuse-based  FPGA is  programmed,  it retains its circuit
     configuration permanently, even in the absence of electrical power. This is
     not true of SRAM-based FPGAs.  Although the  reprogrammability  of SRAM and
     EPROM  switches  is  desirable  in  some  applications,   nonvolatility  is
     necessary in certain military, aerospace, and communications applications.

     Circuit Architecture

     The Company  believes  that the  principal  advantages  of its  proprietary
circuit architecture include the following:

          Synthesisizability

          All of Actel's FPGAs are  "synthesis  friendly" by virtue of their use
     of many,  relatively  simple logic  building  blocks  (referred to as "fine
     granularity") made possible by the antifuse. The Company believes that this
     characteristic will become  increasingly  important to designers as circuit
     capacity increases.

          Few Programming Elements in Interconnect Path

          Actel's circuit  architecture  usually provides for the minimum number
     of antifuses in an  interconnect  path (two),  and never  permits more than
     four antifuses in any interconnect  path. In general,  the fewer the number
     of  switches  in an  interconnect  path,  the faster the  connection.  Many
     competing FPGAs include interconnect paths with considerably more than four
     programming  elements,  which  increase  resistance  and  therefore  impede
     circuit performance.

          Routability

          The plentiful number of antifuses and the patented  segmented  routing
     tracks of different  lengths in Actel's  products  provide numerous routing
     alternatives,  which generally facilitates efficient results with automatic
     place  and  route  software  even  when a  high  percentage  of the  FPGA's
     potential  gate capacity is used.  Actel  believes that these features make
     its circuits easier to design with than most competing FPGAs.

          Flexibility and Utilization

          A  key  competitive   factor  in  the  programmable  logic  market  is
     utilization,  or the  extent  to  which  a  particular  design  can use the
     potential  number of logic resources within a particular chip. A measure of
     logic  resources  frequently  used in the  programmable  logic  industry is
     ASIC-gate  equivalents.  Since this gate  counting  measure is  interpreted
     differently by the various  suppliers and end-users of programmable  logic,
     however,  it is not a  reliable  measure.  A more  accurate  assessment  of
     utilization  is the  number  of logic  modules  within  the  chip  that are
     actually  accessible to the customer's real design. In the case of existing
     SRAM-based FPGAs and EPROM-based  CPLDs,  logic module utilization can vary
     substantially  from design to design, so that a "400 logic module" chip may
     in  practice  yield only a fraction  of that  number as true  usable  logic
     resources.  By contrast,  Actel's circuit architecture permits its products
     to have a more  predictable  capacity  over a broad range of  applications.
     This enables  Actel's  customers to select with a relatively high degree of
     confidence the product that is most  economical for a desired  application.
     It is not  uncommon  for a design  implemented  within an Actel chip to use
     100% of the  potentially  available  logic  modules  and still be fully and
     automatically placed and routed. Users of existing SRAM-based FPGAs, on the
     other  hand,  often  restrict  their  designs to 60% or less of the claimed
     logic resources in order to give their "automatic" place and route tools an
     improved chance of successful completion.

Products

     Actel's  product  line  currently  consists  of seven  families  of  FPGAs,
Designer  Series  Development  System and Core HDL  software,  Silicon  Explorer
debugging and diagnostic tools, and Activator device  programmers.  In 1997, the
first members of the MX family of FPGAs were shipped for revenue and the Company
adopted  a  number  of  new  software  strategies  intended  to  broaden  market
acceptance of high-level design methodologies by mainstream FPGA designers.

     FPGAs

     Currently,  all seven of the Company's FPGA families are in production.  To
meet the diverse customer  requirements in the broad high-capacity  programmable
logic market,  each member of a family (except  RadHard) is offered in a variety
of speed grades, package types, reliability screenings,  and ambient temperature
tolerances.  The five members of the ACT 1 and ACT 2 families,  for example, can
be  ordered  in  more  than  100  speed,  packaging,  screening,  and  tolerance
variations.

          ACT 1

          The ACT 1 family consists of two products: the 1,200-gate A1010, which
     was first shipped for revenue in 1988; and the 2,000-gate A1020,  which was
     first shipped for revenue in 1989. The A1020 is capable of integrating  the
     equivalent  of 60 TTLs into a single  package.  This family of circuits was
     introduced  at 2.0 micron and currently is  manufactured  under 1.0 and 0.9
     micron  design rules.  The Company  offers  3.3-volt  versions of its ACT 1
     products.

          ACT 2

          The ACT 2 family consists of three products:  the 4,000-gate A1240 and
     the 8,000-gate A1280, which were first shipped for revenue in 1991; and the
     2,500-gate A1225, which was first shipped for revenue in 1992. The A1280 is
     capable of integrating  the  equivalent of 240 TTLs into a single  package.
     This family of  circuits  was  introduced  at 1.2 micron and  currently  is
     manufactured under 1.0 micron design rules.

          ACT 3

          The ACT 3 family consists of five products:  the 2,500-gate  A1425 and
     the 6,000-gate A1460, which were first shipped for revenue in 1993; and the
     1,500-gate A1415, the 4,000-gate A1440, and the 10,000-gate  A14100,  which
     were first  shipped for revenue in 1994.  The ACT 3 family was designed for
     applications  requiring  high speed and a high number of inputs and outputs
     ("I/Os").  The five members of the ACT 3 family can be ordered in more than
     70 speed,  packaging,  screening,  and  tolerance  variations.  The Company
     offers 3.3-volt and PCI-compliant versions of its ACT 3 products. The ACT 3
     family was introduced at 0.8 micron and currently is manufactured under 0.6
     micron design rules.

          1200XL

          The  1200XL  family,  which was first  shipped  for  revenue  in 1995,
     consists  of three  members  ranging  from 2,500 to 8,000 gates that can be
     ordered  in  more  than  50  speed,  packaging,  screening,  and  tolerance
     variations.  Taking advantage of 0.6 micron design rules and redesigned I/O
     modules and clock  distribution  networks,  1200XL  products  offer  system
     performance significantly in excess of that offered by pin-compatible ACT 2
     devices.  In 1997,  Actel began  offering  all three  members of its 1200XL
     family in 84-pin Plastic Leaded Chip Carriers ("PL84"). Designers using the
     new  packages  will be able to migrate to higher  density  devices  without
     changing packages. In 1997, the Company also expanded its 3.3-volt offering
     to include all members of the 1200XL family.

          3200DX

          The 3200DX family consists of the 6,500-gate A3265DX,  which was first
     shipped for revenue in 1995; the  14,000-gate  A32140DX and the 20,000-gate
     A32200DX, which were first shipped for revenue in 1996; and the 10,000-gate
     A32100 and the 30,000-gate A32300,  which were first shipped for revenue in
     1997.   The   3200DX   family   permits    designers   to   integrate   the
     register-intensive  datapath  functions  of FPGAs,  the  control and decode
     modules  commonly  implemented  in  CPLDs,  and  the  fast  dual-port  SRAM
     typically  used  for  high-speed  buffering.  Supported  by  the  Company's
     extensive  selection  of  automated  design  tools,  the  3200DX  family is
     optimized  for  synthesis  design   methodologies   to  yield   predictable
     performance for system logic integration. To further assist designers, most
     members of the family offer JTAG boundary scan logic, which permits testing
     of the design during  manufacture.  In 1997, Actel began offering  A3265DX,
     A32100DX,  and A32140DX in PL84  packages,  which will enable  designers to
     migrate  easily from  smaller  PL84  devices.  In 1997,  the  Company  also
     expanded its 3.3-volt offering to include all members of the 3200DX family.
     The 3200DX family is based on 0.6 micron design rules.

          MX

          In 1997, the Company  shipped for revenue the first two devices in its
     new MX family of FPGAs: the 4,000-gate A40MX04 and the 16,000-gate A42MX16.
     The third member of the family,  the 9,000-gate  A40MX09,  was announced as
     immediately available during first week of 1998. The MX family includes the
     best features from Actel's earlier ACT 1, ACT2, 1200XL, and 3200DX families
     and is based on 0.45 micron design  rules,  which will permit the MX family
     to work in pure 5-volt,  pure 3.3-volt,  and mixed 5- and 3.3-volt systems.
     It is anticipated that the larger MX devices will be PCI compliant.  At the
     time of  introduction,  the MX  devices  were  believed  to be the  world's
     fastest  FPGAs.  Like ASICs and all previous  Actel  FPGAs,  MX devices are
     nonvolatile  and do not  require  any  external  configuration  devices  or
     circuitry. The MX family was introduced with volume production pricing that
     the  Company   believes,   in   combination   with  its   performance   and
     functionality, should make it attractive as a single-chip ASIC alternative.
     Over  time,  the MX family  should  replace  all of  Actel's  earlier  FPGA
     families in new commercial designs.

          RH

          The RadHard family currently consists of the 8,000-gate RH1280,  which
     was first shipped for revenue in 1996, and the 2,000-gate RH1020, which was
     first shipped in 1997. Actel and Lockheed-Martin FSC are jointly developing
     the RadHard family to meet the demands of applications requiring guaranteed
     levels  of  performance  and  radiation  immunity,  including  the  growing
     commercial   satellite   market.   The   RadHard   family  is  based  on  a
     high-reliability, radiation-hardened 0.8 micron process.

     Software

     A key element of the  Company's  strategy is to support  users'  electronic
design  automation  ("EDA")  tools of choice  by  establishing  and  maintaining
relationships  with  leading  synthesis  software  vendors  for the  purpose  of
permitting  such  tools  to be used as a  "front  end"  to  Actel's  proprietary
Designer  Series  Development  System.  Rather than  developing  this capability
alone, the Company has established the Actel Industry Alliance, which Actel uses
to  establish  relationships  with EDA  vendors  for the  purpose of  developing
interfaces  between such  vendors' EDA tools and Actel's  proprietary  software.
Under the Alliance  program,  Actel provides  members with,  among other things,
access to its  proprietary  software  specifications,  early  access to software
revisions,  verification services, and participation in joint marketing efforts.
The Alliance currently has more than 20 members, including all major EDA vendors
supporting  high-level  design for both VHDL and Verilog.  The Company  provides
comprehensive  HDL solutions for the EDA environments of Cadence Design Systems,
Exemplar Logic, Mentor Graphics, Synopsys, Synplicity, and Viewlogic.

          Designer Series Development System

          In  1997,  the  Company  introduced  two  significant  updates  to its
     Designer Series  software.  The first of these releases,  known as Designer
     Series  3.1.1,  provided  support  for  many of the new  silicon  products,
     including various new 3200DX family members and the RH1280. Designer Series
     3.1.1 runs on both PC and UNIX  platforms.  On PCs,  Designer  Series 3.1.1
     runs on Windows 3.1,  Windows for Workgroups,  Windows NT 4.01, and Windows
     95 operating systems. On UNIX platforms,  Designer Series 3.1.1 runs on Sun
     SparcStation  workstations  running SunOS or Solaris  operating systems and
     Hewlett Packard HP 9000 workstations running HP-UX operating systems.

          In July 1997,  Actel  announced a new approach to its Designer  Series
     software products, offering a series of integrated,  high-level design FPGA
     development  tools suites and cutting  prices in all packages.  The Company
     believes the aggressive pricing strategy will prove attractive to schematic
     designers  moving  up to  high  level  design  methodologies  as well as to
     experienced synthesis designers.  In total, the new Designer Series product
     line  consists  of  eight  separate  packages.  The  new  suites  integrate
     high-level  design  tools  from  Viewlogic,  including  ViewSynthesis  FPGA
     Synthesis, SpeedWave VHDL Simulator, and WorkView Office, and Synopsys with
     Actel Designer Series 3.1.1. The product line also includes  Designer Lite,
     the first no-cost FPGA development software downloadable from the worldwide
     web.  Designer  Lite is a complete  package of design tools for the PC with
     device libraries  initially up to 8,000 gates. In October 1997, an enhanced
     version of  Designer  Series  3.1.1 was  released  to support  the  initial
     members of the new MX family of FPGAs. The first family member was rated as
     a 16,000-gate device and Designer Lite was extended to include this and the
     smaller  devices  in the MX  family.  Between  July 1997 and the end of the
     year,  more than 10,000  copies of Designer Lite were  downloaded,  thereby
     greatly  expanding the number of potential  designers  for Actel's  silicon
     products.

          CoreHDL Intellectual Property

          As  integrated  circuits  move to ever higher  levels of capacity  and
     integration, the use of intellectual property ("IP"), in the form of cores,
     becomes more  important.  In offering  CoreHDL IP, the Company is targeting
     high-density  FPGA  designers who are  interested  in combining  customized
     logic   with   predefined   functions   optimized   for  high   performance
     applications.   By  using  predefined  cores,  designers  save  engineering
     resources for the  value-added  portions of their designs while  shortening
     the design cycle. In addition,  the portable nature of cores enables design
     reuse across multiple product versions.

          Actel's  CoreHDL IP  portfolio  includes  CorePCI,  telecommunications
     cores,  and industrial  cores.  In 1997,  the Company  enhanced its CorePCI
     models,  which are Peripheral Component Interface (PCI) compliant blocks or
     "cores" that can be used to save  development  time by being "dropped into"
     designs for ACT 3 PCI devices.  Actel  offers  CorePCI  models,  which were
     developed  internally,  in both VHDL and  Verilog-HDL.  The remaining cores
     were developed by Inicore AG, a Swiss IP provider.  The  telecommunications
     cores include an ISDN G704-EI Framer,  an Asynchronous  Transfer Mode (ATM)
     UTOPIA receiver  interface,  and an ATM UTOPIA transmitter  interface.  The
     cores  targeted  to  industrial  control  applications  include a Universal
     Asynchronous  Receiver/Transmitter  (UART), a Controller Area Network (CAN)
     Interface,  and a Serial Control Bus Interface.  The Company has terminated
     its agreement with Inicore and currently does not have a contractual  right
     of access to cores developed by any third party.

     Silicon Explorer

     In April 1997,  Actel  introduced a powerful  debugging and diagnostic tool
known as the  Silicon  Explorer.  This tool can  significantly  reduce  the FPGA
design  verification time by enabling the user to monitor the internal operation
of a programmed FPGA as it performs its functions at speed within a real system.
The  Silicon  Explorer  tool suite  includes  ProbePilot,  a  high-speed  signal
acquisition  hardware  interface  between the Actel FPGA, the board on which the
FPGA resides,  and the  designer's  desktop  computer;  Explore,  an easy-to-use
point-and-click  software  tool that is integrated  with the Company's  Designer
Series  development  software;  and Analyze,  a PC-hosted  logic  analyzer  that
graphically  displays the waveforms accessed through ProbePilot.  The ProbePilot
signal  acquisition  control  takes  advantage  of  the  Company's   ActionProbe
circuitry,  a patented  architectural feature included in all Actel devices that
provides  100%  observability  of internal  nodes from selected  external  pins.
ProbePilot supports 18 separate probing channels and features high-speed 100 MHz
asynchronous or 66 MHz synchronous sampling rates.  ProbePilot connects directly
to any  desktop or laptop  computer or  workstation  through the series port and
operates  off the test  board's 5.0 volt or 3.3 volt power  supply.  The Explore
windows-based  software  drives  the entire  diagnostic  and debug  process  and
resides on the designer's PC or workstation as part of Actel's  Designer  Series
FPGA  development  tools.  The  Analyze  software  tool  essentially  turns  the
designer's PC or workstation  into a  full-featured  18 channel logic  analyzer,
eliminating the need for a costly stand-alone logic analyzer.

     Activator

     The Company's  Activator  device  programmers  are used to program  Actel's
FPGAs.  The  Activator  accepts data from  Designer  Series  Development  System
software,  converts the data to the proper protocol, and applies the appropriate
electrical  signals to the device so as to imprint the user's  circuit design on
the device  permanently.  There are currently two Activator device  programmers,
Activator  2  and  Activator   2S,  both  of  which  execute  all   programming,
verification, and debugging functions.  Customized programming adapters for each
device type permit  different  packages to be programmed by switching  adapters.
Activator 2 programs up to four FPGAs at a time;  Activator 2S programs one FPGA
at a time.

     Actel also supports  programmers  that are  manufactured  by third parties,
including Data I/O and BP Microsystems Inc.

Market and Applications

     FPGAs  can be used in a broad  range  of  applications  across  nearly  all
electronic  system market  segments.  Most customers use the Company's  FPGAs in
low- to  medium-volumes  in the final  production form of their  products.  Some
high-volume  electronic system  manufacturers use Actel's FPGAs as a prototyping
vehicle and convert  production to lower-cost  conventional  gate arrays,  while
others with  time-to-market  constraints  use the Company's FPGAs in the initial
production and then convert to conventional  gate arrays. As product life cycles
continue  to shorten and  manufacturing  efficiencies  increase  in FPGAs,  some
high-volume  electronic  system  manufacturers  are  electing to retain FPGAs in
volume production  because  conversion to conventional gate arrays may not yield
sufficiently  attractive savings before the electronic system reaches the end of
its life. With the introduction of the MX family,  Actel believes that its FPGAs
will increasingly be used in high-volume production.

     Communications

     The high capacity,  high  performance,  and low power  consumption of FPGAs
make them well suited for use in communications equipment.  Increasingly complex
equipment  must  frequently be designed to fit in the space occupied by previous
product  generations.  The rapidly changing  communications  environment rewards
short development times and early market entry.

     Representative Actel customers in the communications market include:  3Com,
ADC Kentrox, Advanced Fibre Communications,  Alcatel, Ascend Communications, Bay
Networks, Cabletron, Cascade, Cisco Systems, Chipcom, DSC Communications, Hughes
Network Systems, Lucent Technologies, Motorola, and Nortel.

     Computer Systems and Peripherals

     The computer systems markets are intensely  competitive,  placing a premium
on early market entry for new  products.  FPGAs  decrease the time to market and
facilitate early completion of production models so that development of hardware
and software can occur in parallel.

     Representative   Actel  customers  in  the  computer  market  include:  AST
Computer, Hewlett-Packard, IBM, Olivetti, Sky Computer, and Tandem Computer.

     Industrial Control Equipment

     Industrial control and  instrumentation  applications often require complex
electronic functions tailored to specific needs. FPGAs offer programmability and
high  capacity,  making  them  attractive  to  this  segment  of the  electronic
equipment market.

     Representative  Actel  customers in the industrial  market  include:  Allen
Bradley/Rockwell,  Eastman Kodak, General Electric, Hewlett-Packard,  Marquette,
and Siemens.

     Military and Aerospace

     Rigorous quality and reliability standards,  stringent volume requirements,
and the need  for  design  security  are  characteristics  of the  military  and
aerospace  market.  The  Company's  FPGAs have high  quality,  reliability,  and
capacity, and are virtually impossible to reverse engineer, making them suitable
for many military and aerospace applications.  Actel's FPGAs are especially well
suited  for  space  applications,  due to the high  radiation  tolerance  of the
Company's antifuse,  and for many aircraft and missile flight applications,  due
to the high density and performance of Actel's FPGAs.

     Representative  Actel  customers in the military  market  include:  Alliant
Technology,   Boeing,  E-Systems,   Harris,  Honeywell,   Hughes  Aircraft,  Jet
Propulsion  Labs  (JPL),  Lockheed-Martin,  Loral,  National  Aeronautics  Space
Administration (NASA), Northrup, Olin Corporation,  Raytheon, SCI Systems, Texas
Instruments Incorporated ("TI"), and TRW.

Sales and Distribution

     The Company maintains a worldwide,  multi-tiered  selling organization that
includes a direct sales force, independent manufacturers'  representatives,  and
electronics distributors.

     Actel's   domestic  sales  force   currently   consists  of  77  sales  and
administrative personnel and field application engineers ("FAEs") operating from
15 sales offices  located in major  metropolitan  areas.  Direct sales personnel
call on target  accounts and support  direct  original  equipment  manufacturers
("OEMs").  Besides  overseeing  the  activities of direct sales  personnel,  the
Company's  sales  managers  also  oversee the  activities  of 21  manufacturers'
representative  firms that operate from  approximately 43 office locations.  The
manufacturers'  representatives  concentrate  on  selling  to  major  industrial
companies  in  North  America.  To  service  smaller,  geographically  dispersed
accounts   in   North   America,   Actel   has   distributor   agreements   with
Pioneer-Standard Electronics, Inc. ("Pioneer"), Arrow Electronics, Inc. and Zeus
Electronics  (collectively,  "Arrow"), and Wyle Electronics ("Wyle").  Arrow has
approximately 50 branch offices in North America;  Pioneer and Wyle have a total
of approximately 60 branch locations in North America.

     The  Company   generates  a  significant   portion  of  its  revenues  from
international  sales.  Sales to  customers  outside the United  States for 1997,
1996, and 1995 accounted for 31%, 33%, and 38% of net revenues, respectively. Of
these export sales,  the largest  portion was derived from  European  customers.
Export sales have declined as a percentage of net revenues  principally  because
the Company's  radiation-hardened  (RH) product family,  which was introduced in
1996, is sold almost exclusively to customers within the United States.  Actel's
European sales  organization  currently  consists of 23 distributors  (including
Arrow  and  Memec,  which  have  16  subsidiary   companies  in  Europe)  having
approximately  45 branch  offices.  The  activities  of these  distributors  are
supervised  from  sales  management  offices  in  Basingstoke  (England),  Paris
(France),  Milano (Italy), and Munich (Germany),  where a total of 17 people are
employed.

     Matsushita,  which is a  foundry  and  strategic  partner  of the  Company,
markets  Actel's  products in Japan under the Company's  brand name. The Company
has two additional  distributors in Japan:  Innotech Corporation and Teksel Ltd.
Actel also has distributors in Australia, China, Egypt, Hong Kong, India, Korea,
Malaysia,  Singapore,  South Africa,  and Taiwan. In 1997, the Company appointed
I&C  Microsystems,  Co.,  Ltd. as its new  distribution  partner for Korea.  The
activities of these distributors are supervised from sales management offices in
Japan and  Korea.  Actel  officially  opened  its  Korean  office  in 1997,  and
currently plans to open an office in Hong Kong in 1998.

     After the  Company's  sales  representatives  and  distributors  evaluate a
customer's  logic design  requirements  and determine if there is an application
suitable for Actel's FPGAs,  the next step typically is a visit to the qualified
customer  by a  regional  sales  manager  or the FAE  from  the  Company  or its
distributor.  The  sales  manager  or FAE may  then  determine  that  additional
analysis is required by engineers based at Actel's  headquarters.  The Company's
sales cycle for the initial  sale of a design  system is  generally  lengthy and
requires the continued  participation  of  salespersons,  FAEs,  engineers,  and
management.

     In 1997, more than half of Actel's sales in the United States and virtually
all of  the  Company's  sales  outside  the  United  States  were  made  through
distributors. As is common in the semiconductor industry, Actel generally grants
price protection to distributors.  Under this policy, distributors are granted a
credit upon a price reduction for the difference between their original purchase
price for  products  in  inventory  and the  reduced  price.  From time to time,
distributors are also granted credit on an individual basis for Company-approved
price reductions on specific transactions to meet competition.  The Company also
generally  grants  distributors  limited  rights  to return  products.  To date,
product  returns  under this  policy  have not been  material.  Actel  maintains
reserves  against  which these  credits and returns are charged.  Because of its
price protection and return policies,  the Company  generally does not recognize
revenue on products  sold to  distributors  until the products are resold to end
customers.

Backlog

     At December 31, 1997,  Actel's  backlog was  approximately  $28.0  million,
compared  with  approximately  $27.0  million at December 31, 1996.  The Company
includes in its backlog all OEM orders scheduled for delivery over the next nine
months and all  distributor  orders  scheduled  for  delivery  over the next six
months.  Actel  produces  standard  products that may be shipped from  inventory
within a short time after receipt of an order. The Company's business,  and to a
large extent that of the entire  semiconductor  industry,  is  characterized  by
short-term order and shipment schedules,  rather than volume purchase contracts.
In  accordance  with  industry  practice,  Actel's  backlog may be  cancelled or
rescheduled by the customer on short notice without  significant  penalty.  As a
result,  the  Company's  backlog  may not be  indicative  of  actual  sales  and
therefore should not be used as a measure of future revenue.

Customer Service and Support

     Actel  believes that superior  customer  service and technical  support are
essential for success in the FPGA market.  The Company  facilitates  service and
support  through  service team meetings that address  particular  aspects of the
overall service  strategy and support.  The most  significant  areas of customer
service and technical support are regularly  measured.  Actel's customer service
organization  emphasizes  prompt,  accurate responses to questions about product
delivery and order status.

     The  Company's  FAEs provide  technical  support to customers in the United
States,  Japan,  Korea and Europe.  This network of experts is augmented by FAEs
working for Actel's sales representatives and distributors throughout the world.
Customers in any stage of design can also obtain  assistance  from the Company's
technical support hotline.  In addition,  Actel offers technical seminars on its
products and comprehensive training classes on its software.

     In 1997, Actel moved to better address the design concerns of its customers
by  establishing  Actel  Design  Services,  an  international  network of design
centers. With offices now in Basingstoke,  Boston, Chicago, and Sunnyvale, Actel
has an  enhanced  capability  to  support  the  increasing  technical  needs  of
customers developing with synthesis tools.

     In November 1997,  Actel further enhanced its worldwide  technical  support
capabilities  with the  introduction of a web-based  technical  support database
called  "Guru."  Actel  users can access  Guru from their  familiar  web browser
through a series of "push  button"  forms and key words.  The Guru  system  will
return relevant information to the questioner in a matter of seconds.

     The Company generally warrants its products against defects in material and
workmanship for one year. Actel also warrants that its automatic place and route
software will achieve gate  utilization  at not less than the rates  advertised.
The Company has not experienced significant warranty returns to date.

Manufacturing and Strategic Relationships

     Actel's current strategy is to utilize  third-party  manufacturers  for its
wafer  requirements,  which  permits the Company to allocate  its  resources  to
product  design,  development,  and marketing.  Wafers used in Actel's FPGAs are
manufactured by Chartered  Semiconductor in Singapore, by Lockheed-Martin FSC in
the United States, by Matsushita in Japan, and by Winbond in Taiwan. The Company
historically  purchased wafers from Matsushita and TI. Chartered  Semiconductor,
Lockheed-Martin  FSC, and Winbond were added in 1994.  During 1997, Actel phased
out wafer purchases from TI in favor of its other suppliers.  The active foundry
relationships  for  Actel's  production  FPGAs  are  currently  manufactured  by
Chartered  Semiconductor  using 0.6 0.45 micron design rules; by Lockheed-Martin
FSC using 0.8 micron design rules; by Matsushita  using 0.8, 0.9, and 1.0 micron
design   rules;   and  by  Winbond  using  0.6  and  0.8  micron  design  rules.
Pre-production  wafers  have been  received  from  Chartered  Semiconductor  for
products designed using 0.35 micron design rules.

     Wafers  purchased by the Company from its suppliers are assembled,  tested,
marked,  and  inspected by Actel and/or a  subcontractor  of the Company  before
shipment to customers.  Actel assembles most of its plastic commercial  products
in Hong Kong and Korea.  Ceramic package assembly,  which is generally  required
for military  applications,  currently is performed at one or more subcontractor
manufacturing facilities, some of which are in the United States.

     In 1997,  the Company and  Lockheed-Martin  FSC entered into an Amended and
Restated M2M Joint Development and Marketing Agreement.  The Agreement calls for
the parties to establish production  capability at Lockheed-Martin FSC for space
quality,  radiation-hardened  versions of Actel's first metal-to-metal  antifuse
FPGAs (see  "Research  and  Development  -- SX  Family").  After the  production
capability is established,  Lockheed-Martin FSC will manufacture,  assemble, and
test the radiation-hardened FPGAs, and the Company will market and sell them.

     In  1997,  Actel  announced  the  availability  of two new  sockets  tooled
specifically  for the  Company  by  Yamaichi  Electronics  of Japan,  one of the
leading suppliers of prototype and production sockets.  Sockets permit designers
to replace a chip  without  damaging the board,  which  reduces some of the risk
commonly  associated with using an antifuse FPGA in prototype board design.  The
two new sockets  increase the total number of Actel sockets  offered by Yamaichi
to nine.  The  complete  line of sockets  accommodates  all Actel FPGAs in TQFP,
PQFP, RQFP, and VQFP packages.

Research and Development

     In 1997,  1996, and 1995,  the Company spent $26.5 million,  $23.9 million,
and $20.6 million,  respectively, on research and development, which represented
approximately 17%, 16%, and 19% of net revenues, respectively, for such periods.
Actel's  research and  development  expenditures  are  currently  divided  among
circuit design, software development,  and process technology activities. In the
areas of circuit  design and process  technology,  the  Company's  research  and
development activities include continuing efforts to reduce the cost and improve
the  performance of current  products,  principally by reducing the design rules
under which such products are manufactured,  and to develop new families of FPGA
products based on existing or emerging  technologies.  Actel's software research
and development activities are dedicated to providing customers with access to a
wide  variety of CAE tools and HDL cores in a  complete  and  automated  desktop
design environment on popular personal computer and workstation platforms,  with
the  objective  of giving logic  designers  the  capability  and  confidence  to
successfully move up to higher level designs.

     The research and development  projects that the Company publicly  discussed
in 1997 included the following:

     SX Family

     In the fourth calendar  quarter of 1997,  Actel won a number of significant
design wins with  pre-production  silicon  and  software of its new SX family of
FPGAs.  It is  currently  anticipated  that  the  SX  family  will  be  formally
introduced in April 1998.  The SX family will be  significantly  faster than the
recently-launched  MX family,  which was believed to be the world's fastest FPGA
family at its  introduction.  This high level of performance in the SX family is
achieved  through a combination  of  architectural  features and a new, very low
impedance  "metal  to  metal"  antifuse  structure.  This  new  antifuse  is the
culmination  of more than six years of research and  development  activities  to
produce a reliable, manufacturable, high-performance metal to metal antifuse.

     ES Architecture and ES Reprogrammable Products

     In 1996,  Actel  announced its intention to enter the  reprogrammable  FPGA
market. The Company's first  reprogrammable  FPGA offering will be an SRAM-based
"ES" product family utilizing Actel's new ES reprogrammable architecture.

     The ES  architecture  combines a new,  fine-grained  cell  structure with a
routing-centric  architecture.  The expected result is logic cells that are more
readily synthesized and more efficient than current programmable  architectures.
The key to the  architectural  efficiencies  is a technology  in which  separate
transistors  are used to  implement  logic  and to drive the  interconnects.  By
separating these  functions,  Actel believes that more efficient die utilization
is achievable,  resulting in lower-cost designs.  In addition,  the interconnect
drivers are tailored to routing  length,  which should provide high  performance
even for  cross-chip  routing.  The ES  architecture  also makes  greater use of
hierarchy than current programmable  architectures.  A constant, maximum routing
delay is  associated  with each level of  hierarchy,  which  should  provide the
device with fanout independent delays. This means that, regardless of the number
of logic elements being driven, the delay should always be constant,  making the
chip's  performance  predictable.  Many  aspects  of  the  ES  architecture  are
switch-technology independent, making it possible that future variants of the ES
architecture will employ antifuse, flash, or other basic programming elements.

     The Company has experienced significant delays in matching the capabilities
of its software and the  resources of its silicon.  Actel  currently is making a
set of changes to both the silicon and the software.  While the result should be
a product as good as or better than the one originally planned, the Company does
not  believe  the product  will be  available  until at least the second half of
1998.  With the  additional  time required for ES  development,  the Company now
anticipates  that the  initial  production  ES devices  will use a 0.25  micron,
five-layer metal process.

Competition

     The FPGA  market  is  highly  competitive,  and the  Company  expects  that
competition will continue to increase as the market grows.  Actel's  competitors
include suppliers of TTLs and ASICs,  including  conventional gate arrays, PLDs,
and  FPGAs.  Of these,  the  Company  competes  principally  with  suppliers  of
conventional gate arrays, CPLDs, and FPGAs.

     The primary advantages of conventional gate arrays are high capacity,  high
speed, and low production cost in high volume.  Actel competes with conventional
gate array suppliers by offering lower design costs,  shorter design cycles, and
reduced inventory risks.  However,  some customers elect to design and prototype
with the  Company's  products  and then convert to  conventional  gate arrays to
achieve  lower  costs  for  volume  production.  For this  reason,  Actel  faces
competition  from  companies  that  specialize  in  converting  CPLDs and FPGAs,
including the Company's products, into conventional gate arrays.

     The Company  also  competes  with  suppliers  of CPLDs.  Suppliers of these
devices include Altera  Corporation  ("Altera"),  Advanced Micro Devices' Vantis
subsidiary,  and Lattice Semiconductor.  The circuit architecture of CPLDs gives
them a performance advantage in certain lower capacity  applications,  but Actel
believes  that its  products  are better  suited for  higher  capacity  designs.
Altera,  however,  has a larger  installed base of development  systems than the
Company.  In  addition,  many  newer  CPLDs are  reprogrammable,  which  permits
customers to reuse a circuit  multiple times during the design  process  (unlike
antifuse-based FPGAs, which permanently retain the programmed configuration). No
assurance  can be given that Actel will be able to  overcome  these  competitive
disadvantages.

     The Company competes most directly with established FPGA suppliers, such as
Xilinx,  Inc.  ("Xilinx") and Lucent  Technologies  (which is a licensed  second
source  of  some  Xilinx  products).  While  Actel  believes  its  products  and
technology  are  superior  to those of  Xilinx  in many  applications  requiring
greater  speed,  lower cost,  or  nonvolatility,  Xilinx came to market with its
FPGAs approximately three years before the Company,  has a larger installed base
of development  systems,  and its  SRAM-based  products are  reprogrammable.  No
assurance  can be given that Actel will be able to  overcome  these  competitive
disadvantages.

     Several  companies  have  either  already  marketed  antifuse-based  FPGAs,
including QuickLogic Corporation ("QuickLogic"), or announced their intention to
do so. See "Legal." On March 31, 1995, the Company  completed its acquisition of
the antifuse FPGA business of TI, which was the only  second-source  supplier of
the Company's products.  Xilinx, which is a licensee of certain of the Company's
patents,  introduced  antifuse-based  FPGAs in 1995 and  terminated its antifuse
FPGA business in 1996. Cypress Semiconductor  Corporation,  which was a licensed
second  source of  QuickLogic,  sold its antifuse FPGA business to QuickLogic in
the first quarter of 1997.

     Actel expects  significant  additional  competition from major domestic and
international semiconductor suppliers, such as Motorola, which has declared that
it is a participant  in the FPGA market.  All such  companies are larger,  offer
broader  product  lines,  and have  substantially  greater  financial  and other
resources than the Company,  including the  capability to manufacture  their own
wafers.   Additional   competition  could  adversely  affect  Actel's  business,
financial condition, or results of operations.

     The Company may also face  competition  from  suppliers  of logic  products
based on new or  emerging  technologies.  For  example,  there are  other  known
techniques  for  manufacturing  programmable  switch  elements  that might offer
certain  advantages  over Actel's  antifuse  technologies.  The Company seeks to
monitor developments in existing and emerging technologies.  No assurance can be
given that Actel will be able to compete  successfully  with suppliers  offering
products based on new or emerging technologies.

Patents and Licenses

     As of December  31,  1997,  the Company had 117 United  States  patents and
applications  pending for an additional 35 United States patents.  Actel has ten
European  patent  and has  applications  pending  for an  additional  42 patents
outside the United  States.  The Company's  patents  cover,  among other things,
Actel's basic circuit architecture,  antifuse structure, and programming method.
The Company expects to continue filing patent  applications  when appropriate to
protect its proprietary  technologies.  Actel believes that patents,  along with
such factors as innovation,  technological expertise, and experienced personnel,
will become increasingly important.

     The  Company  attempts  to protect its  circuit  designs,  software,  trade
secrets,  and  other  proprietary   information  through  patent  and  copyright
protection,  agreements  with customers and suppliers,  proprietary  information
agreements  with  employees,  and other security  measures.  No assurance can be
given that the steps taken by Actel will be adequate to protect its  proprietary
rights.

     In 1995, Actel and BTR, Inc. entered into a License  Agreement  pursuant to
which BTR licensed its proprietary technology to the Company for development and
use in FPGAs and certain  multichip  modules.  As partial  consideration for the
grant of the  license,  the  Company  is  paying to BTR  non-refundable  advance
royalties.  Actel has also employed the  principals of BTR to assist the Company
in its development and implementation of the licensed technology.

     As is typical in the semiconductor  industry, the Company has been notified
of claims that it may be infringing  patents owned by others. If it is necessary
or  appropriate,  Actel may seek to obtain  licenses  under  patents  that it is
alleged to infringe.  Although the Company is unable to estimate with any degree
of  confidence  the cost of such  licenses,  no assurance can be given that they
would not, individually or in the aggregate, have a materially adverse effect on
Actel's financial condition or results of operations.  In addition, there can be
no assurance  that  licenses  will be available or that the terms of any offered
license  will be  acceptable  to the  Company.  Failure to obtain a license  for
technology used by Actel could result in litigation.  In the event of an adverse
result  in any  litigation,  the  Company  may be  required  to pay  substantial
damages;  discontinue the use of infringing  processes;  cease the  manufacture,
use, and sale of infringing  products;  and/or expend  significant  resources to
develop non-infringing technology. All litigation,  whether or not determined in
favor of Actel,  can result in  significant  expense  and divert the  efforts of
technical and management personnel from the Company's  operations.  In addition,
the Company has agreed to defend its customers  from and against any claims that
Actel  products  infringe the patent or other  intellectual  rights of any third
party, and to indemnify its customers up to the dollar amount of their purchases
of any Actel  products  found to  infringe.  Any  successful  third  party claim
against the Company or its customers for patent or other  intellectual  property
infringement may have a materially adverse effect on Actel's business, financial
condition, or results of operations.

Employees

     At the end of 1997, the Company had 380 full-time employees,  including 117
in marketing,  sales, and customer support; 137 in research and development;  94
in  operations;  and 32 in  administration  and finance.  None of the  Company's
employees  is  represented  by a labor  union  nor does  Actel  have  employment
agreements  with any of its employees.  The Company has not experienced any work
stoppages, and believes that its employee relations are satisfactory.

Risk Factors

     Shareholders  and  prospective   shareholders  of  Actel  should  carefully
consider,  along with the other  information in this Annual Report on Form 10-K,
the following risk factors:

     Acts of God

     The  performance  of  Actel  and  each  of  its  suppliers,   distributors,
subcontractors,  and  agents is  subject  to events or  conditions  beyond  such
party's control, including labor disputes, acts of public enemies or terrorists,
war or other military conflicts,  blockades,  insurrections,  riots,  epidemics,
quarantine  restrictions,  landslides,  lightning,  earthquake,  fires,  storms,
floods,  washouts,  arrests,  civil  disturbances,  restraints  by or actions of
governmental bodies acting in a sovereign capacity (including export or security
restrictions  on information,  material,  personnel,  equipment,  or otherwise),
breakdowns of plant or machinery, inability to obtain transport or supplies, and
the  like.  The  occurrence  of any of these  circumstances  could  disrupt  the
Company's  operations and may have a materially  adverse effect on the Company's
business, financial condition, or results of operations.

     "Blank Check" Preferred Stock; Change in Control Arrangements

     Actel's Articles of Incorporation authorize the issuance of up to 5,000,000
shares of "blank  check"  Preferred  Stock (of  which  4,000,000  shares  remain
available for issuance), with such designations,  rights, and preferences as may
be  determined  from time to time by the Board of  Directors.  Accordingly,  the
Board is empowered,  without  approval by holders of the Company's Common Stock,
to issue Preferred  Stock with dividend,  liquidation,  redemption,  conversion,
voting,  or other rights that could  adversely  affect the voting power or other
rights of the holders of the Common Stock. Issuance of the Preferred Stock could
be used as a method of discouraging, delaying, or preventing a change in control
of Actel. In addition,  such issuance could adversely affect the market price of
the Common Stock.  Although the Company does not  currently  intend to issue any
additional  shares of its Preferred Stock,  there can be no assurance that Actel
will not do so in the future.

     The  Company  has  adopted an Employee  Retention  Plan that  provides  for
payment of stock to Actel's  employees  who hold  unvested  stock options in the
event of a change of control of the  Company.  Payment  is  contingent  upon the
employee  remaining  with Actel for six months after the change of control.  The
Company has also entered into Management  Continuity Agreements with each of its
executive officers, which provide for the acceleration of unvested stock options
in the event an executive  officer's  employment  is actually or  constructively
terminated other than for cause following a change of control.

     Competition

     The semiconductor industry is intensely competitive and is characterized by
rapid rates of technological change,  product  obsolescence,  and price erosion.
Actel's  existing  competitors  include  suppliers of conventional  gate arrays,
CPLDs, and FPGAs. The Company's two principle competitors are Xilinx, a supplier
of FPGAs based on SRAM technology,  and Altera, a supplier principally of CPLDs.
In connection  with the settlement of patent  litigation in 1993,  Actel granted
Xilinx a license  under  certain  of  Actel's  patents  that  permits  Xilinx to
manufacture and market antifuse-based products. Xilinx announced in 1996 that it
had  discontinued its  antifuse-based  FPGA product line. The Company also faces
competition  from  companies  that  specialize  in converting  FPGAs,  including
Actel's  products,  into  conventional  gate arrays.  In  addition,  the Company
expects   significant   competition  in  the  future  from  major  domestic  and
international   semiconductor   suppliers,  and  Actel's  patents  may  not  bar
competitors  to which it has not  granted a  license  from  manufacturing  other
antifuse-based products. The Company may also face competition from suppliers of
logic products based on new or emerging technologies. Given the intensity of the
competition  and the research and  development  being done,  no assurance can be
given that Actel's antifuse and architecture technology will remain competitive.

     The Company believes that important  competitive  factors in its market are
price,  performance,  number of usable gates,  ease of use and  functionality of
development system software, installed base of development systems, adaptability
of products to specific  applications,  length of development  cycle  (including
reductions to finer micron design rules), number of I/Os, reliability,  adequate
wafer fabrication capacity and sources of raw materials,  protection of products
by effective  utilization of intellectual  property laws, and technical  service
and support.  Failure of Actel to compete  successfully in any of these or other
areas  could  have  a  materially  adverse  effect  on its  business,  financial
condition,  or results of operations.  In addition, all existing FPGAs not based
on antifuse  technology  and certain  CPLDs are  reprogrammable,  a feature that
makes them more  attractive  to designers.  The Company also  believes  that, if
there were a downturn  in the  market for CPLDs and FPGAs,  companies  that have
broader product lines and longer  standing  customer  relationships  may be in a
stronger  competitive  position than Actel.  Many of the  Company's  current and
potential competitors offer broader product lines and have significantly greater
financial, technical, manufacturing, and marketing resources than Actel.

     Dependence on Customized Manufacturing Process

     Actel's antifuse based FPGAs are  manufactured  using customized steps that
are added to otherwise standard manufacturing processes of its independent wafer
suppliers.  There is  considerably  less  operating  history  for the  Company's
customized  process  steps  than  for  the  foundries'  standard   manufacturing
processes. The dependence of Actel on customized processing steps means that, in
contrast with competitors using standard  manufacturing  processes,  the Company
has  more  difficulty   establishing   relationships   with  independent   wafer
manufacturers, takes longer to qualify a new wafer manufacturer, takes longer to
achieve satisfactory,  sustainable wafer yields on new processes, may experience
a higher incidence of production yield problems,  must pay more for wafers,  and
generally  will not obtain early access to the most  advanced  processes.  These
risks are  particularly  pronounced  with respect to wafers  intended for use in
military  and  aerospace  applications.  Any of the  above  factors  could  be a
material  disadvantage  against the competing  non-antifuse  products of Actel's
competitors,  which use standard manufacturing  processes.  As a result of these
factors,  the Company's  products typically have been fabricated using processes
one or two  generations  behind the processes used on competing  products.  As a
consequence,  Actel to date has not fully  realized  the  price and  performance
benefits of its antifuse technology. The Company is attempting to accelerate the
rate at which its products are reduced to finer  geometries  and is working with
its wafer  suppliers  to obtain  earlier  access to advanced  processes,  but no
assurance can be given that such efforts will be successful.

     Dependence on Design Wins

     In order for the Company to sell an FPGA to a customer,  the customer  must
incorporate  the FPGA into the  customer's  product in the design  phase.  Actel
therefore  devotes  substantial  resources,  which  it may not  recover  through
product sales, in support of potential customer design efforts (including, among
other things,  providing  development system software) and to persuade potential
customers to incorporate the Company's FPGAs into new or updated products. These
efforts  usually  precede  by many  months  (and  sometimes  a year or more) the
generation of volume FPGA sales, if any, by Actel.  The value of any design win,
moreover,  will depend in large part upon the ultimate success of the customer's
product.  No assurance can be given that the Company will win sufficient designs
or that any design win will result in significant revenues.

     Dependence on Independent Assembly Subcontractors

     Actel  relies  primarily  on foreign  subcontractors  for the  assembly and
packaging  of its  products  and,  to a lesser  extent,  for the  testing of its
finished products.  The Company generally relies on one or two subcontractors to
provide particular  services and has from time to time experienced  difficulties
with the  timeliness and quality of product  deliveries.  Actel has no long-term
contracts  with its  subcontractors  and  certain  of those  subcontractors  are
currently  operating at or near full  capacity.  There can be no assurance  that
these  subcontractors will continue to be able and willing to meet the Company's
requirements  for such  components or services.  Any  significant  disruption in
supplies from, or degradation in the quality of components or services  supplied
by,  these  subcontractors  could  delay  shipments  and  result  in the loss of
customers or revenues or otherwise  have a materially  adverse effect on Actel's
business, financial condition, or results of operations.

     Dependence on Independent Software Developers

     Actel  is  dependent   upon   independent   software   developers  for  the
development, maintenance, and support of certain elements of its Designer Series
Development  Systems software.  The Company's  reliance on independent  software
developers  involves  certain risks,  including lack of control over development
and delivery  schedules and the availability of customer  support.  No assurance
can be given that the Company's independent  developers will be able to complete
software currently under development, or provide updates, or customer support in
a timely manner,  which could delay future  releases and disrupt Actel's ability
to provide customer support services. Any significant delays in the availability
of  the  Company's  software  would  be  detrimental  to the  capability  of the
Company's new families of products to win designs, which could have a materially
adverse  effect  on  Actel's  business,   financial  condition,  or  results  of
operations.

     Dependence on Independent Wafer Manufacturers

     Actel does not  manufacture any of the wafers used in the production of its
FPGAs.  Currently,  such wafers are  manufactured by Chartered  Semiconductor in
Singapore,  Lockheed-Martin  FSC in the United States,  Matsushita in Japan, and
Winbond in Taiwan. The Company's reliance on independent wafer  manufacturers to
fabricate its wafers involves  significant  risks,  including the risk of events
limiting  production  and reducing  yields,  such as technical  difficulties  or
damage to production  facilities,  lack of control over capacity  allocation and
delivery  schedules,  and potential lack of adequate  capacity.  These risks are
particularly  pronounced with respect to wafers intended for use in military and
aerospace applications.

     Actel has from time to time experienced delays in obtaining wafers from its
foundries,  and there can be no assurance  that the Company will not  experience
similar or more severe  delays in the future.  In addition,  although  Actel has
supply  agreements  with  most of its wafer  manufacturers,  a  shortage  of raw
materials or production capacity could lead any of the Company's wafer suppliers
to allocate  available  capacity to customers  other than Actel,  or to internal
uses,  which  could  interrupt  the  Company's  capability  to meet its  product
delivery  obligations.  These risks are particularly  pronounced with respect to
wafers intended for use in military and aerospace applications. Any inability or
unwillingness  of Actel's  wafer  suppliers to provide  adequate  quantities  of
finished  wafers to satisfy the  Company's  needs in a timely manner would delay
production and product  shipments and could have a materially  adverse effect on
Actel's business, financial condition, or results of operations.

     If the Company's  current  independent wafer  manufacturers  were unable or
unwilling to manufacture Actel's products as required, the Company would have to
identify and qualify additional  foundries.  The qualification process typically
takes one year or longer.  No assurance can be given that any  additional  wafer
foundries would become available or be able to satisfy Actel's requirements on a
timely  basis  or that  qualification  would be  successful.  In  addition,  the
semiconductor   industry  has  from  time  to  time  experienced   shortages  of
manufacturing  capacity. To secure an adequate supply of wafers, the Company has
considered, and continues to consider, various possible transactions,  including
the  use of  substantial  nonrefundable  deposits  to  secure  commitments  from
foundries for specified levels of manufacturing  capacity over extended periods,
equity  investments (such as Actel's  investment in Chartered  Semiconductor) in
exchange for guaranteed  production,  and the formation of joint ventures to own
foundries. No assurance can be given as to the effect of any such transaction on
the Company's business, financial condition, or results of operations.

     Dependence on International Operations

     Actel buys a majority of its wafers from foreign  foundries and has most of
its  commercial  products  assembled,  packaged,  and  tested by  subcontractors
located  outside  the  United  States.  These  activities  are  subject  to  the
uncertainties associated with international business operations, including trade
barriers and other restrictions, changes in trade policies, foreign governmental
regulations, currency exchange fluctuations, reduced protection for intellectual
property, war and other military activities,  terrorism, changes in political or
economic conditions, and other disruptions or delays in production or shipments,
any of which could have a materially  adverse effect on the Company's  business,
financial condition, or results of operations.

     In order to expand  international sales and service,  the Company will need
to maintain and expand  existing  foreign  operations  or establish  new foreign
operations.   This  entails  hiring  additional  personnel  and  maintaining  or
expanding  existing  relationships  with  international  distributors  and sales
representatives.   This  will  require  significant   management  attention  and
financial  resources and could adversely affect Actel's financial  condition and
operating results. No assurance can be given that the Company will be successful
in  its  maintenance  or  expansion  of  existing  foreign  operations,  in  its
establishment of new foreign operations, or in its efforts to maintain or expand
its relationships with international distributors or sales representatives.

     Dependence on Key Personnel

     The  success of the  Company is  dependent  in large part on the  continued
service  of its key  management,  engineering,  marketing,  sales,  and  support
employees.  Competition for qualified  personnel is intense in the semiconductor
industry, and the loss of Actel's current key employees, or the inability of the
Company to attract other qualified  personnel,  could have a materially  adverse
effect on Actel. The Company does not have employment agreements with any of its
key employees.

     Dependence on Military and Aerospace Customers

     Although  Actel is unable to determine  with certainty the ultimate uses of
its products,  the Company  estimates that sales of its products to customers in
the military and  aerospace  industries,  which  sometimes  carry higher  profit
margins  than  sales  of  products  to  commercial   customers,   accounted  for
approximately  one-quarter  of revenues in 1997.  The Company  believes that the
military  and  aerospace  industries  accounted  for  a  significantly   greater
percentage of the Company's net revenues following the introduction of RH1280 in
1996.  No assurance  can be given that future sales to customers in the military
and  aerospace  industries  will  continue at current  volume or margin  levels.
Orders from the military and aerospace customers tend to be large and irregular,
which creates operational  challenges and contributes to fluctuations in Actel's
net revenues and gross  margins.  These sales are also subject to more extensive
governmental regulations,  including greater import and export restrictions.  In
addition,  products for military and aerospace  applications  require processing
and testing that is more lengthy and stringent than for commercial applications,
increasing the risk of failure. It is often not possible to determine before the
end of  processing  and  testing  whether  products  intended  for  military  or
aerospace  applications will fail and, if they do fail, a significant  period of
time is often required to process and test replacements,  each of which makes it
difficult to accurately  estimate quarterly revenues and could have a materially
adverse  effect  on  Actel's  business,   financial  condition,  or  results  of
operations.

     Dividend Policy

     Actel has never  declared or paid any cash  dividends on its capital stock.
The Company currently intends to retain any earnings for use in its business and
does not anticipate paying any cash dividends in the future.

     Fluctuations in Operating Results

     The  Company's  quarterly  and  annual  operating  results  are  subject to
fluctuations  resulting from general economic  conditions and a variety of risks
specific to Actel or  characteristic of the  semiconductor  industry,  including
booking and shipment uncertainties, supply problems, and price erosion.

          Booking and Shipment Uncertainties

          Actel typically generates a large percentage of its quarterly revenues
     from orders  received  during the quarter and shipped in the final weeks of
     the quarter, making it difficult to accurately estimate quarterly revenues.
     The Company's  backlog  (which may be cancelled or deferred by customers on
     short notice  without  significant  penalty) at the  beginning of a quarter
     accounts for only a fraction of Actel's  revenues during the quarter.  This
     means that the Company  generates the rest of its  quarterly  revenues from
     orders  received  during the quarter and "turned"  for shipment  within the
     quarter,  and that any  shortfall in "turns"  orders will have an immediate
     and adverse impact on quarterly revenues. There are many factors that could
     cause a shortfall in "turns" orders, including but not limited to a decline
     in general  economic  conditions  or the  businesses  of end users,  excess
     inventory in the channel,  conversion to conventional (or non-programmable)
     gate  arrays,  or the loss of  business to other  competitors  for price or
     other reasons.

          Historically,  Actel has shipped a disproportionately large percentage
     of its quarterly revenues in the final weeks of the quarter. Any failure by
     the  Company  to  effect  scheduled  shipments  by the end of the  quarter,
     therefore,  could have a  materially  adverse  effect on revenues  for such
     quarter.  Since Actel generally does not recognize revenue on the sale of a
     product to a distributor  until the  distributor  resells the product,  the
     Company's  quarterly  revenues  are  also  dependent  on,  and  subject  to
     fluctuations  in,  shipments  by  Actel's  distributors.  When  there  is a
     shortfall  in  revenues,  operating  results  are  likely  to be  adversely
     affected because most of the Company's expenses do not vary with revenues.

          Supply Problems

          In a  typical  semiconductor  manufacturing  process,  silicon  wafers
     produced by a foundry  are sorted and cut into  individual  die,  which are
     then assembled into  individual  packages and tested for  performance.  The
     manufacture,  assembly,  and  testing of  semiconductor  products is highly
     complex and subject to a wide variety of risks, including defects in masks,
     impurities in the materials  used,  contaminants  in the  environment,  and
     performance  failures by personnel and  equipment.  Semiconductor  products
     intended  for  military  and  aerospace   applications   are   particularly
     susceptible  to these  conditions,  any of which  could  have a  materially
     adverse  effect on Actel's  business,  financial  condition,  or results of
     operations.

          As is common in the semiconductor industry,  Actel's independent wafer
     suppliers from time to time  experience  lower than  anticipated  yields of
     usable die. For example,  the Company experienced a yield problem at one of
     its foundries in the fourth  quarter of 1993 that was severe enough to have
     a materially  adverse effect on Actel's  operating  results.  To the extent
     yields of usable die  decrease,  the  average  cost to the  Company of each
     usable die increases,  which reduces gross margin. Wafer yields can decline
     without  warning  and may take  substantial  time to analyze  and  correct,
     particularly  for a company  such as Actel  that does not  operate  its own
     manufacturing facility, but instead utilizes independent  facilities,  most
     of which are offshore.  Yield problems may also increase the time to market
     for the Company's products and create inventory  shortages and dissatisfied
     customers. In addition, Actel typically experiences difficulties and delays
     in achieving  satisfactory,  sustainable  yields on new processes or at new
     foundries.  Although the Company eventually has been able to overcome these
     difficulties in the past, no assurance can be given that it will be able to
     do so with  respect  to its  current  or future  new  processes  and/or new
     foundries.  Nor can any  assurance  be  given  that  the  Company  will not
     experience  wafer supply  problems in the future,  or that any such problem
     would not have a materially  adverse effect on Actel's business,  financial
     condition, or results of operations.

          Price Erosion

          The  semiconductor  industry is characterized by intense  competition.
     Historically,   average  selling  prices  in  the  semiconductor   industry
     generally,  and for the  Company's  products in  particular,  have declined
     significantly over the life of each product.  While Actel expects to reduce
     the  average  selling  prices  of its  products  over  time as the  Company
     achieves  manufacturing  cost  reductions,  Actel is sometimes  required by
     competitive  pressures  to reduce the prices of its  products  more quickly
     than such  cost  reductions  can be  achieved.  In  addition,  the  Company
     sometimes  approves price reductions on specific sales to meet competition.
     If not offset by reductions in manufacturing costs or by a shift in the mix
     of products  sold toward  higher-margin  products,  declines in the average
     selling prices of Actel's products will reduce gross margins and could have
     a materially adverse effect on the Company's business, financial condition,
     or results of operations.

     Forward-Looking Statements

     All  forward-looking  statements  contained  in this Annual  Report on Form
10-K,  including  all  forward-looking  statements  contained  in  any  document
incorporated  herein  by  reference,  are  made  pursuant  to  the  safe  harbor
provisions of the Public Securities Litigation Reform Act of 1995. Words such as
"anticipates,"  "believes,"  "estimates," "expects," intends," "plans," "seeks,"
and  variations of such words and similar  expressions  are intended to identify
the  forward-looking   statements.   The   forward-looking   statements  include
projections  relating to trends in markets,  revenues,  average  selling prices,
gross margin,  wafer yields,  research and  development  expenditures,  selling,
general,  and administrative  expenditures,  and the Year 2000 compliance issue.
All forward-looking statements are based on current expectations and projections
about the semiconductor  industry and programmable logic market, and assumptions
made by the Company's  management  that reflect its best judgment based on other
factors  currently  known by  management,  but they are not guarantees of future
performance.  Accordingly,  actual events and results may differ materially from
those  expressed or forecast in the  forward-looking  statements due to the risk
factors  identified herein or for other reasons.  Actel undertakes no obligation
to update any  forward-looking  statement contained or incorporated by reference
in this Annual Report on Form 10-K.

     Future Capital Needs

     The Company must continue to make  significant  investments in research and
development as well as capital  equipment and expansion of  facilities.  Actel's
future  capital  requirements  will  depend on many  factors,  including,  among
others, product development, investments in working capital, and acquisitions of
complementary businesses, products, or technologies. To the extent that existing
resources and future earnings are insufficient to fund the Company's operations,
Actel may need to raise  additional  funds  through  public or  private  debt or
equity financings. If additional funds are raised through the issuance of equity
securities, the percentage ownership of current shareholders will be reduced and
such equity  securities may have rights,  preferences,  or privileges  senior to
those of the holders of the Company's  Common  Stock.  No assurance can be given
that  additional  financing  will be available or that, if available,  it can be
obtained on terms favorable to Actel and its shareholders. If adequate funds are
not available, the Company may be required to delay, limit, or eliminate some or
all of its proposed operations.

     Gross Margin

     The  Company's  gross  margin is the  difference  between  the  revenues it
receives from the sale of its products and the cost of those products. The price
Actel can charge for a product is constrained  principally  by its  competitors.
While   competition  has  always  been  intense,   the  Company  believes  price
competition  is becoming more acute.  This may be due in part to the  transition
toward  high-level  design  methodologies,  which permit designers to wait until
later in the design  process before  selecting a  programmable  logic device and
make it easier to convert from one programmable  logic device to another.  These
competitive  pressures may cause Actel to reduce the prices of its products more
quickly than it can achieve cost  reductions,  which would reduce the  Company's
gross margin and may have a materially adverse effect on its operating results.

     One of the most  important  variables  affecting  the cost of the Company's
products is manufacturing  yields.  With its customized  antifuse  manufacturing
process  requirements,  Actel almost  invariably  experiences  difficulties  and
delays in achieving satisfactory,  sustainable yields on new processes or at new
foundries.  The  Company  introduced  the first  members of the MX family in the
fourth  quarter of 1997 and is currently  scheduled to introduce  new members of
the MX family and the first members of the SX family in 1998. Until satisfactory
yields are achieved on these new product  families,  they generally will be sold
at lower gross margins than Actel's mature product families.  Depending upon the
rate at which sales of these new products ramp (and the MX family is directed at
high-volume  users) and the extent to which they displace mature  products,  the
lower gross  margins  could have a materially  adverse  effect on the  Company's
operating results.

     Management of Growth

     Actel has recently experienced and expects to continue to experience growth
in the number of its  employees  and the scope of its  operations,  resulting in
increased  responsibilities  for  management  personnel.  To manage  recent  and
potential future growth effectively,  the Company will need to continue to hire,
train, motivate, and manage a growing number of employees. The future success of
Actel will also depend on its ability to attract and retain qualified technical,
marketing, and management personnel. In particular,  the current availability of
qualified  silicon  design,  software  design,  process,  and test  engineers is
limited, and competition among companies for skilled and experienced engineering
personnel is very strong.  The Company has been  attempting  to hire a number of
engineering  personnel  and has  experienced  delays in filling such  positions.
During strong business cycles,  Actel expects to experience continued difficulty
in filling its needs for qualified  engineers and other personnel.  No assurance
can be given that the Company will be able to achieve or manage  effectively any
such  growth,  and  failure  to  do  so  could  delay  product  development  and
introductions or otherwise have a materially adverse effect on Actel's business,
financial condition, or results of operations.

     Manufacturing Yields

     Actel depends upon its  independent  wafer suppliers to produce wafers with
acceptable  yields  and to  deliver  them to the  Company  in a  timely  manner.
Currently, substantially all of the Company's revenues are derived from products
based  on  Actel's  proprietary   antifuse  process   technologies.   Successful
implementation  of  antifuse  process  technology  requires  a  high  degree  of
coordination  between the Company and its foundry.  Therefore,  significant lead
time is required to reach volume  production on new processes and at a new wafer
supply locations.  Accordingly, no assurance can be given that volume production
on Actel's new MX and SX families will be achieved in the near term or at all.

     The  manufacture of  high-performance  antifuse wafers is a complex process
that requires a high degree of technical skill,  state-of-the-art equipment, and
effective  cooperation  between the wafer  supplier and the circuit  designer to
produce  acceptable  yields.  Minute  impurities,  errors  in  any  step  of the
fabrication process, defects in the masks used to print circuits on a wafer, and
other  factors can cause a  substantial  percentage  of wafers to be rejected or
numerous  die  on  each  wafer  to  be  non-functional.  As  is  common  in  the
semiconductor  industry,  the Company has from time to time  experienced  in the
past,  and  expects  that it will  experience  in the future,  production  yield
problems and delivery delays. Any prolonged  inability to obtain adequate yields
or deliveries could adversely affect the Actel's business and operating results.

     One-Time Programmability

     While the nonvolatility of Actel's antifuse FPGAs is necessary or desirable
in some applications, logic designers generally would prefer to prototype with a
reprogrammable  logic device,  all other things being equal. This is because the
designer  can reuse the  device  if he or she  makes an  error.  The  visibility
associated with discarding a one-time programmable device often causes designers
to  select  a   reprogrammable   device  even  when  the  alternative   one-time
programmable  device  offers  significant  advantages.  This  bias in  favor  of
designing with  reprogrammable  logic devices appears to increase as the size of
the design increases, and is a major reason the Company has decided to enter the
reprogrammable FPGA market.

     Patent Infringement

     As is typical  in the  semiconductor  industry,  the  Company  has been and
expects to be from time to time  notified  of claims  that it may be  infringing
patents  owned by others.  No  assurance  can be given that such claims  against
Actel will not result in  litigation.  In January  1994,  the Company  brought a
patent infringement  lawsuit against QuickLogic,  which in turn brought a patent
infringement  counterclaim  against  Actel in May 1995.  In  January  1998,  the
Company  brought  a  second  patent  infringement  lawsuit  against  QuickLogic.
Management  of the  Company  believes  that  Actel has  meritorious  claims  and
defenses in these matters,  and that their resolution will not have a materially
adverse effect on the Company's  business,  financial  condition,  or results of
operations,  but no  assurance  can be given  to that  effect.  All  litigation,
whether or not determined in favor of Actel,  can result in significant  expense
to the Company and can divert the efforts of Actel's  technical  and  management
personnel from productive tasks.

     Although  the Company has  obtained  patents  covering  aspects of its FPGA
architecture,  logic  modules,  and certain  techniques  for  manufacturing  its
antifuse,  no assurance can be given that Actel's  patents will be determined to
be valid or that the claims of QuickLogic or any assertions of  infringement  or
invalidity by other parties (or claims for indemnity  from  customers  resulting
from any infringement claims) will not be successful. In the event of an adverse
ruling in the QuickLogic  cases or any other litigation  involving  intellectual
property,  the Company could suffer  significant  (and possibly treble) monetary
damages,  which  might have a  materially  adverse  effect on Actel's  business,
financial condition, or results of operations.  The Company may also be required
to discontinue the use of infringing processes; cease the manufacture,  use, and
sale  of  infringing   products;   expend   significant   resources  to  develop
non-infringing   technology;  or  obtain  licenses  under  patents  that  it  is
infringing.   Although  patent  holders   commonly  offer  licenses  to  alleged
infringers,  no assurance can be given that licenses will be offered or that the
terms of any offered  licenses will be  acceptable  to Actel.  In the event of a
successful  claim against the Company,  Actel's  failure to develop or license a
substitute  technology on commercially  reasonable terms would have a materially
adverse effect on the Company's business,  financial  condition,  and results of
operations.

     Potential Acquisitions

     In  pursuing   its   business   strategy,   Actel  may  acquire   products,
technologies,  or businesses  from third parties.  Identifying  and  negotiating
these  acquisitions  may  divert  substantial  management  time  away  from  the
Company's  operations.  An acquisition could absorb  substantial cash resources,
require Actel to incur or assume debt  obligations,  and/or involve the issuance
of  additional  equity  securities  of the Company.  The issuance of  additional
equity  securities  may dilute,  and could  represent an interest  senior to the
rights of, the holders of Actel's Common Stock. An acquisition  accounted for as
a purchase,  such as the Company's acquisition of TI's antifuse FPGA business in
1995, could involve significant one-time write-offs,  possibility resulting in a
loss  for  the  fiscal  year  in  which  it is  taken,  and  would  require  the
amortization  of any  goodwill  over a number of years,  which  would  adversely
affect earnings in those years. Any acquisition would require attention from the
Company's  management to integrate the acquired entity into Actel's  operations,
may require the Company to develop expertise outside its existing business,  and
could  result in  departures  of  management  from either  Actel or the acquired
entity.  An acquired entity may have unknown  liabilities,  and its business may
not achieve the results anticipated at the time it is acquired by the Company.

     Protection of Intellectual Property

     Actel has  historically  devoted  significant  resources  to  research  and
development  and  believes  that the  intellectual  property  derived  from such
research and  development is a valuable asset that has been and will continue to
be important to the success of the Company's business. Actel relies primarily on
a combination of nondisclosure  agreements,  other contractual  provisions,  and
patent and copyright laws to protect its proprietary rights. No assurance can be
given that the steps  taken by the  Company  will be  adequate  to  protect  its
proprietary  rights.  In  addition,  the laws of  certain  territories  in which
Actel's products are or may be developed,  manufactured, or sold, including Asia
and Europe,  may not protect the Company's  products and  intellectual  property
rights to the same extent as the laws of the United States.  Failure of Actel to
enforce its patents or  copyrights  or to protect its trade secrets could have a
materially adverse effect on the Company's  business,  financial  condition,  or
results of operations.

     Reliance on Distributors

     In 1997, more than half of Actel's sales in the United States and virtually
all of  the  Company's  sales  outside  the  United  States  were  made  through
distributors. Three of Actel's distributors, Wyle, Arrow, and Pioneer, accounted
for approximately 17%, 17%, and 12%, respectively, of the Company's net revenues
in  1997.  No  assurance  can be  given  that  future  sales  by  these or other
distributors will continue at current levels or that the Company will be able to
retain its current distributors on terms that are acceptable to Actel.

     The Company's  distributors  generally offer products of several  different
companies,  including  products  that are  competitive  with  Actel's  products.
Accordingly, there is a risk that these distributors may give higher priority to
products of other  suppliers,  thus reducing their efforts to sell the Company's
products.  In addition,  Actel's  agreements with its distributors are generally
terminable at the  distributor's  option. A reduction in sales efforts by one or
more of the Company's current distributors or a termination of any distributor's
relationship with Actel could have a materially  adverse effect on the Company's
business, financial condition, or results of operations.

     Actel generally defers  recognition of revenue on shipments to distributors
until the product is resold by the  distributor  to the end user.  The Company's
distributors  have on occasion built  inventories in anticipation of substantial
growth in sales and,  when such growth did not occur as rapidly as  anticipated,
substantially  decreased the amount of product  ordered from Actel in subsequent
quarters.  Such a slowdown in orders would generally reduce the Company's profit
margins on future sales of higher cost products because Actel would be unable to
take  advantage  of any  manufacturing  cost  reductions  while the  distributor
depleted its inventory at lower average selling prices.  In addition,  while the
Company  believes  that  its  major   distributors   are  currently   adequately
capitalized,  no assurance can be given that one or more of Actel's distributors
will not experience  financial  difficulties.  The failure of one or more of the
Company's  distributors  to pay for  products  ordered from Actel or to continue
operations  because of financial  difficulties or for other reasons could have a
materially adverse effect on the Company's  business,  financial  condition,  or
results of operations.

     Reliance on International Sales

     Sales  to  customers  located  outside  the  United  States  accounted  for
approximately  31%,  33%,  and 38% of net  revenues  for 1997,  1996,  and 1995,
respectively.  Actel expects that revenues derived from international sales will
continue to represent a significant portion of its total revenues. International
sales are  subject  to a variety  of risks,  including  longer  payment  cycles,
greater difficulty in accounts  receivable  collection,  currency  restrictions,
tariffs, trade barriers,  taxes, export license requirements,  and the impact of
recessionary  environments  in economies  outside the United States.  All of the
Company's  foreign sales are denominated in U.S.  dollars,  so Actel's  products
become less price competitive in countries with currencies that are declining in
value  against the dollar.  In addition,  since  virtually  all of the Company's
foreign sales are made through distributors, such sales are subject to the risks
described above in "Reliance on Distributors."

     Semiconductor Industry Risks

     The semiconductor  industry has historically been cyclical and periodically
subject to significant economic downturns, which are characterized by diminished
product demand, accelerated price erosion, and overcapacity.  The Company may in
the future experience substantial period-to-period  fluctuations in business and
results of operations due to general semiconductor industry conditions,  overall
economic  conditions,  or other factors,  including  legislation and regulations
governing the import or export of semiconductor products.

     Software Development Challenges

     The computational complexities are not yet well understood for the software
tools required to support the largest  members of the ES family of products.  It
is anticipated that both the  computational  memory capacities and tool runtimes
will be several times greater than those presently  required for Actel's current
antifuse  products,  which are  significantly  smaller.  It is expected that the
Company will need to develop and deploy tools  incorporating  significantly more
compact, memory-resident data structures, which must be combined with algorithms
capable of dealing very efficiently with the large circuit sizes.

     Technological Change and Dependence on New Product Development

     The  market for  Actel's  products  is  characterized  by rapidly  changing
technology,  frequent new product  introductions,  and declining average selling
prices over product life cycles,  each of which makes the timely introduction of
new  products a critical  objective of the Company.  Actel's  future  success is
highly dependent upon the timely  completion and introduction of new products at
competitive price and performance  levels. In evaluating new product  decisions,
Actel must  anticipate well in advance both the future demand and the technology
that will be  available to supply such demand.  Failure to  anticipate  customer
demand,  delays  in  developing  new  products  with  anticipated  technological
advances,  and failure to coordinate  the design and  development of silicon and
associated  software  products  each could have a materially  adverse  effect on
Actel's business, financial condition, or results of operation.

     In  addition,   there  are  greater  technological  and  operational  risks
associated with new products.  The inability of the Company's wafer suppliers to
produce advanced products;  delays in commencing or maintaining volume shipments
of new products;  the discovery of product,  process,  software,  or programming
failures;  and any related product returns could each have a materially  adverse
effect on Actel's business, financial condition, or results of operation.

     Actel is currently scheduled to introduce new members of the MX, SX, and ES
families  in 1998.  No  assurance  can be given  that the  Company's  design and
introduction  schedules for such products or the supporting software will be met
or that such products will be  well-received  by customers.  No assurance can be
given  that any  other new  products  will gain  market  acceptance  or that the
Company will respond  effectively  to new  technological  changes or new product
announcements by others. Any failure of Actel to successfully  define,  develop,
market,  manufacture,  assemble,  or test  competitive new products could have a
materially adverse effect on its business,  financial  condition,  or results of
operations.

     The Company must also continue to make significant  investments in research
and  development to develop new products and achieve market  acceptance for such
products.  Actel  currently  conducts  most  of  its  research  and  development
activities   at   facilities   operated  by   Matsushita   in  Japan  and  Extel
Semiconductor,  Inc. in the United States.  Although the Company has not to date
experienced  any  significant  difficulty  in  obtaining  access to its  current
facilities,  no  assurance  can be given that access will not be limited or that
such facilities will be adequate to meet Actel's needs in the future.

     Volatility of Stock

     The price of the Company's Common Stock can fluctuate  substantially on the
basis  of  factors  such  as  announcements  of new  products  by  Actel  or its
competitors,  quarterly  fluctuations in the Company's  financial results or the
financial results of other semiconductor companies, or general conditions in the
semiconductor  industry or in the financial markets. In addition,  stock markets
have recently  experienced extreme price and volume volatility.  This volatility
has had a substantial  effect on the market prices of the  securities  issued by
high  technology  companies,  at times for reasons  unrelated  to the  operating
performance of the specific companies.

     Year 2000 Compliance

     The Year 2000 issue arises because most computer hardware and software were
developed without  considering the impact of the upcoming change in the century.
The hardware and software were originally  designed to accept two-digit  entries
rather  than  four-digit  entries in the date code field.  As a result,  certain
computer  systems and  software  packages  will not be able to  interpret  dates
beyond December 31, 1999; they will, for example,  interpret January 1, 2000, as
January  1,  1900.  This  could  potentially   result  in  computer  failure  or
miscalculations,  causing operating disruptions, including among other things an
inability to process  transactions,  send invoices,  or engage in other ordinary
activities.

     The Company has initiated a  comprehensive  project to prepare its computer
systems  for the  Year  2000 and  plans  to have  changes  to  critical  systems
completed by the first quarter of 1999 to permit time for testing.  A task force
is identifying all areas of application  software,  operating  system  software,
hardware,  and external interfaces that require Year 2000 compliance.  While the
Company currently expects that the Year 2000 will not pose significant  internal
operational  problems,  delays in the implementation of new information systems,
or a failure  to fully  identify  all Year 2000  dependencies  in the  Company's
systems,  could have a  materially  adverse  effect on the  Company's  operating
results.

     The  Company is also  assessing  the  capability  of its  products  sold to
customers over a period of years to handle the Year 2000. The ongoing assessment
has not revealed any significant  compliance issues.  However,  the inability of
these  products to properly  manage and  manipulate  data in the Year 2000 could
result in a material adverse impact on the Company, including increased warranty
costs, customer satisfaction issues, and potential lawsuits.

     Based  on  its  current  understanding,   the  Company  believes  that  the
likelihood of a material adverse impact due to problems with internal systems or
products  sold to customers is remote and expects that the cost of its Year 2000
compliance  program  over the next two years will not have a material  effect on
the Company's financial position or overall trends in results of operations. The
cost of the program  and the date on which the  Company  believes it will become
Year 2000 compliant are based on management's best estimates, which were derived
utilizing  numerous  assumptions  of  future  events,  including  the  continued
availability of certain  resources,  cooperation of vendors,  and other factors.
However,  there can be no guarantee  that these  estimates  will be achieved and
actual  results could differ  materially  from those  anticipated.  If Year 2000
modifications  and  conversions  are not properly  made, or are not completed in
timely manner, the Year 2000 issue could have a materially adverse impact on the
Company's future business operations and, in turn, on its financial position and
results  of  operations.   Specific  factors  that  might  cause  such  material
differences  include,  but are not  limited  to,  the  availability  and cost of
personnel  trained in the area,  the ability to locate and correct all  relevant
computer codes, and similar uncertainties.

     Ultimately,  the  potential  impact of the Year 2000 issue will  depend not
only on the corrective measures the Company  undertakes,  but also on the way in
which the Year 2000 issue is  addressed  by  businesses  and other  entities who
provide data to, or receive data from the Company,  or whose financial condition
or operational capability is important to the Company as suppliers or customers.
Therefore,  the Company is also developing a plan to contact critical  suppliers
of products and services to determine  that the  suppliers'  operations  and the
products  and services  they  provide are Year 2000 capable or to monitor  their
progress toward Year 2000 capability.  The Company's suppliers and customers are
generally  much larger  organizations  than the Company with a greater number of
suppliers  and  customers  of their own. The Company  believes  that many of its
suppliers and customers have not completed their own systems  modification to be
Year 2000  compliant.  The failure of significant  suppliers or customers of the
Company to become Year 2000 compliant could have materially adverse consequences
to the  Company.  Those  consequences  could  include the  inability  to receive
product in a timely  manner or lost sales  opportunities,  either of which could
result in a material decline in the Company's revenues and profits. In addition,
there can be no guarantee  that a conversion by a third party's  system on which
the Company's systems rely would be compatible with the Company's systems. It is
not possible at this time to quantify the potential  impact of such  situations,
but no assurance can be given that another company's failure to ensure Year 2000
capability will not have an adverse effect on the Company.

Executive Officers of the Registrant

     The following table identifies each executive  officer of Actel as of March
27, 1998:
<TABLE>
<CAPTION>
                 Name                      Age                                 Position
- ---------------------------------------- ------- ---------------------------------------------------------
<S>                                        <C>   <C>                                    
John C. East.........................      53    President and Chief Executive Officer

Henry L. Perret......................      52    Vice President of Finance and Chief Financial Officer

Esmat Z. Hamdy.......................      48    Senior Vice President of Technology & Operations

Jeffrey M. Schlageter................      54    Senior Vice President of Engineering & Corporate Programs

Michelle A. Begun....................      41    Vice President of Human Resources

Carl N. Burrow.......................      37    Vice President of Marketing

Douglas D. Goodyear..................      43    Vice President of Worldwide Sales

Fares N. Mubarak.....................      36    Vice President of Engineering

Dennis F. Nye........................      45    Vice President of Strategic Accounts

Robert J. Smith, II..................      53    Vice President of Software

David L. Van De Hey..................      42    Vice President & General Counsel and Secretary
</TABLE>
         
     Mr. East has served as President and Chief Executive Officer of the Company
since  December 1988.  From April 1979 until joining  Actel,  Mr. East served in
various  positions with Advanced Micro Devices,  a  semiconductor  manufacturer,
including Senior Vice President of Logic Products from November 1986 to November
1988.  From December  1976 to March 1979,  he served as  Operations  Manager for
Raytheon  Semiconductor.  From  September  1968 to December  1976,  he served in
various marketing, manufacturing, and engineering positions for Fairchild Camera
and Instrument Corporation, a semiconductor manufacturer.

     Mr.  Perret  joined Actel in January 1996 as  Controller  and has been Vice
President of Finance and Chief  Financial  Officer  since June 1997.  From April
1992 until joining the Company, he was the Site Controller for the manufacturing
division of Applied Materials, a maker of semiconductor manufacturing equipment,
in  Austin,  Texas.  From  1978 to  1991,  Mr.  Perret  held  various  financial
positions,  including divisional controllerships with National Semiconductor,  a
semiconductor manufacturer.

     Dr. Hamdy is a founder of the  Company,  was Vice  President of  Technology
from August  1991 to March 1996 and Senior Vice  President  of  Technology  from
March 1996 to September  1996,  and has been Senior Vice President of Technology
and Operations  since September 1996. From November 1985 to July 1991, he held a
number of management  positions with the Company's  technology  and  development
group.  From January 1981 to November 1985, Dr. Hamdy held various  positions at
Intel Corporation, a semiconductor manufacturer, lastly as project manager.

     Mr.  Schlageter  joined the Company in February  1989 as Vice  President of
Engineering,  was Senior Vice  President of  Engineering  from  November 1992 to
October 1997, and has been Senior Vice  President of  Engineering  and Corporate
Programs  since  October  1997.  From July 1985 to January 1989, he held various
positions at Advanced Micro Devices, a semiconductor manufacturer, where he last
served as Managing Director of Peripheral  Products.  From February 1981 to July
1985,  Mr.  Schlageter  was Vice  President  of  Semicustom  Products  at Mostek
Corporation, a semiconductor manufacturer.

     Ms. Begun joined Actel in May 1989 as Director of Human Resources,  and has
been Vice President of Human  Resources  since August 1991. From May 1984 to May
1989,  she  held  various  human   resources   management   positions  at  Intel
Corporation,  a  semiconductor  manufacturer,  her  last  position  being  Human
Resources  Manager.  From  October  1977 to May  1984,  she held  various  human
resources management positions at Synertek,  Inc., a subsidiary of Honeywell,  a
semiconductor manufacturer.

     Mr. Burrow joined the Company in January 1992 as Southwest  Regional  Sales
Manager,  was Director of Western Area Sales from February 1996 to October 1997,
and has been Vice  President of Marketing  since  October  1997.  From June 1983
until  January  1992,  he held various  sales and  marketing  positions at Texas
Instruments, a semiconductor manufacturer.

     Mr.  Goodyear  joined the Company in  February  1996 as Vice  President  of
Worldwide Sales. From November 1991 until joining the Company, he served as Vice
President of Sales for the components division of Sharp Electronics Corporation,
a semiconductor  manufacturer.  From January 1987 to November 1991, Mr. Goodyear
held various sales  management  positions at Hitachi  America,  a  semiconductor
manufacturer,  lastly as Western Area Sales  Manager.  From June 1983 to January
1987, he held various sales and sales  management.  positions at Advanced  Micro
Devices, a semiconductor manufacturer.

     Mr.  Mubarak  joined the Company in November  1992, was Director of Product
and Test  Engineering  until  October  1997,  and has  been  Vice  President  of
Engineering  since October 1997.  From 1989 until joining Actel, he held various
engineering  and  engineering  management  positions with Samsung  Semiconductor
Inc., a semiconductor manufacturer,  and its spin-off, Integrated Circuit Works,
Inc. From 1984 to 1989, Mr. Mubarak held various engineering,  product planning,
and   engineering   management   positions  with  Advanced   Micro  Devices,   a
semiconductor manufacturer.

     Mr. Nye joined  Actel in October  1990 as European  Business  Manager  with
Actel Europe Ltd., the Company's United Kingdom  subsidiary,  was Vice President
of Marketing  from January 1994 until October 1997,  and has been Vice President
of Strategic Accounts since October 1997. From January 1990 to October 1990, Mr.
Nye served as Director of Sales of Genrad Corporation,  a software company. From
November 1986 to January 1990, he served as European  Sales Manager of Viewlogic
Corporation, a software company.

     Dr. Smith joined Actel in March 1997 as Vice  President of Software.  Prior
to joining the Company, he was an independent consultant specializing in product
development  and  positioning,   software  team  building,   pragmatic  software
engineering practices,  and small company trouble shooting.  From September 1985
to March  1995,  Dr Smith  held  various  positions  with  Microelectronics  and
Computer  Technology  Corporation  (MCC), a consortial  systems and software R&D
company,  where  he last  served  as Vice  President  of  Advanced  Systems  and
Networks.

     Mr.  Van De Hey  joined  Actel in July 1993 as  Corporate  Counsel,  became
Secretary  in May 1994,  and has been Vice  President  & General  Counsel  since
August 1995.  From  November 1988 to September  1993,  he was an associate  with
Wilson, Sonsini, Goodrich & Rosati, Professional Corporation, a law firm in Palo
Alto,  California,  and the Company's  outside legal  counsel.  From August 1985
until October 1988, he was an associate with the Cleveland office of Jones, Day,
Reavis & Pogue, a law firm.

     Executive officers serve at the discretion of the Board of Directors.

ITEM 2.   PROPERTIES

     Actel's  principal  administrative,  marketing,  sales,  customer  support,
design,  research  and  development,  and  testing  facilities  are  located  in
Sunnyvale,  California,  in three buildings that comprise  approximately 138,000
square feet. These buildings are leased through June 2003, and the Company has a
renewal option for an additional five-year term. Actel also leases sales offices
in the metropolitan areas of Atlanta, Baltimore,  Basingstoke (England), Boston,
Chicago,   Dallas,  Denver,  Destin  (Florida),  Los  Angeles,  Milano  (Italy),
Minneapolis,   Munich   (Germany),   Ottawa   (Canada),   and  Paris   (France),
Philadelphia,  Raleigh,  Seoul (Korea),  and Tokyo (Japan). The Company believes
its  facilities  will be adequate  for its needs in 1998,  but is  investigating
options for continued expansion beyond that time.

ITEM 3.   LEGAL

     Except as described  below,  there are no pending  legal  proceedings  of a
material nature to which Actel is a party or of which any of its property is the
subject.  There  are no  such  legal  proceedings  known  by the  Company  to be
contemplated by any governmental authority.

     Actel v. QuickLogic (CV C-94 20050 JW (PVT))

          Claims Asserted

          Actel commenced the above-referenced  action against QuickLogic in the
     United States  District Court for the Northern  District of California (the
     "Court")  on  January  20,  1994.   The  Complaint   asserted   claims  for
     infringement of U. S. Patents Nos.  4,758,745,  4,873,459,  5,055,718,  and
     5,198,705,  respectively,  each relating to field  programmable  gate array
     technology.  The Complaint sought injunctive  relief,  treble damages in an
     unspecified amount, and attorneys' fees.

          On February 10,  1994,  QuickLogic  filed an Answer and  Counterclaim,
     denying   infringement,   asserting   invalidity   defenses,   and  seeking
     declaratory relief.

          On March 15, 1995, Actel filed an Amended and  Supplemental  Complaint
     against QuickLogic asserting,  in addition to claims previously asserted, a
     claim for infringement of U.S. Patent No. 5,367,208.  Actel's  Supplemental
     Complaint  sought  injunctive  relief,  treble  damages  in an  unspecified
     amount, and attorneys' fees.

          On April 14, 1995, QuickLogic filed an Answer and Counterclaim denying
     infringement,  asserting  invalidity  defenses,  and  asserting  two claims
     against Actel for alleged  infringement of U.S. Patents Nos.  5,220,213 and
     5,396,127  relating  to logic  modules.  QuickLogic's  Counterclaim  sought
     declaratory  and  injunctive  relief,  and treble damages in an unspecified
     amount.   On  May  25,  1995,   QuickLogic  filed  an  Amended  Answer  and
     Counterclaim, adding allegations of inequitable conduct.

          In response to  QuickLogic's  counterclaims,  on June 11, 1995,  Actel
     filed a Reply and Counterclaim, denying infringement,  asserting invalidity
     defenses,  naming John Birkner as an  individual  defendant,  and asserting
     causes of action for trade  secret  misappropriation,  breach of  contract,
     breach of  confidential  business  relationship,  and  unfair  competition.
     Actel's  Counterclaim sought declaratory and injunctive relief,  damages in
     an  unspecified  amount,  and an  assignment to Actel of  QuickLogic's  two
     patents-in-suit.  In response,  both  QuickLogic and Mr. Birkner denied all
     allegations.

          On March 7, 1996, Actel filed a Second Supplemental Complaint,  adding
     a claim against QuickLogic for infringement of U.S. Patent No. 5,479,113.

          As of June 13, 1997,  QuickLogic  amended its complaint to assert that
     Actel's ACT 3 products infringe U.S. Patent No. 5,594,364.

          On August 1,  1997,  Actel  answered  QuickLogic's  amended  complaint
     denying   liability  and   restating   Actel's  trade  secret  and  related
     counterclaims.

          On August 15, 1997, Actel filed an amended and supplemental complaint.
     This  complaint  reasserted the patent claims  described  above and added a
     claim under U.S. Patent No. 5,610,534, issued March 11, 1997.

          On  September  3,  1997,  QuickLogic  and  Birkner  filed an answer to
     Actel's  Second Amended and  Supplemental  Complaint,  and alleged  amended
     counterclaims asserting invalidity and other customary affirmative defenses
     in patent cases and demanding  jury. On September 9, 1997,  QuickLogic  and
     Birkner filed an answer to Actel's Amended Counterclaims.

          On March 3, 1998,  QuickLogic advised that it will seek leave to amend
     its   answer   to   assert   additional    defenses   of   invalidity   and
     unenforceability.

          In  summary,  Actel has  asserted  claims of  patent  infringement  as
     against  all  QuickLogic   products  under  U.S.  Patents  Nos.  4,758,745,
     4,873,459,  5,055,718, 5,198,705, 5,357,208, 5,479,113 and 5,610,534. Actel
     has also asserted various  counterclaims against QuickLogic and Mr. Birkner
     based  on  misappropriation  of  Actel  trade  secrets.  QuickLogic  denies
     infringement  and  asserts  invalidity  and  unenforceability  of all Actel
     patents-in-suit.  As  explained  below,  the  Court  has  granted a summary
     judgment finding that QuickLogic's products infringe the `705 patent.

          QuickLogic has asserted claims of patent infringement  against Actel's
     ACT 2 and ACT 3  product  lines  under  U.S.  Patents  Nos.  5,220,213  and
     5,396,127 and against ACT 3 products under U.S. Patent No. 5,594,364. Actel
     denies  infringement  and asserts  invalidity and  unenforceability  of the
     QuickLogic  patents.  Actel further asserts that it is entitled to impose a
     constructive  trust on the  QuickLogic  patents  because those patents were
     obtained using Actel trade secrets.

          Motions

          On November 15, 1994 Actel moved for summary  judgment of infringement
     of its `705  patent.  On October 4, 1996,  after  extensive  discovery  and
     briefing,  the  Special  Master,  to whom all  pretrial  matters  have been
     referred,  filed a  recommendation  with the Court that  Actel's  motion be
     granted.  After further hearings,  on August 8, 1997, the Court adopted the
     Special Master's recommendation.

          On January 18, 1996,  Actel filed a motion seeking summary judgment of
     invalidity  of the two  QuickLogic  patents-in-suit  based  on the  sale of
     Actel's  ACT 2 product  line more than one year  prior to the filing of the
     application  which is the parent of the applications  from which QuickLogic
     obtained  Patents Nos.  5,220,213 and 5,396,127.  This motion was argued to
     the Special Master on December 12, 1997, and is awaiting his action.

          On February 5, 1996, QuickLogic filed a motion for summary judgment of
     infringement  of  QuickLogic  patent no.  5,520,213.  This  motion has been
     withdrawn without prejudice to refiling of a similar motion.

          On February 26, 1996,  QuickLogic  filed a motion to disqualify  Actel
     counsel,  the law  firm of Lyon & Lyon,  on the  ground  that a Lyon & Lyon
     attorney,  in  previous  employment  with  QuickLogic  counsel,   Skjerven,
     Morrill,   MacPherson,   Franklin  &  Friel,  had  access  to  confidential
     QuickLogic information and attorney work product. The Special Master issued
     a recommendation in favor of QuickLogic's  motion and, on May 29, 1996, the
     Court  entered  an  Order  disqualifying  Lyon & Lyon.  On June  19,  1996,
     O'Melveny & Myers was substituted as counsel of record on behalf of Actel.

          On  November  25,  1996,  QuickLogic  moved for  Summary  Judgment  of
     invalidity  with  respect to Claim 1 of Actel  patent no.  5,198,705.  This
     motion is being held in abeyance pending further pretrial planning.

          On June 27, 1997, Actel moved for a summary judgment that QuickLogic's
     products  infringe Claim 11 of U.S.  Patent No.  4,873,459.  This motion is
     being held in abeyance pending further pretrial planning.

          On July 3, 1997, QuickLogic and Mr. Birkner moved for summary judgment
     that all of the  Actel  counterclaims  based on  misappropriation  of trade
     secrets are barred by applicable  statutes of  limitation.  This motion was
     argued to the Special Master on December 12, 1997. In Recommendations dated
     February 13, 1998 and March 3, 1998,  the Special Master  recommended  that
     this motion be granted in its entirety.  Actel has filed  objections to the
     Special Master's  recommendations.  This matter awaits further briefing and
     argument before the district judge.

          On  September  9, 1997,  Actel  moved for leave to file an amended and
     supplemental  complaint joining two individuals as additional defendants on
     Actel's  counterclaims.  One objective of this motion was to establish that
     Actel's trade secret  counterclaims  against  QuickLogic relate back to the
     date of Actel's original complaint.  If the relation-back doctrine applies,
     this would obviate  QuickLogic's  summary judgment defense.  On December 5,
     1997,  pursuant to recommendation of the Special Master, the district court
     denied Actel's motion to join the two additional  defendants.  On March 13,
     1998,  the Special  Master  recommended  that the district  judge hold that
     Actel's  counterclaims  do not relate back.  Actel has filed  objections to
     this  recommendation,  and the matter awaits further proceedings before the
     district judge.

          Each side has advised the Special Master that  additional  motions for
     summary judgment will be made after completion of discovery.

          Trial Schedule

          By order of the Court entered March 19, 1997, the Court  established a
     deadline  for  completion  of fact  discovery  of January  31,  1998.  This
     deadline has passed,  but limited specific fact discovery that could not be
     completed by the deadline remains to be conducted.  Expert disclosures will
     be required in advance of trial,  but no specific date for such disclosures
     is currently in effect.

          The parties are discussing a process for  simplification of the issues
     to be tried and  expect to enter into a  stipulation  to  bifurcate  damage
     issues from liability and  infringement  issues and to try a limited subset
     of issues in phases. A process for selecting  claims has commenced,  but it
     is too early to predict what claims will be selected for trial.

          No trial date has been set.  The parties have  stipulated  that purely
     equitable  will be  tried to the  judge  prior  to jury  trial of  selected
     claims.  Trial of the equitable issues is currently  expected to take place
     in the fourth quarter of 1998.

     Actel v. QuickLogic (CV C-97 21107 JW (EAI))

          Claims Asserted

          On December 15, 1997,  Actel  commenced  the  above-referenced  action
     against   QuickLogic  in  the  Court.  The  Complaint  asserts  claims  for
     infringement of U. S. Patents Nos.  5,132,571 and 5,191,214,  respectively,
     each relating to field  programmable gate array  technology.  The Complaint
     seeks  injunctive  relief,  treble  damages in an unspecified  amount,  and
     attorneys' fees.

          On January  13,  1998,  QuickLogic  filed an Answer and  Counterclaim,
     denying infringement, asserting invalidity defenses and seeking declaratory
     relief.

          Motions

          No motions have been filed in this action.

          Trial

          The parties have begun to disclose  relevant  information  as required
     under the Local Rules of the United States  District Court for the Northern
     District of California.  There have been no  communications  from the Court
     concerning a trial date.

     After  considering the facts currently  known,  management does not believe
that the  ultimate  outcome of the either  case will have a  materially  adverse
effect on the Company's  business,  financial  condition,  or operating results,
although no assurance can be given to that effect.

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     No matters were  submitted to a vote of security  holders during the fourth
quarter of the fiscal year covered by this report.

                                     PART II

ITEM 5.   MARKET  FOR THE  REGISTRANT'S  COMMON  STOCK AND  RELATED  SHAREHOLDER
          MATTERS

     The  information  appearing  under  the  caption  "Stock  Listing"  in  the
Registrant's  annual  report to  security  holders  for the  fiscal  year  ended
December 28, 1997 (the "1997 Annual  Report"),  is  incorporated  herein by this
reference.

ITEM 6.   SELECTED FINANCIAL DATA

     The  information   appearing  under  the  caption  "Selected   Consolidated
Financial  Data"  in the 1997  Annual  Report  is  incorporated  herein  by this
reference.

ITEM 7.   MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF  FINANCIAL  CONDITION  AND
          RESULTS OF OPERATIONS

     The information  appearing under the caption  "Management's  Discussion and
Analysis of Financial  Conditions  and Results of Operations" of the 1997 Annual
Report is incorporated herein by this reference.

ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

     The information appearing under the captions "Consolidated Balance Sheets,"
"Consolidated   Statements   of   Operations,"   "Consolidated   Statements   of
Shareholders'  Equity,"  "Consolidated  Statements  of Cash  Flows,"  "Notes  to
Consolidated   Financial   Statements,"  and  "Report  of  Ernst  &  Young  LLP,
Independent  Auditors" in the 1997 Annual Report is incorporated  herein by this
reference.

ITEM 9.   CHANGES  IN AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
          FINANCIAL DISCLOSURE

     None.

                                    PART III

     Except for the  information  specifically  incorporated  by reference  from
Actel's  definitive Proxy Statement for the Annual Meeting of Shareholders to be
held on May 22, 1998,  as filed on or about April 7, 1998,  with the  Securities
and Exchange  Commission (the "1997 Proxy Statement") in Part III of this Annual
Report on Form 10-K, the 1997 Proxy Statement shall not be deemed to be filed as
part of this Report.  Without limiting the foregoing,  the information under the
captions  "Compensation  Committee Report" and "Company Stock Performance" under
the main  caption  "OTHER  INFORMATION"  in the  1997  Proxy  Statement  are not
incorporated by reference in this Annual Report on Form 10-K.

ITEM 10.  DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

     The information  regarding the  identification  and business  experience of
Actel's directors under the caption  "Nominees" under the main caption "PROPOSAL
NO. 1 -- ELECTION OF DIRECTORS" in the 1997 Proxy  Statement and the information
under the main caption "COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE
ACT OF  1934"  in the 1997  Proxy  Statement  are  incorporated  herein  by this
reference.  For information regarding the identification and business experience
of Actel's executive officers, see "Executive Officers of the Registrant" at the
end of Item 1 in Part I of this Annual Report on Form 10-K.

ITEM 11.  EXECUTIVE COMPENSATION

     The information  under the caption "Director  Compensation"  under the main
caption  "PROPOSAL NO. 1 -- ELECTION OF  DIRECTORS" in the 1997 Proxy  Statement
and the information under the caption  "Executive  Compensation"  under the main
caption "OTHER  INFORMATION" in the 1997 Proxy Statement are incorporated herein
by this reference.

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The information  under the caption "Share Ownership" under the main caption
"INFORMATION CONCERNING SOLICITATION AND VOTING" in the 1997 Proxy Statement and
the information under the caption  "Security  Ownership of Management" under the
main caption "OTHER  INFORMATION" in the 1997 Proxy  Statement are  incorporated
herein by this reference.

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

     The information  under the caption  "Certain  Transactions"  under the main
caption "OTHER  INFORMATION" in the 1997 Proxy Statement is incorporated  herein
by this reference.

                                     PART IV

ITEM 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULE AND REPORTS ON FORM 8-K

     (a) The following documents are filed as part of this Annual Report on Form
10-K:

          (1)  Financial  Statements.   The  following   consolidated  financial
     statements  of Actel  Corporation  included in the 1997  Annual  Report are
     incorporated by reference in Item 8 of this Annual Report on Form 10-K:

          Consolidated balance sheets at December 31, 1997 and 1996

          Consolidated  statements of operations  for each of the three years in
          the period ended December 31, 1997

          Consolidated  statements of shareholders' equity for each of the three
          years in the period ended December 31, 1997

          Consolidated  statements  of cash flows for each of the three years in
          the period ended December 31, 1997

          Notes to consolidated financial statements

          (2) Financial  Statement  Schedule.  The financial  statement schedule
     listed under 14(d) hereof is filed with this Annual Report on Form 10-K.

          (3)  Exhibits.  The exhibits  listed under Item 14(c) hereof are filed
     with, or incorporated by reference into, this Annual Report on Form 10-K.

     (b) Reports on Form 8-K. No reports on Form 8-K were filed by Actel  during
the quarter ended December 28, 1997.

     (c) Exhibits.  The following exhibits are filed as part of, or incorporated
by reference into, this Report on Form 10-K:

    Exhibit Number                               Description
- ------------------------ -------------------------------------------------------

        2.1 (1)          Asset Purchase Agreement dated as of February 12, 1995,
                         between   the   Registrant   and   Texas    Instruments
                         Incorporated  (filed as Exhibit 2.1 to the Registrant's
                         Current  Report on Form 8-K (File  No.  0-21970)  filed
                         with the  Securities  and Exchange  Commission on April
                         17, 1995).


        2.2              Amendment No. 1 to the Asset Purchase  Agreement  dated
                         as of March 31, 1995,  between the Registrant and Texas
                         Instruments  Incorporated  (filed as Exhibit 2.2 to the
                         Registrant's  Current  Report  on Form  8-K  (File  No.
                         0-21970)   filed  with  the   Securities  and  Exchange
                         Commission on April 17, 1995).

        3.1              Restated  Articles of  Incorporation  (filed as Exhibit
                         3.2 to the Registrant's  Registration Statement on Form
                         S-1 (File No. 33-64704),  declared  effective on August
                         2, 1993).

        3.2              Restated Bylaws of the Registrant (filed as Exhibit 3.3
                         to the Registrant's  Registration Statement on Form S-1
                         (File No.  33-64704),  declared  effective on August 2,
                         1993).

        3.3              Certificate of Determination of Rights, Preferences and
                         Privileges   of  Series  A   Preferred   Stock  of  the
                         Registrant  (filed as Exhibit  3.3 to the  Registrant's
                         Current  Report on Form 8-K (File  No.  0-21970)  filed
                         with the  Securities  and Exchange  Commission on April
                         17,  1995).

       10.1 (2)          Form of  Indemnification  Agreement  for  directors and
                         officers  (filed as  Exhibit  10.1 to the  Registrant's
                         Registration Statement on Form S-1 (File No. 33-64704),
                         declared     effective     on    August    2,    1993).

       10.2 (2)          1986 Incentive Stock Option Plan (filed as Exhibit 10.2
                         to the  Registrant's  Annual  Report on Form 10-K (File
                         No.  0-21970)  for the fiscal year ended  December  28,
                         1997).

       10.3 (2)          1993  Directors'  Stock  Option  Plan,  as amended  and
                         restated.

       10.4 (2)          1993  Employee  Stock  Purchase  Plan,  as amended  and
                         restated.

       10.5 (2)          1995 Employee and Consultant Stock Plan, as amended and
                         restated  (filed as  Exhibit  10.5 to the  Registrant's
                         Annual  Report on Form 10-K (File No.  0-21970) for the
                         fiscal    year    ended     December     28,     1997).

       10.6              Form of Distribution  Agreement (filed as Exhibit 10.13
                         to the Registrant's  Registration Statement on Form S-1
                         (File No.  33-64704),  declared  effective on August 2,
                         1993).

       10.7 (1)          Patent  Cross  License  Agreement  dated April 22, 1993
                         between  the  Registrant  and  Xilinx,  Inc.  (filed as
                         Exhibit   10.14   to  the   Registrant's   Registration
                         Statement  on Form S-1  (File No.  33-64704),  declared
                         effective on August 2, 1993).

       10.8              Subscription and Participation Agreement dated February
                         3, 1994 between the Registrant,  Singapore Technologies
                         Ventures   Pte   Ltd   and   Chartered    Semiconductor
                         Manufacturing  Pte Ltd (filed as  Exhibit  10.16 to the
                         Registrant's  Annual  Report  on Form  10-K  (File  No.
                         0-21970)  for the fiscal  year ended  January 2, 1994).

       10.9              Manufacturing  Agreement dated February 3, 1994 between
                         the    Registrant    and    Chartered     Semiconductor
                         Manufacturing  Pte Ltd (filed as  Exhibit  10.17 to the
                         Registrant's  Annual  Report  on Form  10-K  (File  No.
                         0-21970)  for the fiscal  year ended  January 2, 1994).

       10.10             Distribution  Agreement dated June 1, 1994, between the
                         Registrant  and  Arrow  Electronics,   Inc.  (filed  as
                         Exhibit 10.18 to the  Registrant's  Quarterly Report on
                         Form 10-Q (File No.  0-21970) for the quarterly  period
                         ended July 3, 1994).

       10.11 (1)         Product   Development  and  Marketing  Agreement  dated
                         August  1,  1994,  between  the  Registrant  and  Loral
                         Federal  Systems Company (filed as Exhibit 10.19 to the
                         Registrant's  Quarterly  Report on Form 10-Q  (File No.
                         0-21970)  for the  quarterly  period  ended  October 2,
                         1994).

       10.12 (1)         M2M Joint  Development  and Marketing  Agreement  dated
                         August  1,  1994,  between  the  Registrant  and  Loral
                         Federal  Systems Company (filed as Exhibit 10.20 to the
                         Registrant's  Quarterly  Report on Form 10-Q  (File No.
                         0-21970)  for the  quarterly  period  ended  October 2,
                         1994).

       10.13 (1)         License  Agreement  dated as of April 1, 1995,  between
                         the  Registrant  and  Texas  Instruments   Incorporated
                         (filed as  Exhibit  10.22 to the  Registrant's  Current
                         Report on Form 8-K (File No.  0-21970)  filed  with the
                         Securities and Exchange  Commission on April 17, 1995).

       10.14 (1)         Foundry  Agreement  dated as of June 29, 1995,  between
                         the Registrant and Matsushita  Electric Industrial Co.,
                         Ltd and Matsushita  Electronics  Corporation  (filed as
                         Exhibit 10.25 to the  Registrant's  Quarterly Report on
                         Form 10-Q (File No.  0-21970) for the quarterly  period
                         ended July 2, 1995).

       10.15 (1)         Distribution  Agreement  dated  as of  June  29,  1995,
                         between  the   Registrant   and   Matsushita   Electric
                         Industrial   Co.,   Ltd  and   Matsushita   Electronics
                         Corporation (filed as Exhibit 10.26 to the Registrant's
                         Quarterly  Report on Form 10-Q (File No.  0-21970)  for
                         the    quarterly    period   ended   July   2,   1995).

       10.16             Lease  Agreement  for  the   Registrant's   offices  in
                         Sunnyvale,  California,  dated May 10,  1995  (filed as
                         Exhibit 10.19 to the Registrant's Annual Report on Form
                         10-K  (File No.  0-21970)  for the  fiscal  year  ended
                         December 31, 1995).

       10.17 (1)         License  Agreement  dated as of March 6, 1995,  between
                         the Registrant and BTR, Inc. (filed as Exhibit 10.20 to
                         the  Registrant's  Annual Report on Form 10-K (File No.
                         0-21970) for the fiscal year ended  December 28, 1997).

       13                Portions of Registrant's  Annual Report to Shareholders
                         for  the  fiscal   year  ended   December   28,   1997,
                         incorporated  by  reference  into  this  Report on Form
                         10-K.

       21                Subsidiaries    of    Registrant    (see    page   47).

       23                Consent of Ernst & Young LLP, Independent Auditors (see
                         page 45).

       24                Power     of      Attorney      (see      page     44).

       27.1              Financial Data Schedule - 1997.

       27.2              Financial Data Schedule - 1996.
  
- ---------------------------------------

     (1)  Confidential treatment requested as to a portion of this Exhibit.

     (2)  This  Exhibit  is  a  management  contract  or  compensatory  plan  or
          arrangement.

     Pursuant to Item 601(b)(2) of Regulation  S-K, the schedules to Exhibit 2.1
have been omitted. The Registrant hereby agrees to furnish supplementally a copy
of any omitted schedule to the Securities and Exchange  Commission upon request.
The omitted schedules are listed below:

     Schedule 1.1(a)      Capital Equipment
     Schedule 1.1(b)      Expensed Assets
     Schedule 1.1(d)      Contracts
     Schedule 1.1(f)      Software
     Schedule 1.1(h)      Testing Hardware and Software
     Schedule 1.1(i)      Research and Development Projects 
     Schedule 2.2         Calculation of Net Revenues of the Business
     Schedule 2.5         Inventory  Transfer Pricing 
     Schedule 5.2(a)      Seller Consents 
     Schedule 5.16        Seller's Knowledge 
     Schedule 6.2(a)      Buyer Consents 
     Schedule 6.2(b)      Buyer Violations 
     Schedule 6.4         Capitalization of Buyer
     Schedule 6.7         Registration Rights 
     Schedule 12.3(d)     Buyer's Knowledge

     (d)  Financial  Statement  Schedule.   The  following  financial  statement
schedule of Actel  Corporation  is filed as part of this Report on Form 10-K and
should be read in  conjunction  with the  Consolidated  Financial  Statements of
Actel  Corporation,  including the notes thereto,  and the Report of Independent
Auditors with respect thereto:

    Schedule                          Description                        Page
- ---------------  ----------------------------------------------------- ---------
       II                   Valuation and qualifying accounts             46

     All  other  schedules  for  which  provision  is  made  in  the  applicable
accounting  regulations  of the  Securities  and  Exchange  Commission  are  not
required under the related  instructions or are  inapplicable and therefore have
been omitted.


                                   SIGNATURES

     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                  ACTEL CORPORATION




March 27, 1998                    By:              /s/ John C. East
                                     -------------------------------------------
                                                      John C. East
                                         President and Chief Executive Officer

<PAGE>

                                                                     SCHEDULE II

                                ACTEL CORPORATION

                     --------------------------------------

                        Valuation and Qualifying Accounts
                                 (in thousands)


<TABLE>
<CAPTION>
                                                               Balance at                                Balance at
                                                               beginning                                   end of
                                                               of period     Provisions    Write-Offs      period
                                                              ------------  ------------  ------------  ------------ 
<S>                                                           <C>           <C>           <C>           <C>         
Allowance for doubtful accounts:
   Year ended December 31, 1995...........................    $        597  $         --  $         30  $        567
   Year ended December 31, 1996...........................             567            81            15           633
   Year ended December 31, 1997...........................             633         1,611           612         1,632
</TABLE>


                                ACTEL CORPORATION

                        1993 DIRECTORS' STOCK OPTION PLAN

                   Amended and Restated as of January 23, 1998


     1.   Purposes of the Plan.  The  purposes of this  Directors'  Stock Option
Plan are to attract  and  retain the best  available  personnel  for  service as
Directors  of the  Company,  to  provide  additional  incentive  to the  Outside
Directors of the Company to serve as Directors, and to encourage their continued
service on the Board.

          All options granted hereunder shall be "nonstatutory stock options".

     2.   Definitions. As used herein, the following definitions shall apply:

          (a)  "Board" shall mean the Board of Directors of the Company.

          (b)  "Code" shall mean the Internal Revenue Code of 1986, as amended.

          (c)  "Common Stock" shall mean the Common Stock of the Company.

          (d)  "Company" shall mean Actel Corporation, a California corporation.

          (e)  "Continuous  Status as a Director"  shall mean the absence of any
     interruption or termination of service as a Director.

          (f)  "Director" shall mean a member of the Board.

          (g)  "Effective Date" shall have the meaning as set forth in Section 6
     below.

          (h)  "Employee"  shall  mean  any  person,   including   officers  and
     Directors,  employed  by the  Company  or any Parent or  Subsidiary  of the
     Company.  The  payment  of a  director's  fee by the  Company  shall not be
     sufficient in and of itself to constitute "employment" by the Company.

          (i)  "Exchange Act" shall mean the Securities Exchange Act of 1934, as
     amended.

          (j)  "First  Option"  shall  have the  meaning as set forth in Section
     4(b)(ii) below.

          (k)  "Option" shall mean a stock option granted pursuant to the Plan.

          (l)  "Optioned  Stock"  shall  mean the  Common  Stock  subject  to an
     Option.

          (m)  "Optionee" shall mean an Outside Director who receives an Option.

          (n)  "Outside Director" shall mean a Director who is not an Employee.

          (o)  "Parent"  shall  mean  a  "parent  corporation",  whether  now or
     hereafter existing, as defined in Section 424(e) of the Code.

          (p)  "Plan" shall mean this 1993 Directors' Stock Option Plan.

          (q)  "Share"  shall mean a share of the Common  Stock,  as adjusted in
     accordance with Section 11 of the Plan.

          (r)  "Subsequent  Option"  shall  have  the  meaning  as set  forth in
     Section 4(b)(iii) below.

          (s)  "Subsidiary" shall mean a "subsidiary  corporation",  whether now
     or hereafter existing, as defined in Section 424(f) of the Code.

        3. Stock Subject to the Plan. Subject to the provisions of Section 11 of
the Plan, the maximum  aggregate number of Shares which may be optioned and sold
under  the Plan is  230,000  Shares  (the  "Pool")  of Common  Stock,  increased
annually  (subsequent to the January 23, 1998,  amendment and restatement of the
Plan) on the first day of each fiscal year by (x) 100,000 less (y) the number of
shares  available  for issuance  under the Director  Plan on the last day of the
immediately  preceding fiscal year. The Shares may be authorized,  but unissued,
or reacquired Common Stock.

          If an Option  should  expire or become  unexercisable  for any  reason
without having been exercised in full, the unpurchased Shares which were subject
thereto shall, unless the Plan shall have been terminated,  become available for
future grant under the Plan.  If Shares which were  acquired upon exercise of an
Option are subsequently repurchased by the Company, such Shares shall not in any
event be returned to the Plan and shall not become  available  for future  grant
under the Plan.

     4.   Administration of and Grants of Options under the Plan.

          (a)  Administrator.  Except as  otherwise  required  herein,  the Plan
     shall be administered by the Board.

          (b)  Procedure  for  Grants.  The Board may grant  Options  to Outside
     Directors  hereunder,  and on such terms, as are decided in its discretion.
     Additionally,   Options  shall   automatically  be  granted   hereunder  in
     accordance with the following provisions:

               (i)  After  August 1,  1997,  each  person  who first  becomes an
          Outside Director shall be automatically  granted an Option to purchase
          15,000  Shares (the  "First  Option") on the date on which such person
          first becomes an Outside  Director,  whether  through  election by the
          shareholders  of the Company or  appointment by the Board of Directors
          to fill a vacancy.

              (ii)  Beginning on August 1, 1997, each Outside  Director shall be
          automatically   granted  an  Option  to  purchase   5,000   Shares  (a
          "Subsequent  Option") on August 1 of each year if, on such date, he or
          she shall have served on the Board for at least six (6) months.

             (iii)  Notwithstanding  the provisions of subsections  (i) and (ii)
          hereof,  in the event  that a grant  would  cause the number of Shares
          subject to  outstanding  Options plus the number of Shares  previously
          purchased upon exercise of Options to exceed the Pool,  then each such
          automatic  grant  shall be for that  number  of Shares  determined  by
          dividing the total number of Shares  remaining  available for grant by
          the number of Outside  Directors  on the  automatic  grant  date.  Any
          further  grants  shall then be  deferred  until such time,  if any, as
          additional  Shares  become  available for grant under the Plan through
          action of the  shareholders to increase the number of Shares which may
          be issued  under the Plan or through  cancellation  or  expiration  of
          Options previously granted hereunder.

              (iv)  Notwithstanding  the provisions of subsections  (i) and (ii)
          hereof,  any grant of an Option made  before the Company has  obtained
          shareholder  approval of the Plan in accordance with Section 17 hereof
          shall be conditioned upon obtaining such  shareholder  approval of the
          Plan in accordance with Section 17 hereof.

               (v)  The terms of a First Option  granted  hereunder  shall be as
          follows:

                    (A)  the First  Option shall be  exercisable  only while the
               Outside Director remains a Director of the Company, except as set
               forth in Section 9 hereof.

                    (B)  the exercise  price per Share shall be 100% of the fair
               market value (as defined in Section 8(b)  hereunder) per Share on
               the date of grant of the First Option.

                    (C)  the First Option shall vest and become  exercisable  as
               to 25% of the  Shares  subject  to the First  Option on the first
               anniversary  of the  date  of the  Company's  annual  shareholder
               meeting occurring in each of the first, second, third, and fourth
               calendar  year  following  the calendar year in which the date of
               grant occurred,  subject to the provisions set forth in Section 9
               below.

              (vi)  The terms of a Subsequent  Option granted hereunder shall be
          as follows:

                    (A)  the Subsequent  Option shall be exercisable  only while
               the Outside Director remains a Director of the Company, except as
               set forth in Section 9 hereof.

                    (B)  the exercise  price per Share shall be 100% of the fair
               market  value  per  Share on the date of grant of the  Subsequent
               Option.

                    (C)  the  Subsequent  Option shall become  exercisable as to
               one  hundred   percent  (100%)  of  the  Shares  subject  to  the
               Subsequent Option on the date of the Company's annual shareholder
               meeting  occurring  in the fourth  calendar  year  following  the
               calendar year in which the date of grant occurred, subject to the
               provisions set forth in Section 9 below.

          (c)  Powers of the Board.  Subject to the provisions and  restrictions
     of the Plan, the Board shall have the authority, in its discretion:  (i) to
     grant discretionary stock options to Outside Directors,  upon such terms as
     are  determined by the Board in its  discretion,  (ii) to  determine,  upon
     review of relevant  information  and in accordance with Section 8(b) of the
     Plan,  the fair market value of the Common  Stock;  (iii) to determine  the
     exercise  price per share of Options to be granted,  which  exercise  price
     shall be determined in  accordance  with Section 8(a) of the Plan;  (iv) to
     interpret  the  Plan  and  to  prescribe,   amend  and  rescind  rules  and
     regulations relating to the Plan; (v) to authorize any person to execute on
     behalf of the Company any instrument required to effectuate the grant of an
     Option  previously   granted   hereunder;   and  (vi)  to  make  all  other
     determinations  deemed necessary or advisable for the administration of the
     Plan.

          (d)  Effect of Board's  Decision.  All decisions,  determinations  and
     interpretations  of the Board shall be final and  binding on all  Optionees
     and any other holders of any Options granted under the Plan.

          (e)  Suspension or Termination  of Option.  If the President or his or
     her designee  reasonably  believes that an Optionee has committed an act of
     misconduct,  the President may suspend the Optionee's right to exercise any
     option  pending a  determination  by the Board of Directors  (excluding the
     Outside  Director  accused of such  misconduct).  If the Board of Directors
     (excluding the Outside Director  accused of such misconduct)  determines an
     Optionee  has  committed  an  act  of  embezzlement,   fraud,   dishonesty,
     nonpayment of an obligation  owed to the Company,  breach of fiduciary duty
     or deliberate  disregard of the Company rules resulting in loss,  damage or
     injury to the Company,  or if an Optionee makes an unauthorized  disclosure
     of any Company  trade secret or  confidential  information,  engages in any
     conduct  constituting unfair  competition,  induces any Company customer to
     breach a contract  with the Company or induces any  principal  for whom the
     Company acts as agent to terminate  such agency  relationship,  neither the
     Optionee  nor his or her estate  shall be entitled  to exercise  any option
     whatsoever. In making such determination, the Board of Directors (excluding
     the Outside Director accused of such misconduct) shall act fairly and shall
     give the  Optionee  an  opportunity  to  appear  and  present  evidence  on
     Optionee's  behalf at a hearing  before  the  Board or a  committee  of the
     Board.

     5.   Eligibility.  Options  may be granted  only to Outside  Directors.  An
Outside  Director  who has been granted an Option may, if he or she is otherwise
eligible, be granted an additional Option or Options.

          The Plan shall not confer upon any  Optionee any right with respect to
continuation of service as a Director or nomination to serve as a Director,  nor
shall it  interfere in any way with any rights which the Director or the Company
may have to terminate his or her directorship at any time.

     6.   Term of Plan;  Effective Date. The Plan shall become  effective on the
date on which the Company's registration statement on Form S-1 (or any successor
form thereof) is declared  effective by the Securities  and Exchange  Commission
(the "Effective Date"). It shall continue in effect for a term of ten (10) years
unless  sooner  terminated  under  Section  13  of  the  Plan,  subject  to  the
limitations set forth in this Plan.

     7.   Term of Option.  The term of each Option  shall be ten (10) years from
the date of grant thereof.

     8.   Exercise Price and Consideration.

          (a)  Exercise Price. The per Share exercise price for the Shares to be
     issued  pursuant to exercise of an Option  shall be 100% of the fair market
     value per Share on the date of grant of the Option.

          (b)  Fair Market  Value.  The fair market value per Share shall be the
     mean  of  the  bid  and   asked   prices  of  the   Common   Stock  in  the
     over-the-counter  market  on the date of  grant,  as  reported  in The Wall
     Street  Journal  (or,  if not so  reported,  as  otherwise  reported by the
     National  Association of Securities Dealers Automated Quotation  ("NASDAQ")
     System)  or, in the event  that the  Common  Stock is traded on the  NASDAQ
     National Market System or listed on a stock exchange, the fair market value
     per Share shall be the closing price on such system or exchange on the date
     of grant of the Option,  as reported in The Wall Street Journal,  provided,
     however, that if such market or exchange is closed on the date of the grant
     of the Option  then the fair  market  value per Share shall be based on the
     most recent date on which such trading  occurred  immediately  prior to the
     date of the grant of the Option;  provided,  further,  that for purposes of
     First  Options  granted on the  Effective  Date,  the fair market value per
     share shall be the initial public  offering price as set forth in the final
     prospectus  filed with the Securities and Exchange  Commission  pursuant to
     Rule 424 under the Securities Act of 1933, as amended.

          (c)  Form of  Consideration.  The  consideration  to be  paid  for the
     Shares to be issued upon  exercise of an Option shall  consist  entirely of
     cash,  check,  other  Shares  having  a fair  market  value  on the date of
     surrender  equal to the aggregate  exercise price of the Shares as to which
     said Option shall be exercised (which, if acquired from the Company,  shall
     have been held for at least six  months),  delivery of a properly  executed
     exercise notice together with  instructions to a broker to deliver promptly
     to the Company  the amount of sale  proceeds  required to pay the  exercise
     price,  or any  combination  of such  methods of  payment  and/or any other
     consideration  or method of payment as shall be permitted under  applicable
     corporate law.

     9.   Exercise of Option.

          (a)  Procedure  for  Exercise;  Rights as a  Shareholder.  Any  Option
     granted  hereunder  shall be  exercisable at such times as are set forth in
     Section 4(b) hereof or, with respect to a  discretionary  grant, as decided
     by the Board in its discretion; provided, however, that no Options shall be
     exercisable  until  shareholder  approval  of the Plan in  accordance  with
     Section 17 hereof has been obtained.

               An Option may not be exercised for a fraction of a Share.

               An Option shall be deemed to be exercised  when written notice of
     such exercise has been given to the Company in accordance with the terms of
     the Option by the person  entitled to exercise  the Option and full payment
     for the  Shares  with  respect to which the  Option is  exercised  has been
     received by the Company.  Full payment may consist of any consideration and
     method of  payment  allowable  under  Section  8(c) of the Plan.  Until the
     issuance (as evidenced by the appropriate entry on the books of the Company
     or of a duly  authorized  transfer  agent  of  the  Company)  of the  stock
     certificate  evidencing such Shares,  no right to vote or receive dividends
     or any other  rights as a  shareholder  shall  exist  with  respect  to the
     Optioned  Stock,  notwithstanding  the  exercise  of the  Option.  A  share
     certificate  for the  number of Shares so  acquired  shall be issued to the
     Optionee as soon as practicable after exercise of the Option. No adjustment
     will be made for a dividend  or other  right for which the  record  date is
     prior to the date the stock  certificate  is issued,  except as provided in
     Section 11 of the Plan.

               Exercise of an Option in any manner shall result in a decrease in
     the number of Shares which  thereafter may be available,  both for purposes
     of the Plan and for sale  under the  Option,  by the number of Shares as to
     which the Option is exercised.

          (b)  Termination  of  Status as a  Director.  If an  Outside  Director
     ceases to serve as a Director,  he or she may,  but only  within  three (3)
     months (or such  other  period of time not  exceeding  six (6) months as is
     determined  by the Board)  after the date he or she ceases to be a Director
     of the Company, exercise his or her Option to the extent that he or she was
     entitled to exercise  it at the date of such  termination.  Notwithstanding
     the foregoing,  in no event may the Option be exercised  after its term set
     forth in Section 7 has expired.  To the extent that such  Outside  Director
     was not entitled to exercise an Option at the date of such termination,  or
     does not  exercise  such Option  (which he or she was entitled to exercise)
     within the time specified herein, the Option shall terminate.

          (c)  Disability of Optionee. Notwithstanding the provisions of Section
     9(b)  above,  in the event a  Director  is unable  to  continue  his or her
     service as a Director  with the Company as a result of his or her total and
     permanent  disability  (as  defined in  Section  22(e)(3)  of the  Internal
     Revenue Code), he or she may, but only within six (6) months (or such other
     period of time not  exceeding  twelve (12) months as is  determined  by the
     Board) from the date of such termination, exercise his or her Option to the
     extent  he or  she  was  entitled  to  exercise  it at  the  date  of  such
     termination.  Notwithstanding the foregoing,  in no event may the Option be
     exercised after its term set forth in Section 7 has expired.  To the extent
     that he or she was not  entitled  to  exercise  the  Option  at the date of
     termination, or if he or she does not exercise such Option (which he or she
     was  entitled to exercise)  within the time  specified  herein,  the Option
     shall terminate.

          (d)  Death of Optionee. In the event of the death of an Optionee:

               (i)  during  the term of the Option who is, at the time of his or
          her  death,  a  Director  of the  Company  and who shall  have been in
          Continuous Status as a Director since the date of grant of the Option,
          the Option may be exercised in full, at any time within six (6) months
          (or  such  lesser  period  of  time  as is  determined  by the  Board)
          following the date of death,  by the Optionee's  estate or by a person
          who   acquired  the  right  to  exercise  the  Option  by  bequest  or
          inheritance,  whether  or not the right to  exercise  that  would have
          accrued  had  the  Optionee  continued  living.   Notwithstanding  the
          foregoing,  in no event may the Option be exercised after its term set
          forth in Section 7 has expired.

              (ii)  within three (3) months (or such lesser period of time as is
          determined by the Board) after the termination of Continuous Status as
          a Director,  the Option may be  exercised,  at any time within six (6)
          months  following the date of death, by the Optionee's  estate or by a
          person who  acquired  the right to  exercise  the Option by bequest or
          inheritance,  but only to the extent of the right to exercise that had
          accrued at the date of termination.  Notwithstanding the foregoing, in
          no event  may the  option  be  exercised  after  its term set forth in
          Section 7 has expired.

     10.  Nontransferability  of Options.  The Option may not be sold,  pledged,
assigned, hypothecated,  transferred, or disposed of in any manner other than by
will or by the laws of descent or distribution. The designation of a beneficiary
by an Optionee does not constitute a transfer. An Option may be exercised during
the lifetime of an Optionee  only by the  Optionee or a transferee  permitted by
this Section.

     11.  Adjustments Upon Changes in Capitalization  or Merger.  Subject to any
required  action by the  shareholders  of the  Company,  the number of shares of
Common Stock  covered by each  outstanding  Option,  and the number of shares of
Common Stock which have been  authorized  for issuance  under the Plan but as to
which no Options have yet been  granted or which have been  returned to the Plan
upon  cancellation or expiration of an Option, as well as the price per share of
Common Stock covered by each such outstanding  Option,  shall be proportionately
adjusted for any  increase or decrease in the number of issued  shares of Common
Stock  resulting  from a stock  split,  reverse  stock  split,  stock  dividend,
combination or  reclassification  of the Common Stock,  or any other increase or
decrease in the number of issued shares of Common Stock effected without receipt
of  consideration  by the Company;  provided,  however,  that  conversion of any
convertible securities of the Company shall not be deemed to have been "effected
without receipt of  consideration."  Such adjustment shall be made by the Board,
whose  determination  in that respect  shall be final,  binding and  conclusive.
Except as  expressly  provided  herein,  no issuance by the Company of shares of
stock of any class, or securities convertible into shares of stock of any class,
shall affect, and no adjustment by reason thereof shall be made with respect to,
the number or price of shares of Common Stock subject to an Option.

          In the  event  of  the  proposed  dissolution  or  liquidation  of the
Company, the Option will terminate immediately prior to the consummation of such
proposed action,  unless otherwise  provided by the Board. The Board may, in the
exercise of its sole discretion in such instances, declare that any Option shall
terminate  as of a date fixed by the Board and give each  Optionee  the right to
exercise  his  or her  Option  as to all or  any  part  of the  Optioned  Stock,
including Shares as to which the Option would not otherwise be exercisable.

          In the event of a  proposed  sale of all or  substantially  all of the
assets  of the  Company,  or the  merger  of the  Company  with or into  another
corporation,  each outstanding  Option shall be assumed or an equivalent  option
shall be substituted  by the successor  corporation or a Parent or Subsidiary of
the successor corporation.  In the event that such successor corporation refuses
to assume such Option or to substitute an equivalent option,  such Options shall
become fully vested and exercisable as to all of the Optioned  Stock,  including
the  Shares  as  to  which  the  Options  would  not  otherwise  be  vested  and
exercisable.  If  Options  become  fully  vested  and  exercisable  in  lieu  of
assumption or substitution in the event of a merger or sale of assets, the Board
shall  notify the  Optionee  that the Option  shall be fully  exercisable  for a
period of thirty  (30) days from the date of such  notice,  and the Option  will
terminate upon the expiration of such period.

     12.  Time of Granting  Options.  The date of grant of an Option shall,  for
all purposes,  be the date  determined  in accordance  with Section 4(b) hereof.
Notice of the  determination  shall be given to each Outside Director to whom an
Option is so granted within a reasonable time after the date of such grant.

     13.  Amendment and Termination of the Plan

          (a)  Amendment and  Termination.  The Board may amend or terminate the
     Plan from time to time in such  respects  as the Board may deem  advisable;
     provided  that,  to the extent  necessary and desirable to comply with Rule
     16b-3 under the Exchange Act (or any other  applicable law or  regulation),
     the Company  shall obtain  approval of the  shareholders  of the Company to
     Plan  amendments  to the extent and in the manner  required  by such law or
     regulation.

          (b)  Effect  of  Amendment  or  Termination.  Any  such  amendment  or
     termination  of the Plan that would impair the rights of any Optionee shall
     not affect Options  already granted to such Optionee and such Options shall
     remain in full  force and  effect as if this Plan had not been  amended  or
     terminated,  unless mutually agreed otherwise  between the Optionee and the
     Board,  which  agreement  must be in writing and signed by the Optionee and
     the Company.

     14.  Conditions  Upon  Issuance  of  Shares.  Shares  shall  not be  issued
pursuant to the exercise of an Option unless the exercise of such Option and the
issuance  and  delivery of such Shares  pursuant  thereto  shall comply with all
relevant provisions of law, including, without limitation, the Securities Act of
1933,  as amended,  the  Exchange  Act,  the rules and  regulations  promulgated
thereunder,  state  securities  laws, and the requirements of any stock exchange
upon which the Shares  may then be listed,  and shall be further  subject to the
approval of counsel for the Company with respect to such compliance.

          As a condition to the  exercise of an Option,  the Company may require
the person  exercising  such Option to represent  and warrant at the time of any
such  exercise  that the  Shares are being  purchased  only for  investment  and
without any present  intention to sell or  distribute  such  Shares,  if, in the
opinion of counsel for the Company,  such a representation is required by any of
the aforementioned relevant provisions of law.

          Inability of the Company to obtain  authority from any regulatory body
having  jurisdiction,  which authority is deemed by the Company's  counsel to be
necessary to the lawful issuance and sale of any Shares hereunder, shall relieve
the  Company of any  liability  in respect of the  failure to issue or sell such
Shares as to which such requisite authority shall not have been obtained.

     15.  Reservation of Shares. The Company, during the term of this Plan, will
at all  times  reserve  and keep  available  such  number  of Shares as shall be
sufficient to satisfy the requirements of the Plan.

     16.  Option  Agreement.  Options  shall  be  evidenced  by  written  option
agreements in such form as the Board shall approve.

     17.  Shareholder Approval.

          (a)  Continuance  of the Plan  shall be  subject  to  approval  by the
     shareholders  of the  Company  at or prior to the first  annual  meeting of
     shareholders  held  subsequent to the granting of an Option  hereunder.  If
     such shareholder approval is obtained at a duly held shareholders' meeting,
     it may be obtained by the affirmative  vote of the holders of a majority of
     the  outstanding  shares of the Company present or represented and entitled
     to vote  thereon.  If such  shareholder  approval  is  obtained  by written
     consent,  it may be  obtained  by the  written  consent of the holders of a
     majority of the outstanding shares of the Company.

          (b)  Any required approval of the shareholders of the Company shall be
     solicited  substantially  in accordance  with Section 14(a) of the Exchange
     Act and the rules and regulations promulgated thereunder.

     18.  Information to Optionees.  The Company shall provide to each Optionee,
during the period for which such  Optionee has one or more Options  outstanding,
copies  of all  annual  reports  to  shareholders,  proxy  statements  and other
information provided to all shareholders of the Company.

                                ACTEL CORPORATION

                        1993 EMPLOYEE STOCK PURCHASE PLAN

                   Amended and Restated as of January 23, 1998


     The following constitute the provisions of the 1993 Employee Stock Purchase
Plan of Actel Corporation.

     1.   Purpose.  The  purpose  of the  Plan is to  provide  employees  of the
Company and its Designated  Subsidiaries  with an opportunity to purchase Common
Stock of the Company through accumulated payroll deductions. It is the intention
of the Company to have the Plan qualify as an  "Employee  Stock  Purchase  Plan"
under Section 423 of the Code. The provisions of the Plan, accordingly, shall be
construed so as to extend and limit  participation  in a manner  consistent with
the requirements of that section of the Code.

     2.   Definitions.

          (a)  "Board" shall mean the Board of Directors of the Company.

          (b)  "Code" shall mean the Internal Revenue Code of 1986, as amended.

          (c)  "Common Stock" shall mean the Common Stock of the Company.

          (d)  "Company" shall mean Actel Corporation, a California corporation.

          (e)  "Compensation"  shall mean all base straight time gross  earnings
     including  commissions,  overtime  and shift  premiums,  and all  incentive
     compensation, incentive payments, bonuses and other compensation.

          (f)  "Designated  Subsidiaries" shall mean the Subsidiaries which have
     been  designated  by the Board from time to time in its sole  discretion as
     eligible to participate in the Plan.

          (g)  "Employee"  shall mean any  individual  who is an employee of the
     Company or any Designated Subsidiary for tax purposes whose employment with
     the Company or any  Designated  Subsidiary  averages  at least  twenty (20)
     hours per week and more than five (5)  months  in any  calendar  year.  For
     purposes  of the Plan,  the  employment  relationship  shall be  treated as
     continuing  intact while the  individual is on sick leave or other leave of
     absence approved by the Company.  Where the period of leave exceeds 90 days
     and the  individual's  right to  reemployment  is not guaranteed  either by
     statute or by contract, the employment  relationship will be deemed to have
     terminated on the 91st day of such leave.

          (h)  "Enrollment  Date"  shall  mean the  first  day of each  Offering
     Period.

          (i)  "Exercise Date" shall mean the last day of each Purchase Period.

          (j)  "Fair  Market  Value"  shall mean,  as of any date,  the value of
     Common Stock determined as follows:

               (1)  If the  Common  Stock is  listed  on any  established  stock
          exchange or a national market system, including without limitation the
          National  Market  System of the  National  Association  of  Securities
          Dealers,  Inc. Automated Quotation  ("NASDAQ") System, its Fair Market
          Value  shall be the  closing  sale price for the Common  Stock (or the
          mean of the closing bid and asked prices,  if no sales were reported),
          as quoted on such exchange (or the exchange  with the greatest  volume
          of  trading   in  Common   Stock)  or  system  on  the  date  of  such
          determination,  as reported  in the Wall Street  Journal or such other
          source as the Board deems reliable, or;

               (2)  If the Common Stock is quoted on the NASDAQ  system (but not
          on the National  Market  System  thereof) or is regularly  quoted by a
          recognized securities dealer but selling prices are not reported,  its
          Fair  Market  Value  shall be the mean of the  closing  bid and  asked
          prices  for the  Common  Stock on the date of such  determination,  as
          reported in the Wall Street  Journal or such other source as the Board
          deems reliable, or;

               (3)  In the  absence  of an  established  market  for the  Common
          Stock, the Fair Market Value thereof shall be determined in good faith
          by the Board.

               (4)  For purposes of the Enrollment Date under the first Offering
          Period under the Plan, the Fair Market Value of the Common Stock shall
          be the Price to Public as set forth in the final prospectus filed with
          the Securities and Exchange  Commission pursuant to Rule 424 under the
          Securities Act of 1933, as amended.

          (k)  "Offering   Period"  shall  mean  the  period  of   approximately
     twenty-four (24) months during which an option granted pursuant to the Plan
     may be exercised. The first offering period shall commence with the date on
     which the  Company's  registration  statement on Form S-1 (or any successor
     form  thereof)  is  declared  effective  by  the  Securities  and  Exchange
     Commission.  This first offering period shall terminate on the last Trading
     Day in the period  ending  August 1 or February 1  approximately  24 months
     later.  Subsequent offering periods shall commence on the first Trading Day
     on or after August 1 and February 1 of each year and  terminate on the last
     Trading Day of the periods ending  twenty-four  months later.  The duration
     and timing of Offering Periods may be changed pursuant to Section 4 of this
     Plan.

          (l)  "Plan" shall mean this Employee Stock Purchase Plan.

          (m)  "Purchase  Price"  shall mean an amount  equal to 85% of the Fair
     Market  Value of a share of Common Stock on the  Enrollment  Date or on the
     Exercise Date, whichever is lower.

          (n)  "Purchase  Period" shall mean the  approximately six month period
     commencing  after one Exercise Date and ending with the next Exercise Date,
     except that the first Purchase Period of any Offering Period shall commence
     on the Enrollment  Date and end with the next Exercise Date.  However,  the
     first Purchase  Period of the first  Offering  Period under the Plan may be
     more or less than six months in duration.

          (o)  "Reserves"  shall  mean the  number of  shares  of  Common  Stock
     covered by each option under the Plan which have not yet been exercised and
     the  number of  shares  of Common  Stock  which  have been  authorized  for
     issuance under the Plan but not yet placed under options.

          (p)  "Subsidiary"  shall mean a corporation,  domestic or foreign,  of
     which not less than 50% of the voting  shares are held by the  Company or a
     Subsidiary,  whether or not such  corporation  now  exists or is  hereafter
     organized or acquired by the Company or a Subsidiary.

          (q)  "Trading Day" shall mean a day on which national stock  exchanges
     and the National  Association  of Securities  Dealers  Automated  Quotation
     (NASDAQ) System are open for trading.

     3.   Eligibility.

          (a)  Any Employee (as defined in Section 2(g)),  who shall be employed
     by the Company on a given  Enrollment Date shall be eligible to participate
     in the Plan.

          (b)  Any  provisions of the Plan to the contrary  notwithstanding,  no
     Employee shall be granted an option under the Plan (i) if immediately after
     the  grant,  such  Employee  (or any  other  person  whose  stock  would be
     attributed to such Employee  pursuant to Section  424(d) of the Code) would
     own  capital  stock of the  Company  and/or  hold  outstanding  options  to
     purchase  such  stock  possessing  five  percent  (5%) or more of the total
     combined  voting power or value of all classes of the capital  stock of the
     Company or of any  Subsidiary,  or (ii) which  permits his or her rights to
     purchase  stock under all employee  stock purchase plans of the Company and
     its  subsidiaries  to accrue at a rate which exceeds  twenty-five  thousand
     dollars  ($25,000)  of Fair Market Value of such stock  (determined  at the
     time such option is granted) for each calendar year in which such option is
     outstanding at any time.

     4.   Offering  Periods.  The Plan  shall  be  implemented  by  consecutive,
overlapping  Offering Periods with the first Offering Period commencing with the
date on which the Company's registration statement on Form S-1 (or any successor
form thereof) is declared  effective by the Securities and Exchange  Commission.
The Board  shall  have the power to change  the  duration  of  Offering  Periods
(including  the  commencement  dates  thereof) with respect to future  offerings
without shareholder  approval if such change is announced at least five (5) days
prior to the scheduled  beginning of the first  Offering  Period to be affected.
Absent  action  by the  Board,  each  Offering  Period  shall be for a period of
approximately twenty-four months (24) and new Offering Periods shall commence on
the first  Trading Day of February and August of each year.  The first  Offering
Period  under  the Plan may be more or less  than  twenty-four  (24)  months  in
duration.

     5.   Participation.

          (a)  An  eligible  Employee  may become a  participant  in the Plan by
     completing a subscription  agreement authorizing payroll deductions (in the
     form of Exhibit A to this Plan) and  filing it with the  Company's  payroll
     office prior to the applicable Enrollment Date.

          (b)  Payroll  deductions for a participant shall commence on the first
     payroll  following the Enrollment Date and shall end on the last payroll in
     the  Offering  Period to which such  authorization  is  applicable,  unless
     sooner terminated by the participant as provided in Section 10 hereof.

     6.   Payroll Deductions.

          (a) At the time a participant files his or her subscription agreement,
     he or she  shall  elect  to have  payroll  deductions  made on each pay day
     during the Offering Period in an amount not exceeding fifteen percent (15%)
     of the  Compensation  which he or she  receives  on each pay day during the
     Offering Period,  and the aggregate of such payroll  deductions  during the
     Offering Period shall not exceed fifteen percent (15%) of the participant's
     Compensation during said Offering Period.

          (b)  All payroll  deductions made for a participant  shall be credited
     to his or her  account  under  the  Plan  and  will be  withheld  in  whole
     percentages  only. A participant may not make any additional  payments into
     such account.

          (c)  A participant  may discontinue  his or her  participation  in the
     Plan as provided in Section 10 hereof, or may increase or decrease the rate
     of his or her payroll  deductions during the Offering Period by filing with
     the Company a new  subscription  agreement  authorizing a change in payroll
     deduction  rate.  The Board  may,  in its  discretion,  limit the number of
     participation  rate changes during any Offering Period.  The change in rate
     shall be effective  with the first full payroll  period  following five (5)
     business days after the Company's receipt of the new subscription agreement
     unless the Company elects to process a given change in  participation  more
     quickly. A participant's  subscription agreement shall remain in effect for
     successive  Offering  Periods  unless  terminated as provided in Section 10
     hereof.

          (d)  Notwithstanding the foregoing,  to the extent necessary to comply
     with Section 423(b)(8) of the Code and Section 3(b) hereof, a participant's
     payroll  deductions  may be decreased to 0% if the following  should occur:
     For the Purchase Periods that end during a single calendar year, the sum of
     all payroll deductions that have been used to purchase stock under the Plan
     plus all payroll  deductions  accumulated  for the purchase of stock equals
     $21,250.  Payroll  deductions shall recommence at the rate provided in such
     participant's subscription agreement at the beginning of the first Purchase
     Period which is scheduled to end in the subsequent  calendar  year,  unless
     terminated by the participant as provided in Section 10 hereof.

          (e)  At the time the option is  exercised,  in whole or in part, or at
     the time some or all of the Company's Common Stock issued under the Plan is
     disposed of, the participant must make adequate provision for the Company's
     federal, state, or other tax withholding  obligations,  if any, which arise
     upon the exercise of the option or the  disposition of the Common Stock. At
     any time, the Company may, but will not be obligated to,  withhold from the
     participant's  compensation  the amount  necessary  for the Company to meet
     applicable withholding  obligations,  including any withholding required to
     make available to the Company any tax  deductions or benefits  attributable
     to sale or early disposition of Common Stock by the Employee.

     7.   Grant of Option. On the Enrollment Date of each Offering  Period, each
eligible  Employee  participating  in such  Offering  Period shall be granted an
option  to  purchase  on the  Exercise  Date of  such  Offering  Period  (at the
applicable  Purchase  Price) up to a number of  shares of the  Company's  Common
Stock  determined by dividing such  Employee's  payroll  deductions  accumulated
prior to such Exercise Date and retained in the Participant's  account as of the
Exercise  Date by the  applicable  Purchase  Price;  provided that such purchase
shall be subject to the  limitations  set forth in Sections  3(b) and 12 hereof;
provided, further, that in no event shall any Employee purchase in excess of ten
thousand  shares in any Offering  Period.  Exercise of the option shall occur as
provided in Section 8 hereof,  unless the participant has withdrawn  pursuant to
Section 10 hereof,  and the option  shall expire on the last day of the Offering
Period.

     8.   Exercise of Option.  Unless a participant  withdraws  from the Plan as
provided in Section 10 hereof, his or her option for the purchase of shares will
be exercised  automatically on the Exercise Date, and the maximum number of full
shares  subject to the option shall be  purchased  for such  participant  at the
applicable  Purchase Price with the accumulated payroll deductions in his or her
account.  No  fractional  shares  will  be  purchased;  any  payroll  deductions
accumulated  in a  participant's  account which are not sufficient to purchase a
full share  shall be retained in the  participant's  account for the  subsequent
Purchase Period, subject to earlier withdrawal by the participant as provided in
Section 10 hereof.  Any other monies left over in a participant's  account after
the Exercise Date shall be returned to the  participant.  During a participant's
lifetime,  a participant's  option to purchase  shares  hereunder is exercisable
only by him or her.

     9.   Delivery. As promptly as practicable after each Exercise Date on which
a purchase of shares  occurs,  the Company  shall  arrange the  delivery to each
participant,  as appropriate, of a certificate representing the shares purchased
upon exercise of his or her option.

     10.  Withdrawal; Termination of Employment.

          (a)  A participant  may withdraw all but not less than all the payroll
     deductions  credited to his or her account and not yet used to exercise his
     or her option  under the Plan at any time by giving  written  notice to the
     Company  in the form of Exhibit B to this  Plan.  All of the  participant's
     payroll  deductions  credited  to his or her  account  will be paid to such
     participant  promptly  after  receipt  of  notice  of  withdrawal  and such
     participant's   option  for  the  Offering  Period  will  be  automatically
     terminated,  and no further  payroll  deductions for the purchase of shares
     will be made during the Offering Period. If a participant withdraws from an
     Offering Period, payroll deductions will not resume at the beginning of the
     succeeding Offering Period unless the participant delivers to the Company a
     new subscription agreement.

          (b)  Upon a  participant's  ceasing to be an  Employee  (as defined in
     Section  2(g)  hereof),  for any reason,  including by virtue of him or her
     having failed to remain an Employee of the Company for at least twenty (20)
     hours  per week  during  a  Purchase  Period  in which  the  Employee  is a
     participant,  he or she will be deemed to have elected to withdraw from the
     Plan and the  payroll  deductions  credited to such  participant's  account
     during the Offering  Period but not yet used to exercise the option will be
     returned to such  participant  or, in the case of his or her death,  to the
     person or persons  entitled  thereto  under  Section  14  hereof,  and such
     participant's option will be automatically terminated.

     11.  Interest.  No interest  shall  accrue on the payroll  deductions  of a
participant in the Plan.

     12.  Stock.

               (a) The maximum  number of shares of the  Company's  Common Stock
        which shall be made available for sale under the Plan shall be 3,019,680
        shares,  subject to  adjustment  upon changes in  capitalization  of the
        Company as provided in Section 18 hereof.  If on a given  Exercise  Date
        the number of shares with  respect to which  options are to be exercised
        exceeds the number of shares then available  under the Plan, the Company
        shall make a pro rata allocation of the shares  remaining  available for
        purchase in as uniform a manner as shall be practicable  and as it shall
        determine to be equitable.

          (b)  The  participant  will have no interest or voting right in shares
     covered by his option until such option has been exercised.

          (c)  Shares to be  delivered to a  participant  under the Plan will be
     registered in the name of the participant or in the name of the participant
     and his or her spouse.

     13.  Administration.

          (a)  Administrative  Body. The Plan shall be administered by the Board
     or a committee of members of the Board appointed by the Board. The Board or
     its  committee  shall have full and  exclusive  discretionary  authority to
     construe,  interpret  and  apply  the  terms  of  the  Plan,  to  determine
     eligibility  and to  adjudicate  all disputed  claims filed under the Plan.
     Every  finding,  decision  and  determination  made  by  the  Board  or its
     committee  shall, to the full extent permitted by law, be final and binding
     upon all  parties.  Members  of the Board who are  eligible  Employees  are
     permitted to participate in the Plan, provided that:

               (1)  Members of the Board who are eligible to  participate in the
          Plan may not vote on any matter  affecting the  administration  of the
          Plan or the grant of any option pursuant to the Plan.

               (2)  If a Committee is  established  to  administer  the Plan, no
          member of the Board who is eligible to  participate in the Plan may be
          a member of the Committee.

          (b)  Rule  16b-3  Limitations.   Notwithstanding   the  provisions  of
     Subsection (a) of this Section 13, in the event that Rule 16b-3 promulgated
     under the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
     or any successor  provision ("Rule 16b-3") provides  specific  requirements
     for the  administrators  of plans  of this  type,  the  Plan  shall be only
     administered  by such a body and in such a manner as shall  comply with the
     applicable  requirements of Rule 16b-3.  Unless permitted by Rule 16b-3, no
     discretion concerning decisions regarding the Plan shall be afforded to any
     committee  or person  that is not  "disinterested"  as that term is used in
     Rule 16b-3.

     14.  Designation of Beneficiary.

          (a)  A participant may file a written designation of a beneficiary who
     is to receive any shares and cash, if any, from the  participant's  account
     under the Plan in the event of such  participant's  death  subsequent to an
     Exercise  Date on which the option is  exercised  but prior to  delivery to
     such  participant of such shares and cash. In addition,  a participant  may
     file a written designation of a beneficiary who is to receive any cash from
     the participant's account under the Plan in the event of such participant's
     death prior to exercise of the option.  If a participant is married and the
     designated beneficiary is not the spouse, spousal consent shall be required
     for such designation to be effective.

          (b)  Such designation of beneficiary may be changed by the participant
     at any time by written  notice.  In the event of the death of a participant
     and in the absence of a beneficiary  validly  designated under the Plan who
     is  living  at the time of such  participant's  death,  the  Company  shall
     deliver  such shares  and/or cash to the executor or  administrator  of the
     estate of the participant, or if no such executor or administrator has been
     appointed  (to  the  knowledge  of  the  Company),   the  Company,  in  its
     discretion, may deliver such shares and/or cash to the spouse or to any one
     or more  dependents  or  relatives  of the  participant,  or if no  spouse,
     dependent or relative is known to the Company, then to such other person as
     the Company may designate.

     15.  Transferability.    Neither   payroll   deductions   credited   to   a
participant's account nor any rights with regard to the exercise of an option or
to  receive  shares  under the Plan may be  assigned,  transferred,  pledged  or
otherwise  disposed of in any way (other  than by will,  the laws of descent and
distribution or as provided in Section 14 hereof) by the  participant.  Any such
attempt at assignment,  transfer,  pledge or other  disposition shall be without
effect,  except  that the  Company may treat such act as an election to withdraw
funds from an Offering Period in accordance with Section 10 hereof.

     16.  Use of Funds. All payroll  deductions  received or held by the Company
under the Plan may be used by the Company  for any  corporate  purpose,  and the
Company shall not be obligated to segregate such payroll deductions.

     17.  Reports.  Individual  accounts will be maintained for each participant
in the Plan.  Statements of account will be given to participating  Employees at
least  annually,  which  statements  will  set  forth  the  amounts  of  payroll
deductions, the Purchase Price, the number of shares purchased and the remaining
cash balance, if any.

     18.  Adjustments Upon Changes in Capitalization.

          (a)  Changes in Capitalization.  Subject to any required action by the
     shareholders of the Company, the Reserves as well as the price per share of
     Common  Stock  covered by each option under the Plan which has not yet been
     exercised shall be proportionately adjusted for any increase or decrease in
     the number of issued shares of Common Stock  resulting  from a stock split,
     reverse stock split, stock dividend, combination or reclassification of the
     Common Stock,  or any other increase or decrease in the number of shares of
     Common Stock  effected  without  receipt of  consideration  by the Company;
     provided,  however,  that conversion of any  convertible  securities of the
     Company  shall  not be deemed to have been  "effected  without  receipt  of
     consideration".   Such  adjustment  shall  be  made  by  the  Board,  whose
     determination  in that  respect  shall be final,  binding  and  conclusive.
     Except as expressly  provided herein,  no issuance by the Company of shares
     of stock of any class,  or securities  convertible  into shares of stock of
     any class,  shall affect, and no adjustment by reason thereof shall be made
     with respect to, the number or price of shares of Common  Stock  subject to
     an option.

          (b)  Dissolution  or  Liquidation.   In  the  event  of  the  proposed
     dissolution  or  liquidation  of the  Company,  the  Offering  Periods will
     terminate  immediately  prior to the  consummation of such proposed action,
     unless otherwise provided by the Board.

          (c)  Merger or Asset Sale.  In the event of a proposed  sale of all or
     substantially  all of the  assets  of the  Company,  or the  merger  of the
     Company with or into another corporation,  each option under the Plan shall
     be assumed or an equivalent  option shall be  substituted by such successor
     corporation or a parent or subsidiary of such successor corporation, unless
     the Board determines, in the exercise of its sole discretion and in lieu of
     such assumption or  substitution,  to shorten the Offering  Periods then in
     progress by setting a new  Exercise  Date (the "New  Exercise  Date") or to
     cancel each  outstanding  option to purchase and refund all sums  collected
     from participants during the Offering Period then in progress. If the Board
     shortens the Offering  Periods  then in progress in lieu of  assumption  or
     substitution  in the event of a merger or sale of assets,  the Board  shall
     notify each  participant in writing,  at least ten (10) business days prior
     to the New Exercise  Date,  that the Exercise  Date for his option has been
     changed  to the New  Exercise  Date and that his option  will be  exercised
     automatically  on the New Exercise  Date,  unless prior to such date he has
     withdrawn  from the Offering  Period as provided in Section 10 hereof.  For
     purposes  of this  paragraph,  an option  granted  under the Plan  shall be
     deemed to be assumed if, following the sale of assets or merger, the option
     confers  the right to  purchase,  for each  share of stock  subject  to the
     option immediately prior to the sale of assets or merger, the consideration
     (whether stock, cash or other securities or property)  received in the sale
     of assets or merger by  holders  of Common  Stock for each  share of Common
     Stock held on the effective  date of the  transaction  (and if such holders
     were offered a choice of consideration, the type of consideration chosen by
     the  holders  of a majority  of the  outstanding  shares of Common  Stock);
     provided,  however,  that if such  consideration  received  in the  sale of
     assets or merger was not solely common stock of the  successor  corporation
     or its parent (as  defined in Section  424(e) of the Code),  the Board may,
     with the consent of the successor corporation and the participant,  provide
     for the  consideration  to be  received  upon  exercise of the option to be
     solely  common stock of the  successor  corporation  or its parent equal in
     fair  market  value to the per share  consideration  received by holders of
     Common Stock and the sale of assets or merger.

               The Board may, if it so  determines  in the  exercise of its sole
     discretion,  also make provision for adjusting the Reserves, as well as the
     price per share of Common Stock covered by each outstanding  option, in the
     event the Company effects one or more  reorganizations,  recapitalizations,
     rights  offerings  or  other  increases  or  reductions  of  shares  of its
     outstanding   Common  Stock,   and  in  the  event  of  the  Company  being
     consolidated with or merged into any other corporation.

     19.  Amendment or Termination.

          (a) The Board of  Directors of the Company may at any time and for any
     reason  terminate or amend the Plan.  Except as provided in Sections 18 and
     19 hereof,  no such  termination  can affect  options  previously  granted,
     provided that  outstanding  and/or future Offering Periods may be shortened
     and/or terminated by the Board of Directors at any time. Except as provided
     in Section 18 hereof and in the preceding  sentence,  no amendment may make
     any change in any option  theretofore  granted which adversely  affects the
     rights of any  participant.  To the extent  necessary  to comply  with Rule
     16b-3 or under Section 423 of the Code (or any successor  rule or provision
     or any other  applicable  law or  regulation),  the  Company  shall  obtain
     shareholder approval in such a manner and to such a degree as required.

          (b)  Without  shareholder  consent and  without  regard to whether any
     participant rights may be considered to have been "adversely affected," the
     Board (or its committee) shall be entitled to change the Offering  Periods,
     limit the frequency  and/or number of changes in the amount withheld during
     an Offering  Period,  establish  the exchange  ratio  applicable to amounts
     withheld in a currency other than U.S. dollars,  permit payroll withholding
     in excess of the amount  designated by a participant in order to adjust for
     delays or  mistakes  in the  Company's  processing  of  properly  completed
     withholding elections,  establish reasonable waiting and adjustment periods
     and/or  accounting and crediting  procedures to ensure that amounts applied
     toward  the  purchase  of  Common  Stock  for  each  participant   properly
     correspond with amounts withheld from the participant's  Compensation,  and
     establish  such  other  limitations  or  procedures  as the  Board  (or its
     committee) determines in its sole discretion advisable which are consistent
     with the Plan.

     20.  Notices.  All notices or other  communications by a participant to the
Company under or in  connection  with the Plan shall be deemed to have been duly
given when received in the form specified by the Company at the location,  or by
the person, designated by the Company for the receipt thereof.

     21.  Conditions  Upon  Issuance of Shares.  Shares shall not be issued with
respect to an option  unless the  exercise of such option and the  issuance  and
delivery of such  shares  pursuant  thereto  shall  comply  with all  applicable
provisions  of law,  domestic or foreign,  including,  without  limitation,  the
Securities  Act of 1933,  as amended,  the  Securities  Exchange Act of 1934, as
amended, the rules and regulations promulgated thereunder,  and the requirements
of any stock  exchange  upon which the  shares may then be listed,  and shall be
further  subject to the approval of counsel for the Company with respect to such
compliance.

          As a condition to the  exercise of an option,  the Company may require
the person  exercising  such option to represent  and warrant at the time of any
such  exercise  that the  shares are being  purchased  only for  investment  and
without  any  present  intention  to sell or  distribute  such shares if, in the
opinion of counsel for the Company,  such a representation is required by any of
the aforementioned applicable provisions of law.

     22.  Term of Plan.  The Plan shall  become  effective  upon the  earlier to
occur  of its  adoption  by the  Board  of  Directors  or  its  approval  by the
shareholders of the Company.  It shall continue in effect for a term of ten (10)
years unless sooner terminated under Section 19 hereof.

     23.  Additional  Restrictions  of Rule 16b-3.  The terms and  conditions of
options granted  hereunder to, and the purchase of shares by, persons subject to
Section 16 of the Exchange Act shall comply with the  applicable  provisions  of
Rule  16b-3.  This Plan  shall be  deemed to  contain,  and such  options  shall
contain,  and the shares issued upon exercise  thereof shall be subject to, such
additional  conditions  and  restrictions  as may be  required  by Rule 16b-3 to
qualify for the  maximum  exemption  from  Section 16 of the  Exchange  Act with
respect to Plan transactions.

     24.  Automatic  Transfer  to Low  Price  Offering  Period.  To  the  extent
permitted by Rule 16b-3 of the Securities  Exchange Act of 1934, as amended,  if
the Fair Market Value of the Common  Stock on any  Exercise  Date in an Offering
Period is lower than the Fair Market Value of the Common Stock on the Enrollment
Date of such Offering  Period,  then all  participants  in such Offering  Period
shall be automatically withdrawn from such Offering Period immediately after the
exercise of their options on such Exercise Date and automatically re-enrolled in
the immediately following Offering Period as of the first day thereof.


                                    EXHIBIT A

                                ACTEL CORPORATION
                        1993 EMPLOYEE STOCK PURCHASE PLAN

                             SUBSCRIPTION AGREEMENT

__________ Original Application          Enrollment Date: ______________________
__________ Change in Payroll Deduction Rate
__________ Change of Beneficiary(ies)

     1.   ____________________________________________________  hereby elects to
participate  in the Actel  Corporation  1993 Employee  Stock  Purchase Plan (the
"Employee  Stock  Purchase  Plan")  and  subscribes  to  purchase  shares of the
Company's  Common Stock in accordance with this  Subscription  Agreement and the
Employee Stock Purchase Plan.

     2.   I hereby authorize payroll deductions from each paycheck in the amount
of _________% of my  Compensation  on each payday (not to exceed 15%) during the
Offering  Period in accordance  with the Employee Stock  Purchase Plan.  (Please
note that no fractional percentages are permitted.)

     3.   I understand that said payroll deductions shall be accumulated for the
purchase of shares of Common Stock at the applicable  Purchase Price  determined
in accordance  with the Employee Stock Purchase Plan. I understand  that if I do
not withdraw from an Offering Period, any accumulated payroll deductions will be
used to automatically exercise my option.

     4.   I  have  received  a copy  of the  complete  "Actel  Corporation  1993
Employee  Stock  Purchase  Plan."  I  understand  that my  participation  in the
Employee  Stock  Purchase  Plan is in all  respects  subject to the terms of the
Plan.  I  understand  that the grant of the  option by the  Company  under  this
Subscription  Agreement  is subject to  obtaining  shareholder  approval  of the
Employee Stock Purchase Plan.

     5.   Shares  purchased for me under the Employee Stock Purchase Plan should
be  issued  in  the  name(s)  of  (Employee   or  Employee  and  Spouse   Only):
_______________________________________________________________________________.

     6.   I understand  that if I dispose of any shares  received by me pursuant
to the Plan  within 2 years  after the  Enrollment  Date  (the  first day of the
Offering  Period  during  which I purchased  such  shares) or one year after the
Exercise  Date,  I will be treated  for  federal  income tax  purposes as having
received  ordinary income at the time of such  disposition in an amount equal to
the excess of the fair  market  value of the shares at the time such shares were
purchased  over the price which I paid for the shares.  I hereby agree to notify
the Company in writing  within 30 days after the date of any  disposition  of my
shares  and I will  make  adequate  provision  for  Federal,  state or other tax
withholding obligations,  if any, which arise upon the disposition of the Common
Stock.  The  Company  may,  but  will  not be  obligated  to,  withhold  from my
compensation the amount necessary to meet any applicable  withholding obligation
including  any  withholding  necessary to make  available to the Company any tax
deductions or benefits attributable to sale or early disposition of Common Stock
by me.  If I dispose  of such  shares at any time  after the  expiration  of the
2-year and 1-year  holding  periods,  I  understand  that I will be treated  for
federal income tax purposes as having  received  income only at the time of such
disposition,  and that such income will be taxed as ordinary  income only to the
extent of an amount  equal to the  lesser of (1) the  excess of the fair  market
value of the  shares at the time of such  disposition  over the  purchase  price
which I paid for the shares,  or (2) 15% of the fair market  value of the shares
on the first day of the Offering  Period.  The  remainder  of the gain,  if any,
recognized on such disposition will be taxed as capital gain.

     7.   I hereby agree to be bound by the terms of the Employee Stock Purchase
Plan.  The  effectiveness  of this  Subscription  Agreement is dependent upon my
eligibility to participate in the Employee Stock Purchase Plan.

     8.   In the event of my  death,  I hereby  designate  the  following  as my
beneficiary  to receive all payments and shares due me under the Employee  Stock
Purchase Plan (if you wish to designate more than one  beneficiary,  execute and
deliver copies of this page):

                                  PLEASE PRINT!

NAME:___________________________________________________________________________
           (First)              (Middle)               (Last)

_______________________________________
           Relationship
                                        ________________________________________
                                        ________________________________________
                                        ________________________________________
                                                       (Address)

     I  UNDERSTAND  THAT  THIS  SUBSCRIPTION  AGREEMENT  SHALL  REMAIN IN EFFECT
THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS TERMINATED BY ME.


Dated:_________________________________ ________________________________________
                                                 Signature of Employee

                                        ________________________________________
                                                   Spouse's Signature
                                           (If beneficiary other than spouse)


                                    EXHIBIT B

                                ACTEL CORPORATION

                        1993 EMPLOYEE STOCK PURCHASE PLAN

                              NOTICE OF WITHDRAWAL


     The undersigned participant in the Offering Period of the Actel Corporation
1993 Employee  Stock  Purchase  Plan which began on  __________________________,
19_____  (the  "Enrollment  Date")  hereby  notifies  the Company that he or she
hereby withdraws from the Offering Period.  He or she hereby directs the Company
to pay to the undersigned as promptly as practicable all the payroll  deductions
credited  to his or her  account  with  respect  to such  Offering  Period.  The
undersigned  understands  and agrees  that his or her  option for such  Offering
Period will be automatically  terminated.  The undersigned  understands  further
that no further  payroll  deductions  will be made for the purchase of shares in
the current Offering Period and the undersigned shall be eligible to participate
in  succeeding  Offering  Periods  only  by  delivering  to  the  Company  a new
Subscription Agreement.

                                        ________________________________________
                                        ________________________________________
                                        ________________________________________
                                        ________________________________________
                                            (Name and Address of Participant)

                                        ________________________________________
                                                       (Signature)

                                        ________________________________________
                                                          (Date)


                                                 ACTEL CORPORATION

                                       SELECTED CONSOLIDATED FINANCIAL DATA
                                       (in thousands, except per share data)

<TABLE>
<CAPTION>
                                                                      Year Ended December 31,
                                                --------------------------------------------------------------------
                                                    1997          1996          1995          1994          1993
                                                ------------  ------------  ------------  ------------  ------------
<S>                                             <C>           <C>           <C>           <C>           <C>         
Statements of Operations Data:
Net revenues................................    $    155,858  $    148,779  $    108,516  $     76,007  $     59,598
Costs and expenses:
   Cost of revenues.........................          64,244        64,420        52,517        33,349        26,389
   Research and development.................          26,465        23,934        20,560        14,406        10,953
   Selling, general, and administrative.....          41,194        38,395        27,364        19,699        16,708
   In-process R&D (1).......................              --            --        16,600            --            --
                                                ------------  ------------  ------------  ------------  ------------
         Total costs and expenses...........         131,903       126,749       117,041        67,454        54,050
                                                ------------  ------------  ------------  ------------  ------------
Income (loss) from operations...............          23,955        22,030        (8,525)        8,553         5,548
Interest expense............................              --           (13)          (93)         (232)         (559)
Interest income and other, net..............           1,842         1,068           846           935           569
                                                ------------  ------------  ------------  ------------  ------------
Income (loss) before taxes..................          25,797        23,085        (7,772)        9,256         5,558
Tax provision (benefit).....................           9,029         8,147        (6,640)        1,389           555
                                                ------------  ------------  ------------  ------------  ------------
Net income (loss)...........................    $     16,768  $     14,938  $     (1,132) $      7,867  $      5,003
                                                ============  ============  ============  ============  ============
Net income (loss) per share:
   Basic (2)................................    $       0.82  $       0.84  $     (0.07)  $       0.46  $       0.33
                                                ============  ============  ============  ============  ============
   Diluted (2)..............................    $       0.76  $       0.70  $     (0.07)  $       0.45  $       0.32
                                                ============  ============  ============  ============  ============
Shares used in computing net income (loss) per share:
   Basic....................................          20,370        17,826        17,367        16,995        15,086
                                                ============  ============  ============  ============  ============
   Diluted..................................          21,968        21,485        17,367        17,579        15,811
                                                ============  ============  ============  ============  ============
</TABLE>
<TABLE>
<CAPTION>
                                                                            December 31,
                                                --------------------------------------------------------------------
                                                    1997          1996          1995          1994          1993
                                                ------------  ------------  ------------  ------------  ------------
<S>                                             <C>           <C>           <C>           <C>           <C>         
 Consolidated Balance Sheet Data:
 Working capital............................    $     76,279  $     55,397  $     39,867  $     35,971  $     32,330
 Total assets...............................         159,994       136,712       107,119        67,855        61,130
 Long-term obligations (3)..................              --            --            --            72           926
 Convertible preferred stock (4)............              --        18,147        18,147            --            --
 Total shareholders' equity.................         109,010        69,357        50,920        49,311        40,223

- -----------------------------------------------------------
<FN>
   (1)      Represents a charge for in-process research and development incurred
            in the  first  quarter  of 1995 in  connection  with  the  Company's
            acquisition of the field  programmable  gate array business of Texas
            Instruments Incorporated ("TI").

   (2)      The earnings per share  amounts  prior to 1997 have been restated as
            required to comply with Statement of Financial  Accounting Standards
            No.  128,  "Earnings  Per  Share."  See  Notes 1 and 13 of  Notes to
            Consolidated Financial Statements for further discussion of earnings
            per share and the impact of Statement No. 128.

   (3)      Includes   long-term   portion  of  notes  payable,   capital  lease
            obligations, and settlement payable.

   (4)      Represents  redeemable,  convertible preferred stock issued to TI in
            connection with the Company's acquisition of TI's field programmable
            gate array  business.  On March 12, 1997,  TI converted the Series A
            Preferred Stock into 2,631,578 shares of Common Stock.
</FN>
</TABLE>
<PAGE>
                      MANAGEMENT'S DISCUSSION AND ANALYSIS
                OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     Actel Corporation is the world's leading supplier of  antifuse-based  field
programmable gate arrays ("FPGAs") and associated  software  development  tools.
FPGAs are used by  designers of  communication,  computer,  industrial  control,
military/aerospace, and other electronic systems to differentiate their products
and get them to market faster.

Results of Operations

     The following table sets forth certain financial data from the Consolidated
Statements of Operations expressed as a percentage of net revenues:
<TABLE>
<CAPTION>
                                                                                    Year Ended December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
<S>                                                                            <C>           <C>           <C>   
Net revenues............................................................       100.0%        100.0%        100.0%
Cost of revenues........................................................        41.2          43.3          48.4
                                                                            ------------  ------------  ------------
Gross margin............................................................        58.8          56.7          51.6
Research and development................................................        17.0          16.1          19.0
Selling, general, and administrative....................................        26.4          25.8          25.2
In-process research and development.....................................         --            --           15.3
                                                                            ------------  ------------  ------------
Income (loss) from operations...........................................        15.4          14.8          (7.9)
Interest and other income, net..........................................         1.2           0.7           0.7
                                                                            ------------  ------------  ------------
Income (loss) before taxes..............................................        16.6          15.5          (7.2)
Tax provision (benefit).................................................         5.8           5.5          (6.2)
                                                                            ------------  ------------  ------------
Net income (loss).......................................................        10.8%         10.0%         (1.0)%
                                                                            ============  ============  ============
</TABLE>

The  Company's  fiscal year ends on the Sunday  closest to December  31.  Fiscal
1997, 1996, and 1995 ended on December 28, 1997, December 29, 1996, and December
31, 1995, respectively. For ease of presentation,  December 31 has been utilized
as the fiscal year-end for all years.

     Acquisition of TI Antifuse FPGA Business

     On March 31, 1995,  the Company  completed its  acquisition of the antifuse
FPGA business of Texas Instruments  Incorporated  ("TI"), the only second-source
supplier of the Company's  products,  in a  transaction  accounted for using the
purchase method.  As consideration for the business  acquired,  the Company paid
$10.0 million in cash and issued  1,000,000  shares of Series A Preferred Stock.
The Preferred  Stock was valued for purposes of the transaction at $18.9 million
and was converted on March 12, 1997, into 2,631,578  shares of Common Stock. The
Company  expensed  the  in-process  research  and  development  acquired  in the
transaction, taking a pretax charge of $16.6 million against income in the first
quarter of 1995.  The Company  allocated  $4.4 million of the purchase  price to
intangible  assets (i.e.,  the customer base and goodwill  acquired),  which are
being amortized over five years.  Amortization  expense was $877,000,  $876,000,
and  $657,000  for  the  years  ended   December  31,  1997,   1996,  and  1995,
respectively.

     As a result of the acquisition,  the revenues of the business acquired from
TI are included  (beginning with the second quarter of 1995) in the net revenues
of the Company.  The Company  assumed and  subsequently  fulfilled TI's backlog,
which consisted  primarily of lower-margin ACT 1 and ACT 2 products with average
selling prices  generally lower than those charged by the Company for comparable
products.  These  product mix and average  selling price  influences  negatively
affected the Company's gross margin for 1995 and the absence of these influences
positively  affected the  Company's  gross  margin in  subsequent  quarters.  In
addition, the Company ceased receiving royalties (which had no associated costs)
from TI on sales  of FPGAs  following  the  acquisition.  See Note 3 of Notes to
Consolidated Financial Statements.

     Net Revenues

     Net  revenues for fiscal 1997 were $155.9  million,  an increase of 5% over
net revenues for fiscal 1996.  This compares with an increase in net revenues of
37% for fiscal 1996 over fiscal 1995. The Company's acquisition of TI's antifuse
FPGA business had a negative  influence on net revenues for the first quarter of
1995 and a positive effect on net revenues for subsequent quarters. Accordingly,
the year-over-year  growth rates in net revenues are not necessarily  indicative
of future results.

     The Company  derives its revenues  primarily from the sale of FPGAs,  which
accounted  for 98% of net revenues for 1997,  compared with 97% for 1996 and 95%
for 1995. The Company also derives revenues from the sale of development systems
and receipt of royalties.

     Net revenues from the sale of FPGAs for 1997 increased 6% over net revenues
from the sale of FPGAs for 1996.  This  compares  with an increase of 41% in net
revenues  from the sale of FPGAs for 1996 over 1995.  The growth in net revenues
from the sale of FPGAs for 1997 over 1996 was due  primarily to a 3% increase in
unit sales  coupled with a 2% increase in the overall  average  selling price of
FPGAs.  The growth in net revenues from the sale of FPGAs for 1996 over 1995 was
due  primarily to a 39% increase in unit sales coupled with a 7% increase in the
overall average selling prices of FPGAs. The increase in unit sales of FPGAs for
1996 was due  principally  to the  Company's  acquisition  of TI's antifuse FPGA
business.  The increases in the overall  average selling price of FPGAs for 1997
and  1996 was due  principally  to  proportionately  greater  unit  sales of the
Company's  newer (ACT 3, XL,  DX,  and RH)  product  families,  which  generally
command higher average selling prices than the Company's older (ACT 1 and ACT 2)
product families.

     Net  revenues  from the sale of FPGAs for the second half of 1997  declined
from the first half of 1997. This decline occurred in the Company's business for
both  commercial and  high-reliability  (or HiRel) FPGAs.  Commercial  FPGAs are
processed  using  the  Company's  standard  testing,  screening,  and  packaging
procedures.  In 1997,  the Company's  HiRel  business  consisted of military and
radiation-hardened  (or RH) FPGAs.  Military  FPGAs undergo  special or extended
testing,  screening,  and  packaging  procedures.  RH FPGAs are purchased by the
Company from Lockheed Martin Federal  Systems,  which has a proprietary  process
that makes RH products radiation-hardened without special testing, screening, or
packaging.  Orders for military and RH products tend to be large but  irregular,
and hence difficult to predict.  While the Company  believes that the demand for
HiRel FPGAs should rebound eventually, no assurance to that effect can be given.
The Company further believes that its commercial  business will resume a pattern
of growth as new products  are  introduced  and designed  into systems and those
systems come into  production.  The Company  introduced a new family of products
(MX) in the second half of 1997 and currently  expects to introduce  another new
family  (SX) in the first half of 1998.  Since  design wins take time and design
cycles are  lengthy,  the Company  views the  introduction  of new  products and
technologies as having an impact on revenues in the medium- to long-term.

     As is typical in the semiconductor  industry, the average selling prices of
the Company's  products  generally  decline over the lives of such products.  To
increase  revenues,  the  Company  seeks to  increase  unit  sales  of  existing
products,  principally  by  reducing  prices,  and to  introduce  and  sell  new
products. No assurance can be given that these efforts will be successful.

     Over  the  last  three  fiscal  years,  sales  to the  Company's  principal
distributors  have increased as a percentage of the Company's net revenues.  The
Company's principal  distributors are Wyle Electronics  Marketing Group ("Wyle")
and  Pioneer-Standard  Electronics,  Inc. ("Pioneer") in North America and Arrow
Electronics,  Inc. and Zeus Electronics  (collectively,  "Arrow") worldwide. The
following table sets forth,  for each of the last three years, the percentage of
revenues  derived from all customers  accounting for 10% or more of net revenues
in any of such years:
<TABLE>
<CAPTION>
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
<S>                                                                              <C>           <C>           <C>
Wyle....................................................................         17%           14%           14%
Arrow...................................................................         17            14            12
Pioneer.................................................................         12            11            11
</TABLE>

The  Company  generally  does not  recognize  revenue on a product  shipped to a
distributor until the distributor resells the product to its customer.

     Sales to  customers  outside  the United  States for 1997,  1996,  and 1995
accounted for 31%, 33%, and 38% of net revenues,  respectively.  Of these export
sales,  the largest  portion was derived from European  customers.  Export sales
have declined as a percentage of net revenues  principally because the Company's
radiation-hardened  (RH) product  family,  which was introduced in 1996, is sold
almost exclusively to customers within the United States.

     Gross Margin

     Gross  margin for 1997 was 59% of net  revenues,  compared  with 57% of net
revenues  for 1996 and 52% of net revenues for 1995.  The  improvement  in gross
margin for 1997 over 1996 resulted primarily from improved manufacturing yields;
wafer  price  reductions;  the  generation  of an  increased  percentage  of net
revenues from sales of the company's  newer product  families,  which  generally
command  higher  margins;  and  appreciation  in the value of the United  States
dollar versus the Japanese yen, in which some of the Company's  wafer  purchases
are denominated.

     The improvement in gross margin for 1996 over 1995 resulted  primarily from
the Company's acquisition of TI's FPGA business, which positively influenced the
Company's net revenues and overall  average  selling price.  The Company's gross
margin for 1996 also  benefited  from many of the same factors  indicated  above
that contributed to gross margin improvement for 1997.

     As is  typical in the  semiconductor  industry,  margins  on the  Company's
products  generally  decline  as the  average  selling  prices of such  products
decline.  The  Company  seeks to  offset  margin  erosion  by  selling  a higher
percentage of new products,  which tend to have higher  margins than more mature
products,  and by reducing costs. The Company seeks to reduce costs by improving
wafer yields, negotiating price reductions with suppliers,  increasing the level
and efficiency of its testing and packaging  operations,  achieving economies of
scale by means of higher  production  levels,  and  increasing the number of die
produced per wafer by shrinking the die size of its  products.  No assurance can
be given that these efforts will be successful. The capability of the Company to
shrink  the die  size of its  FPGAs is  dependent  on the  availability  of more
advanced  manufacturing   processes.   Due  to  the  custom  steps  involved  in
manufacturing  antifuse  FPGAs,  the  Company  typically  obtains  access to new
manufacturing  processes later than its competitors using standard manufacturing
processes.

     Research and Development

     Research and development  expenditures for 1997 were $26.5 million,  or 17%
of net revenues,  compared with $23.9 million, or 16% of net revenues,  for 1996
and $20.6 million,  or 19% of net revenues,  for 1995.  Research and development
expenditures  for 1997  increased by 11% compared with 1996,  and increased as a
percentage of net revenues  principally because net revenues for the second half
of  1997  declined  from  the  first  half of  1997.  Research  and  development
expenditures  for 1996  increased by 16% compared  with 1995,  but declined as a
percentage of net revenues due to economies of scale resulting from the expanded
scope of the Company's  operations.  The Company  currently intends to boost the
level  of  its  research  and   development   expenditures   to  accelerate  the
introduction of new products. As a result, research and development expenditures
may again increase as a percentage of net revenues.

     The Company's research and development consists of circuit design, software
development,  and  process  technology  activities.  The Company  believes  that
continued  substantial  investment  in research and  development  is critical to
maintaining  a strong  technological  position in the industry  and,  therefore,
expects to continue increasing its research and development expenditures.  Since
the Company's  antifuse FPGAs are manufactured using a customized  process,  the
Company's  research and development  expenditures will probably always be higher
as a percentage of net revenues than that of its major competitors.

     Selling, General, and Administrative

     Selling,  general, and administrative expenses for 1997 were $41.2 million,
or 26% of net revenues, compared with $38.4 million, or 26% of net revenues, for
1996 and $27.4 million, or 25% of net revenues, for 1995. Selling,  general, and
administrative  expenses for 1997 increased by 7% compared with 1996,  while the
Company's  net revenues for 1997  increased by 5% compared  with 1996.  Selling,
general,  and administrative  expenses for 1997 increased as a percentage of net
revenues  principally  because net revenues for the second half of 1997 declined
from the first half of 1997. Selling,  general, and administrative  expenses for
1996  increased by 40% compared with 1995,  while the Company's net revenues for
1996 increased by 37% compared with 1995. Selling,  general,  and administrative
expenses for 1996 increased as a percentage of net revenues  principally because
of an  increased  level of sales and  marketing  activities  in  support  of new
products. The Company currently intends to again increase its level of sales and
marketing activity in support of new products. In addition, the Company believes
that  its  legal  expenses  will  increase  as a  percentage  of  net  revenues,
principally  because of the  Company's  continuing  litigation  with  QuickLogic
Corporation.  See Note 12 of Notes to Consolidated  Financial  Statements.  As a
result, selling, general, and administrative  expenditures may again increase as
a percentage of net revenues.

     In-Process Research and Development

     The $16.6 million pretax charge for in-process research and development for
1995 resulted from a write-off  taken in the first quarter of 1995 in connection
with the Company's acquisition of TI's antifuse FPGA business.  The value of the
in-process research and development was established by an independent  valuation
specialist.

     Tax Provision

     The  Company's  effective  tax rate for 1997 and 1996 was 35%.  Significant
components affecting the effective tax rate include benefits of federal research
and  development  credits,  and the  recognition of certain  deferred tax assets
subject to valuation allowances as of December 31, 1996, and December 31, 1995.

     The  Company  recorded  a  credit  for  income  taxes  for  1995 due to the
realization of deferred tax assets previously  subject to valuation  allowances.
The  Company  recorded  additional  deferred  tax assets of  approximately  $3.0
million  related  to the  1995  charge  for  acquired  in-process  research  and
development, the realization of which is dependent upon the generation of future
taxable income.

Financial Condition, Liquidity, and Capital Resources

     The Company's total assets were $160.0 million at the end of 1997, compared
with  $136.7  million  at the end of 1996.  The  increase  in total  assets  was
attributable  principally to increased  cash, cash  equivalents,  and short-term
investments.  The  following  table sets forth certain  financial  data from the
Consolidated  Balance Sheets expressed as the percentage  change from the end of
fiscal 1996 to the end of fiscal 1997:
<TABLE>
<CAPTION>
                                                                                              Percentage Change
                                                                                              From 1996 to 1997
                                                                                          --------------------------
<S>                                                                                                  <C>  
Cash, cash equivalents, and short-term investments.....................................             102.4%
Accounts receivable, net...............................................................             (14.8)
Inventories............................................................................             (23.7)
Property and equipment, net............................................................              (5.6)
Total assets...........................................................................              17.0
Total current liabilities..............................................................               3.6
Shareholders' equity...................................................................              57.2
</TABLE>

     Cash, Cash Equivalents, and Short-Term Investments

     The Company's cash, cash equivalents, and short-term investments were $59.0
million at the end of 1997,  compared with $29.2 million at the end of 1996. The
amount of cash,  cash  equivalents,  and short-term  investments  increased as a
result of $34.0 million of cash provided by operations  and $4.0 million of cash
provided by financing  activities,  which were offset in part by $8.2 million of
cash used in investing activities.

     The Company presently has no material financial  obligations to its current
wafer  suppliers.   However,  wafer  manufacturers  are  increasingly  demanding
financial  support from customers in the form of equity  investments and advance
purchase price deposits, which in some cases are substantial. Should the Company
require   additional   capacity,   it  may  be  required  to  incur  significant
expenditures to secure such capacity.

     The Company believes that the availability of adequate financial  resources
is a substantial  competitive factor. To take advantage of opportunities as they
arise, or to withstand  adverse  business  conditions  should they occur, it may
become  prudent or necessary for the Company to raise  additional  capital.  The
Company  intends to  monitor  the  availability  and cost of  potential  capital
resources, including equity, debt, and off-balance sheet financing arrangements,
with a view toward  raising  additional  capital on terms that are acceptable to
the  Company.  No  assurance  can be given that  additional  capital will become
available on acceptable terms.

     Notwithstanding  the  foregoing,  the Company  believes that existing cash,
cash  equivalents,   and  short-term   investments,   together  with  cash  from
operations, will be sufficient to meet its cash requirements for 1998. A portion
of available cash may be used for investment in or acquisition of  complementary
businesses, products, or technologies.

     Accounts Receivable

     The  Company's  net accounts  receivable  were $25.1  million at the end of
1997, compared with $29.5 million at the end of 1996. This decline of 15% in net
accounts  receivable compares favorably with the 5% increase in net revenues for
1997 compared with 1996. The Company  believes that its net accounts  receivable
for  1997  declined  through  more  focused   collection   efforts  and  process
improvements.

     Inventories

     The Company's  inventories were $20.5 million at the end of 1997,  compared
with $26.8 million at the end of 1996.  With the decline of inventories in 1997,
the Company is approaching its inventory model of 120 days.  Since the Company's
FPGAs are  manufactured  using  customized  steps that are added to the standard
manufacturing  processes  of its  independent  wafer  suppliers,  the  Company's
manufacturing  cycle is longer and hence more difficult to adjust in response to
changing demands or delivery  schedules.  Accordingly,  the Company's  inventory
model will probably  always be higher than that of its major  competitors  using
standard  processes.  Excess  inventories  increase  the  risk of  obsolescence,
represent a non-productive  use of capital  resources,  increase handling costs,
and delay realization of the price and performance benefits associated with more
advanced manufacturing processes.

     Property and Equipment

     The  Company's  net property and  equipment was $15.1 million at the end of
1997,  compared with $16.0 million at the end of 1996. The Company invested $6.8
million in property and  equipment in 1997,  compared with $7.8 million in 1996.
Depreciation  and  amortization  of property and equipment were $7.5 million for
1997, compared with $5.9 million for 1996. Capital  expenditures during the past
two years have been primarily for leasehold  improvements  and for  engineering,
manufacturing,  and office  equipment.  The  Company  anticipates  that  capital
expenditures may increase in 1998.

     Current Liabilities

     The Company's  total current  liabilities  were $51.0 million at the end of
1997, compared with $49.2 million at the end of 1996.

     Shareholders' Equity

     Shareholders'  equity was $109.0 million at the end of 1997,  compared with
$69.4 million at the end of 1996.  The increase  included $18.1 million from the
conversion of the Series A Preferred  Stock into Common Stock,  $16.8 million of
net income,  and  proceeds of $4.0  million  from the sale of Common Stock under
employee stock plans.

Employees

     At the end of 1997, the Company had 380 full-time employees,  including 117
in marketing,  sales, and customer support; 137 in research and development;  94
in  operations;  and 32 in  administration  and finance.  This compares with 356
full-time  employees  at the end of 1996,  an increase of 7%. Net  revenues  per
employee  was  approximately  $410,000  for 1997,  compared  with  approximately
$418,000 for 1996.

Impact of Recently Issued Accounting Standards

     In February 1997, the Financial Accounting Standards Board issued Statement
No. 128, "Earnings per Share" ("SFAS 128"), which is applicable to all financial
statements  issued for periods ending after  December 15, 1997.  Under SFAS 128,
the Company is required to change the method it has used to compute earnings per
share  and to  restate  all  prior  periods.  The  new  requirements  include  a
calculation of basic earnings per share, from which the dilutive effect of stock
options,  warrants,  and  convertible  debt are excluded;  and a calculation  of
diluted earnings per share,  which does not differ from previously  reported net
income (loss) per share. Accordingly, the Company adopted the provisions of SFAS
128 for the year ended  December 31, 1997, and all share and per share data have
been adjusted retroactively to comply with the new requirement.

     In June 1997, the Financial  Accounting Standards Board issued Statement of
Financial Accounting Standards No. 130, "Reporting  Comprehensive Income" ("SFAS
130"),  which establishes  standards for reporting and displaying  comprehensive
income and its  components in a full set of  general-purpose  statements  and is
expected to be first  reflected in the  Company's  first quarter of 1998 interim
financial  statements.  The  Company's  management is currently  evaluating  the
impact of SFAS 130 on operations.

     In  June  1997,  the  Financial  Accounting  Standards  Board  also  issued
Statement of Financial Accounting Standards No. 131, "Disclosures about Segments
of an  Enterprise  and Related  Information"  ("SFAS  131"),  which  established
standards for the way pubic enterprises  report information in annual statements
and  financial  reports  regarding  operating  segments,   products,   services,
geographic  areas, and major customers.  SFAS 131 will be first reflected in the
Company's 1998 Annual Report. The Company's  management is currently  evaluating
the impact of SFAS 131 on operations.

Quarterly Information

     The following table presents certain  unaudited  quarterly results for each
of the eight  quarters in the period ended  December 28, 1997. In the opinion of
management, this information has been presented on the same basis as the audited
consolidated  financial statements appearing elsewhere in this Annual Report and
all necessary  adjustments  (consisting only of normal recurring  accruals) have
been  included  in the  amounts  stated  below to present  fairly the  unaudited
quarterly  results  when  read in  conjunction  with  the  audited  consolidated
financial statements of the Company and notes thereto. These quarterly operating
results,  however, are not necessarily  indicative of the results for any future
period.

<PAGE>
<TABLE>
<CAPTION>
                                                                             Three Months Ended
                                         ------------------------------------------------------------------------------------------
                                          Dec. 28,   Sept. 28,   June 29,   Mar. 30,    Dec. 29,   Sept. 29,   June 30,   Mar. 31,
                                            1997       1997        1997       1997        1996       1996        1996       1996
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
                                                                  (in thousands, except per share amounts)
<S>                                      <C>         <C>        <C>         <C>        <C>         <C>        <C>         <C>      
Statements of Operations Data:
Net revenues..........................   $  37,012   $ 38,220   $   40,823  $  39,803  $   39,027  $  38,014  $   36,694  $  35,043
Cost of revenues......................      15,287     15,788       16,731     16,439      16,381     16,164      16,105     15,769
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
Gross profit..........................      21,725     22,432       24,092     23,364      22,646     21,850      20,589     19,274
Research and development..............       6,816      6,641        6,461      6,547       5,855      6,417       5,650      6,011
Selling, general, and administrative..      10,313     10,355       10,394     10,131      10,651      9,854       9,582      8,308
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
Income from operations................       4,596      5,436        7,237      6,686       6,140      5,579       5,357      4,955
Net income............................   $   3,382   $  3,921   $    4,934  $   4,531  $    4,153  $   3,905   $   3,606  $   3,277
Net income per share:
  Basic (1)...........................   $    0.16   $   0.19   $     0.24  $    0.24  $     0.23  $    0.22   $    0.20  $    0.19
                                         =========   ========   ==========  =========  ==========  =========  ==========  =========
  Diluted (1).........................   $    0.16   $   0.18   $     0.23  $    0.21  $     0.19  $    0.18   $    0.17  $    0.16
                                         =========   ========   ==========  =========  ==========  =========  ==========  =========
Shares used in computing 
  net income per share:
  Basic...............................      21,032     20,956       20,834     18,636     17,971      17,890      17,761     17,667
                                         =========   ========   ==========  =========  ==========  =========  ==========  =========
  Diluted.............................      21,623     22,172       21,890     22,082     21,893      21,475      21,467     21,068
                                         =========   ========   ==========  =========  ==========  =========  ==========  =========
</TABLE>
<TABLE>
<CAPTION>
                                                                             Three Months Ended
                                         ------------------------------------------------------------------------------------------
                                          Dec. 28,   Sept. 28,   June 29,   Mar. 30,    Dec. 29,   Sept. 29,   June 30,   Mar. 31,
                                            1997       1997        1997       1997        1996       1996        1996       1996
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
<S>                                        <C>         <C>        <C>         <C>        <C>         <C>        <C>         <C>   
As a Percentage of Net Revenues:
Net revenues..........................     100.0%      100.0%     100.0%      100.0%     100.0%      100.0%     100.0%      100.0%
Cost of revenues......................      41.3        41.3       41.0        41.3       42.0        42.5       43.9        45.0
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
Gross margin..........................      58.7        58.7       59.0        58.7       58.0        57.5       56.1        55.0
Research and development..............      18.4        17.4       15.8        16.4       15.0        16.9       15.4        17.2
Selling, general, and administrative..      27.9        27.1       25.5        25.5       27.3        25.9       26.1        23.7
                                         ---------   --------   ----------  ---------  ----------  ---------  ----------  ---------
Income from operations................      12.4        14.2       17.7        16.8       15.7        14.7       14.6        14.1
Net income............................       9.1        10.3       12.1        11.4       10.6        10.3        9.8         9.4

- ------------------------------------------------
<FN>
   (1)     The 1996 and first three  quarters of 1997 earnings per share amounts
           have been restated to comply with  Statement of Financial  Accounting
           Standards No. 128, "Earnings Per Share."

</FN>
</TABLE>
<PAGE>

Year 2000 Compliance and Other Factors Affecting Future Operating Results

     Like most other  companies,  the year 2000 computer  issue creates risk for
the Company.  If internal  systems do not correctly  recognize date  information
when the year changes to 2000, there could be an adverse impact on the Company's
operations.  The Company has  initiated a  comprehensive  project to prepare its
computer systems for the year 2000 and plans to have changes to critical systems
completed by the first quarter of 1999 to allow time for testing. The Company is
also assessing the capability of its products sold to customers over a period of
years to handle the year 2000, but does not currently  believe there are product
issues. Management believes that the likelihood of a material adverse impact due
to problems  with  internal  systems or products sold to customers is remote and
expects that the cost of these  projects over the next two years will not have a
material effect on the Company's financial position or overall trends in results
of  operations.  The  Company  is also  developing  a plan to  contact  critical
suppliers of products and services to determine that the  suppliers'  operations
and the products  and services  they provide are year 2000 capable or to monitor
their  progress  toward year 2000  capability.  There can be no  assurance  that
another  company's  failure  to  ensure  year 2000  capability  will not have an
adverse effect on the Company.

     The Company's  operating results are subject to general economic conditions
and a variety of risks  characteristic of the semiconductor  industry (including
booking  and  shipment  uncertainties,  wafer  supply  fluctuations,  and  price
erosion)  or  specific to the  Company,  any of which could cause the  Company's
operating  results to differ  materially from past results.  For a discussion of
such risks,  see "Risk Factors" in Part I of the Company's Annual Report on Form
10-K for 1997, which is incorporated herein by this reference.





                                ACTEL CORPORATION

                           CONSOLIDATED BALANCE SHEETS
                      (in thousands, except share amounts)
<TABLE>
<CAPTION>
                                                                                                 December 31,
                                                                                           ------------------------
                                                                                              1997         1996
                                                                                           -----------  -----------
                                                       ASSETS
<S>                                                                                        <C>          <C>        
Current assets:
   Cash and cash equivalents...........................................................    $     7,763  $     3,543
   Short-term investments..............................................................         51,272       25,626
   Accounts receivable, net............................................................         25,135       29,495
   Inventories, net....................................................................         20,472       26,848
   Deferred income taxes...............................................................         20,782       16,677
   Notes receivable from officers......................................................            364           --
   Other current assets................................................................          1,475        2,416
                                                                                           -----------  -----------
         Total current assets..........................................................        127,263      104,605
Property and equipment, net............................................................         15,081       15,973
Investment in Chartered Semiconductor..................................................         10,680       10,680
Other assets, net......................................................................          6,970        5,454
                                                                                           -----------  -----------
                                                                                           $   159,994  $   136,712
                                                                                           ===========  ===========

                                        LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
   Accounts payable....................................................................    $    12,440  $     9,933
   Accrued salaries and employee benefits..............................................          4,718        5,967
   Other accrued liabilities...........................................................          2,898        5,922
   Deferred income.....................................................................         30,928       27,386
                                                                                           -----------  -----------
         Total current liabilities.....................................................         50,984       49,208

Commitments and contingencies

Redeemable, convertible preferred stock (Series A), $.001 par value, $25.00 liquidation
   preference; 1,000,000 shares authorized; none and 1,000,000 shares issued and                     
   outstanding at December 31, 1997 and 1996, respectively.............................             --       18,147
                                                                                                      
Shareholders' equity:
   Preferred stock, $.001 par value; 4,000,000 shares authorized; none issued and
     outstanding.......................................................................             --           --
   Common stock, $.001 par value; 30,000,000 shares authorized; 21,046,894 and
     17,991,503 shares issued and outstanding at December 31, 1997 and 1996,
     respectively......................................................................             21           18
   Additional paid-in capital..........................................................         85,965       63,133
   Retained earnings ..................................................................         23,024        6,206
                                                                                           -----------  -----------
         Total shareholders' equity....................................................        109,010       69,357
                                                                                           -----------  -----------
                                                                                           $   159,994  $   136,712
                                                                                           ===========  ===========
</TABLE>

<PAGE>


                                ACTEL CORPORATION

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    (in thousands, except per share amounts)

<TABLE>
<CAPTION>
                                                                                    Year Ended December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
<S>                                                                         <C>           <C>           <C>         
Net revenues............................................................    $    155,858  $    148,779  $    108,516
Costs and expenses:
   Cost of revenues.....................................................          64,244        64,420        52,517
   Research and development.............................................          26,465        23,934        20,560
   Selling, general, and administrative.................................          41,194        38,395        27,364
   In-process research and development..................................              --            --        16,600
                                                                            ------------  ------------  ------------
         Total costs and expenses.......................................         131,903       126,749       117,041
                                                                            ------------  ------------  ------------
Income (loss) from operations...........................................          23,955        22,030        (8,525)
Interest expense........................................................              --           (13)          (93)
Interest income and other, net..........................................           1,842         1,068           846
                                                                            ------------  ------------  ------------
Income (loss) before taxes..............................................          25,797        23,085        (7,772)
Tax provision (benefit).................................................           9,029         8,147        (6,640)
                                                                            ------------  ------------  ------------
Net income (loss).......................................................    $     16,768  $     14,938  $     (1,132)
                                                                            ============  ============  ============
Net income (loss) per share:
   Basic................................................................    $       0.82  $       0.84  $     (0.07)
                                                                            ============  ============  ============
   Diluted..............................................................    $       0.76  $       0.70  $     (0.07)
                                                                            ============  ============  ============
Shares used in computing net income (loss) per share:
   Basic................................................................          20,370        17,826        17,367
                                                                            ============  ============  ============
   Diluted..............................................................          21,968        21,485        17,367
                                                                            ============  ============  ============
</TABLE>

<PAGE>


                                ACTEL CORPORATION

                 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
                      (in thousands, except share amounts)

<TABLE>
<CAPTION>

                                                                                      Retained
                                                                                      Earnings/           Total
                                                                    Additional      (Accumulated      Shareholders'
                                                 Common Stock     Paid-In Capital     Deficit)           Equity
                                                ---------------  ----------------  ---------------  -----------------
<S>                                             <C>              <C>               <C>              <C>              
Balance at December 31, 1994................    $            17  $         57,306  $        (8,012) $          49,311
Issuance of 455,393 shares of common stock
   under employee stock plans...............                  1             1,894               --              1,895
Securities valuation adjustment.............                 --                --              408                408
Tax benefit from exercise of stock options..                 --               438               --                438
Net loss....................................                 --                --           (1,132)            (1,132)
                                                ---------------  ----------------  ---------------  -----------------
Balance at December 31, 1995................    $            18  $         59,638  $        (8,736) $          50,920
                                                ===============  ================  ===============  =================  
Issuance of 429,745 shares of common stock
   under employee stock plans...............                 --             2,955               --              2,955
Securities valuation adjustment.............                 --                --                4                  4
Tax benefit from exercise of stock options..
                                                             --               540               --                540
Net income..................................                 --                --           14,938             14,938
                                                ---------------  ----------------  ---------------  -----------------
Balance at December 31, 1996................    $            18  $         63,133  $         6,206  $          69,357
                                                ===============  ================  ===============  =================
Conversion of 1,000,000 shares of redeemable,
   convertible preferred stock into 2,631,578   
   shares of common stock...................                  3            18,144               --             18,147
Issuance of 423,813 shares of common stock
   under employee stock plans...............                 --             3,970               --              3,970
Securities valuation adjustment.............                 --               --                50                 50
Tax benefit from exercise of stock options..                 --               718               --                718
Net income..................................                 --                --           16,768             16,768
                                                ---------------  ----------------  ---------------  -----------------
Balance at December 31, 1997................    $            21  $        85,965   $        23,024  $         109,010
                                                ===============  ================  ===============  =================
</TABLE>

<PAGE>


                                ACTEL CORPORATION

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (in thousands)

<TABLE>
<CAPTION>
                                                                                    Year Ended December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
<S>                                                                         <C>           <C>           <C>         
Operating activities:
   Net income (loss)....................................................    $     16,768  $     14,938  $     (1,132)
   Adjustments to reconcile  net income (loss) to net cash provided by
     operating activities:
     Depreciation and amortization......................................           8,358         6,755         4,412
     Loss on disposal of fixed assets...................................             175            --            --
     In-process research and development................................              --            --        16,600
     Changes in operating assets and liabilities:
       Accounts receivable..............................................           4,360       (11,690)       (4,973)
       Inventories......................................................           6,376           878        (9,095)
       Deferred income taxes............................................          (5,050)       (6,373)       (9,394)
       Other current assets.............................................             577          (319)        2,710
       Accounts payable, accrued salaries and employee benefits, and
         other accrued liabilities......................................          (1,048)        5,140         8,058
       Deferred income..................................................           3,542         8,238        10,802
                                                                            ------------  ------------  ------------
   Net cash provided by operating activities............................          34,058        17,567        17,988
Investing activities:
   Purchase of TI FPGA business.........................................              --            --       (10,000)
   Purchases of property and equipment..................................          (6,764)       (7,786)      (10,111)
   Purchases of short-term investments..................................        (157,753)      (49,429)           --
   Sales and maturities of short-term investments.......................         132,156        26,096        16,761
   Investment in Chartered Semiconductor................................              --        (3,611)       (3,033)
   Other assets.........................................................          (1,447)          126        (2,629)
                                                                            ------------  ------------  ------------
    Net cash used in investing activities................................        (33,808)      (34,604)       (9,012)
Financing activities:
   Sale of common stock.................................................           3,970         2,955         1,895
   Proceeds from line of credit.........................................              --            --         4,500
   Payments on line of credit...........................................              --            --        (4,500)
   Principal payments under notes payable and capital lease obligations.              --           (66)         (494)
                                                                            ------------  ------------  ------------
   Net cash provided by financing activities............................           3,970         2,889         1,401
Net increase (decrease) in cash and cash equivalents....................           4,220       (14,148)       10,377
Cash and cash equivalents, beginning of year............................           3,543        17,691         7,314
                                                                            ------------  ------------  ------------
Cash and cash equivalents, end of year..................................    $      7,763  $      3,543  $     17,691
                                                                            ============  ============  ============
Supplemental  disclosures of cash flows  information and non-cash
   investing and financing activities:
   Cash paid during the year for interest...............................    $         --  $          2  $         88
   Cash paid during the year for taxes..................................          15,398        12,370         4,593
Tax benefits from exercise of stock options.............................             718           540           438
Preferred stock issued to TI, net of estimated future issuance costs....              --            --        18,147
Conversion of preferred stock into common stock.........................         (18,147)           --            --
</TABLE>

                               ACTEL CORPORATION

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


1.   Organization and Summary of Significant Accounting Policies

     Actel  Corporation  (the  "Company")  was  incorporated  under  the laws of
California on October 17, 1985. The Company designs, develops, and markets field
programmable  gate arrays ("FPGAs") and associated  development  system software
and programming hardware.  Net revenues from the sale of FPGAs accounted for 98%
of the Company's  net revenues for 1997,  compared with 97% for 1996 and 95% for
1995. FPGAs are logic integrated  circuits,  which adapt the microprocessing and
memory  capabilities  of  electronic  systems  to  specific  applications.   The
Company's  operating  results  are  therefore  subject  to a  variety  of  risks
characteristic  of the  semiconductor  industry,  including booking and shipment
uncertainties,  wafer yield fluctuations,  and price erosion, as well as general
economic  conditions.  FPGAs are used by designers of  communication,  computer,
industrial  control,   military/aerospace,   and  other  electronic  systems  to
differentiate  their products and get them to market faster.  Information on the
Company's sales by geographic area is included in Note 11.

     Advertising and Promotion Costs

     The Company's policy is to expense  advertising and promotion costs as they
are  incurred.   The   Company's   advertising   and  promotion   expenses  were
approximately $4,050,000,  $3,595,000,  and $2,736,000 for 1997, 1996, and 1995,
respectively.

     Basis of Presentation

     The consolidated  financial  statements include the accounts of the Company
and its wholly-owned  subsidiaries.  All significant  intercompany  accounts and
transactions have been eliminated in consolidation.

     The Company's fiscal year ends on the Sunday closest to December 31. Fiscal
1997, 1996, and 1995 ended on December 28, 1997, December 29, 1996, and December
31, 1995, respectively. For ease of presentation,  December 31 has been utilized
as the fiscal year-end in the consolidated financial statements and accompanying
notes.

     Cash Equivalents and Short-Term Investments

     For financial statement  purposes,  the Company considers all highly liquid
debt  instruments with  insignificant  interest rate risk and with a maturity of
three months or less when  purchased to be cash  equivalents.  Cash  equivalents
consist  primarily of cash deposits in money market funds that are available for
withdrawal without  restriction.  Short-term  investments consist principally of
state and local municipal obligations.

     The Company  accounts for its investment in accordance  with the provisions
of Statement of Financial  Accounting Standards No. 115, "Accounting for Certain
Investments  in  Debt  and  Equity   Securities."   Management   determines  the
appropriate  classification  of debt  securities  at the  time of  purchase  and
re-evaluates  such  designation  as of each balance  sheet date. At December 31,
1997,   all   debt    securities    are   designated   as    available-for-sale.
Available-for-sale  securities  are carried at fair value,  with the  unrealized
gains and losses reported in  shareholders'  equity.  The amortized cost of debt
securities  in this  category  is adjusted  for  amortization  of  premiums  and
accretion of discounts to maturity.  Such  amortization  is included in interest
and other income.  Realized  gains and losses and declines in value judged to be
other than temporary on  available-for-sale  securities are included in interest
income  and  other.  The  cost of  securities  sold  is  based  on the  specific
identification  method.  Interest and  dividends  on  securities  classified  as
available-for-sale are included in interest income and other.

     Concentration of Credit Risk

     Financial   instruments   that   potentially   subject   the   Company   to
concentrations of credit risk consist  principally of cash investments and trade
receivables.  The  Company  invests  in  securities  of A, A1, or P1 grade.  The
Company  manufactures  and  sells  its  products  to  customers  in  diversified
industries.  The Company performs  ongoing credit  evaluations of its customers'
financial condition and generally requires no collateral. Three of the Company's
distributors -- Wyle,  Arrow,  and Pioneer -- accounted for  approximately  17%,
17%, and 12% of the  Company's  net revenues  for 1997,  respectively.  The same
three  distributors  accounted in the  aggregate  for  approximately  39% of the
Company's  net revenues for 1996 and 37% for 1995.  The loss of any one of these
distributors  could have a materially adverse effect on the Company's results of
operations and financial position.

     Fair Value of Financial Instruments

     The  following  methods  and  assumptions  were  used  by  the  Company  in
estimating its fair value disclosures for financial instruments:

          Cash and Cash Equivalents. The carrying amount reported in the balance
     sheets for cash and cash equivalents approximate fair value.

          Investment Securities.  The fair values for marketable debt securities
     are based on quoted market prices.

          Foreign Currency Exchange  Contracts.  The fair value of the Company's
     foreign currency  exchange forward  contracts are estimated based on quoted
     market prices of comparable contracts.

     Impact of Recently Issued Accounting Standards

     In February 1997, the Financial Accounting Standards Board issued Statement
No. 128, "Earnings per Share" ("SFAS 128"), which is applicable to all financial
statements  issued for periods ending after  December 15, 1997.  Under SFAS 128,
the Company is required to change the method it has used to compute earnings per
share  and to  restate  all  prior  periods.  The  new  requirements  include  a
calculation of basic earnings per share, from which the dilutive effect of stock
options,  warrants,  and  convertible  debt are excluded;  and a calculation  of
diluted earnings per share,  which does not differ from previously  reported net
income (loss) per share. Accordingly, the Company adopted the provisions of SFAS
128 for the year ended  December 31, 1997, and all share and per share data have
been adjusted retroactively to comply with the new requirement.

     In June 1997, the Financial  Accounting Standards Board issued Statement of
Financial Accounting Standards No. 130, "Reporting  Comprehensive Income" ("SFAS
130"),  which establishes  standards for reporting and displaying  comprehensive
income and its  components in a full set of  general-purpose  statements  and is
expected to be first  reflected in the  Company's  first quarter of 1998 interim
financial  statements.  The  Company's  management is currently  evaluating  the
impact of SFAS 130 on operations.

     In  June  1997,  the  Financial  Accounting  Standards  Board  also  issued
Statement of Financial Accounting Standards No. 131, "Disclosures about Segments
of an  Enterprise  and Related  Information"  ("SFAS  131"),  which  established
standards for the way pubic enterprises  report information in annual statements
and  financial  reports  regarding  operating  segments,   products,   services,
geographic  areas, and major customers.  SFAS 131 will be first reflected in the
Company's 1998 Annual Report. The Company's  management is currently  evaluating
the impact of SFAS 131 on operations.

     Income Taxes

     The Company  accounts for income taxes in accordance with the provisions of
Statement of Financial  Accounting  Standards  No. 109,  "Accounting  for Income
Taxes" ("SFAS 109").  Under SFAS 109, the liability method is used in accounting
for income taxes.  Deferred tax assets and liabilities  are determined  based on
the  differences  between  financial  reporting  and the tax basis of assets and
liabilities,  and are measured using the enacted tax rates and laws that will be
in effect when the differences are expected to reverse.

     Inventories

     Inventories are stated at the lower of cost (first-in, first-out) or market
(net  realizable  value).  Given the  volatility of the market for the Company's
products,  the Company makes  inventory  provisions for  potentially  excess and
obsolete inventory based on backlog and forecast demand.  However,  such backlog
demand is subject to revisions,  cancellations, and rescheduling.  Actual demand
will  inevitably  differ  from  such  backlog  and  forecast  demand,  and  such
differences  may be material to the  financial  statements.  Excess  inventories
increase the risk of  obsolescence,  represent a  non-productive  use of capital
resources,  increase  handling  costs,  and delay  realization  of the price and
performance benefits associated with more advanced manufacturing processes.

     Off-Balance-Sheet Risk

     The Company enters into foreign  exchange  contracts to hedge firm purchase
commitments denominated in foreign currencies. The Company's accounting policies
for these instruments are based on the Company's designation of such instruments
as hedging  transactions.  The  criteria  the Company  uses for  designating  an
instrument  as a hedge  includes its  effectiveness  in exposure  reduction  and
one-to-one  matching of the  derivative  financial  instrument to the underlying
transaction  being hedged.  Gains and losses on these  contracts are  recognized
upon  maturity  of the  contracts  and are  included  in the cost of  sales.  At
December  31,  1997,  the  Company had foreign  exchange  contracts  maturing in
January 1998 to purchase Japanese yen for  approximately  $830,000 at an average
rate of 124 yen per dollar.

     In addition,  the Company had  approximately  $775,000  outstanding under a
standby letter of credit at December 31, 1997.

     Property and Equipment

     Property and  equipment are carried at cost less  accumulated  depreciation
(see  Note  2).   Depreciation  and   amortization   have  been  provided  on  a
straight-line basis over the following estimated useful lives:

Equipment......................   2 to 5 years
Furniture and fixtures.........   3 to 5 years
Leasehold improvements.........   Estimated useful life or lease term,
                                  whichever is shorter

     Revenue Recognition

     Revenue from product shipped to customers is generally recorded at the time
of  shipment.   Revenue  related  to  products  shipped  subject  to  customers'
evaluation is recognized upon final  acceptance.  Shipments to distributors  are
made under agreements  allowing certain rights of return and price protection on
unsold merchandise.  For that reason, the Company defers recognition of revenues
and related  cost of revenues  on sales of products to  distributors  until such
products are sold by the distributor. Royalty income is recognized upon the sale
by others of products subject to royalties.

     Stock-Based Compensation

     The  Company  accounts  for  stock-based  awards  to  employees  using  the
intrinsic value method in accordance with  Accounting  Principles  Board Opinion
No. 25, "Accounting for Stock Issued to Employees" ("APB 25").  Accordingly,  no
compensation  cost has been  recognized for its fixed cost stock option plans or
its associated  stock purchase plan. The Company  provides  additional pro forma
disclosures as required under  Statement of Financial  Accounting  Standards No.
123, "Accounting for Stock Based Compensation" ("SFAS 123").

     Use of Estimates

     The  preparation of the financial  statements in conformity  with generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that affect the amounts  reported in the financial  statements  and
accompanying notes. Actual results could differ from those estimated.

2.   Balance Sheet Detail

<TABLE>
<CAPTION>
                                                                                                 December 31,
                                                                                          --------------------------
                                                                                              1997          1996
                                                                                          ------------  ------------
                                                                                                (in thousands)
<S>                                                                                       <C>           <C>         
 Accounts receivable:
    Trade accounts receivable..........................................................   $     26,767  $     30,128
    Allowance for doubtful accounts....................................................         (1,632)         (633)
                                                                                          ------------  ------------
                                                                                          $     25,135  $     29,495
                                                                                          ============  ============
 Inventories:
    Purchased parts and raw materials..................................................   $      3,681  $      1,792
    Work-in-process....................................................................          8,438        17,080
    Finished goods.....................................................................          8,353         7,976
                                                                                          ------------  ------------
                                                                                          $     20,472  $     26,848
                                                                                          ============  ============
 Property and equipment:
    Equipment..........................................................................   $     33,664  $     27,539
    Furniture and fixtures.............................................................          2,171         2,088
    Leasehold improvements.............................................................          4,476         4,210
                                                                                          ------------  ------------
                                                                                                40,311        33,837
    Accumulated depreciation and amortization..........................................        (25,230)      (17,864)
                                                                                          ------------  ------------
                                                                                          $     15,081  $     15,973
                                                                                          ============  ============
</TABLE>

     Depreciation  and  amortization   expense  was  approximately   $7,481,000,
$5,879,000,   and   $3,755,000   for  1997,   1996,   and  1995,   respectively.

3.   Purchase of TI FPGA Business

     On February 12, 1995, the Company entered into an Asset Purchase  Agreement
with Texas  Instruments  Incorporated  ("TI") under which TI agreed to convey to
the Company all tangible and intangible assets and intellectual  property rights
necessary to operate TI's antifuse FPGA business (the "TI FPGA  Business").  The
acquisition was completed on March 31, 1995, in a transaction accounted for as a
purchase.  The Company acquired approximately  $9,100,000 of inventory,  prepaid
research  and  development,  and other  credits  receivable.  The  Company  also
acquired  certain fixed assets used in the TI FPGA Business.  Beginning with the
second quarter of 1995, the Company's net revenues  included the revenues of the
TI FPGA Business, but no longer included royalties from TI.

     As  consideration  for the TI FPGA Business,  the Company  assumed  certain
liabilities,  paid  $10,000,000 in cash, and issued 1,000,000 shares of Series A
Preferred  Stock  (valued  at  approximately  $18,947,000  for  purposes  of the
transaction),  which on March 12,  1997,  were  converted  by TI into  2,631,578
shares of Common  Stock.  The total  purchase  price  booked by the  Company was
approximately  $28,947,000,  of which  approximately  $16,600,000  of in-process
research and  development  was charged  against  income in the first  quarter of
1995. The amount was  established by an independent  valuation  specialist.  The
remaining  amount of  consideration,  approximately  $4,400,000,  represents the
valuation  of  the  customer  base  and  goodwill  acquired,  was  allocated  to
intangible assets, and is being amortized over a five-year period.  Amortization
expense was $877,000,  $876,000,  and $657,000 for the years ended  December 31,
1997, 1996, and 1995, respectively.

4.   Short-Term Investments

     The following is a summary of available-for-sale securities at December 31,
1997 and 1996:
<TABLE>
<CAPTION>
                                                                              Gross         Gross
                                                                            Unrealized    Unrealized    Estimated
                                                                 Cost         Gains         Losses     Fair Values
                                                             ------------  ------------  ------------  ------------
                                                                                 (in thousands)
<S>                                                          <C>           <C>           <C>           <C>         
December 31, 1997
   Municipal obligations included in short-term investments
                                                             $     51,222  $         50  $         --  $     51,272
                                                             ============  ============  ============  ============
December 31, 1996
   Municipal obligations included in short-term investments
                                                             $     25,618  $          8  $         --  $     25,626
                                                             ============  ============  ============  ============
</TABLE>

     There  were no  realized  gains or losses in 1997 or 1996.  Gross  realized
gains and (losses) were  approximately  $4,000 and ($8,000),  respectively,  for
1995.

     The  adjustments  to net  unrealized  gains  and  (losses)  on  investments
included as a separate component of shareholders'  equity totaled  approximately
$50,000 and $4,000 for 1997 and 1996, respectively.

     The expected maturities of the Company's  investments at December 31, 1997,
are shown below.  Expected  maturities  may differ from  contractual  maturities
because the issuers of the securities  may have the right to prepay  obligations
without prepayment penalties.

 Available-for-sale (in thousands):
    Due in less than one year....................................   $     19,061
    Due in one year or more......................................         32,211
                                                                    ------------
                                                                    $     51,272
                                                                    ============

A significant  proportion of the Company's securities  represent  investments in
floating  rate  municipal  bonds with  contractual  maturities  greater than ten
years.  However,  the interest rates on these debt  securities  generally  reset
every ninety days, at which time the Company has the option to sell the security
or roll-over the investment at the new interest rate. As it is not the Company's
intention to hold these securities  until their  contractual  maturities,  these
amounts     have     been     classified     as     short-term      investments.

5.   Investment in Chartered Semiconductor

     In  February  1994,  the  Company  entered  into  an  agreement  to  invest
approximately   $10,000,000  in  Chartered   Semiconductor   Manufacturing   Ltd
("Chartered Semiconductor"), a semiconductor company located in Singapore. Under
the terms of the  agreement,  the  Company has  acquired  an equity  interest in
Chartered Semiconductor of less than 2%. The investment was payable in Singapore
dollars, with the initial installment of approximately  $2,000,000 paid in March
1994, the second installment of approximately $2,000,000 paid in September 1994,
the third  installment of  approximately  $3,000,000 paid in March 1995, and the
last installment of approximately  $2,900,000 paid in January 1996. In 1996, the
Company  purchased an  additional  equity  interest in Chartered  Semiconductor,
pursuant to a contractual right of first refusal,  for  approximately  $698,000.
The  investment  in  Chartered  Semiconductor  is  accounted  for under the cost
method;  therefore,  changes in the value of the  investment  are not recognized
unless an impairment  in the value of the  investment is deemed by management to
be "other than temporary."

6.   Line of Credit

     The Company has a line of credit with a bank that  provides for  borrowings
not to exceed  $10,000,000.  The agreement  contains  covenants that require the
Company to  maintain  certain  financial  ratios  and  levels of net  worth.  At
December 31, 1997, the Company was in compliance with the covenants for the line
of credit.  Borrowings  against the line of credit  bear  interest at the bank's
prime rate. There were no borrowings  against the line of credit at December 31,
1997. The line of credit, which expires in May 1998, may be terminated by either
party upon not less than thirty days' prior written notice.

7.   Commitments

     The   Company   leases  its   facilities   and  certain   equipment   under
non-cancellable  lease agreements.  The principal facility lease expires in June
1998, and provides for two consecutive  five-year renewal options. The equipment
leases are accounted for as operating leases.  The lease terms expire at various
dates through  September  2001.  All of these leases  require the Company to pay
property  taxes,  insurance,  and  maintenance and repair costs. At December 31,
1997, the Company had no capital lease obligations.

     Future  minimum  lease  payments  under all  non-cancellable  leases are as
follows:

                                                                     Operating
                                                                       Leases
                                                                    ------------
1998............................................................    $      1,530
1999............................................................             866
2000............................................................             805
2001............................................................             575
2002............................................................             101
                                                                    ------------
Total minimum lease payments....................................    $      3,877
                                                                    ============

     Rental  expense  under  operating  leases  was  approximately   $2,481,313,
$1,615,000,   and   $1,193,000   for  1997,   1996,   and  1995,   respectively.

8.   Retirement Plan

     Effective  December 10, 1987,  the Company  adopted a tax deferred  savings
plan for the  benefit of  qualified  employees.  The plan is designed to provide
employees with an  accumulation  of funds at retirement.  Employees may elect at
any time to have salary reduction contributions made to the plan.

     The Company may make  contributions  to the plan at the  discretion  of the
Board of Directors. The first contributions to the plan by the Company were made
in March 1998,  based on net  revenues  and net income for the 1997 fiscal year.
For 1997,  the plan provided for a maximum  contribution  of 2.5% of an eligible
employee's gross earnings or $1,500,  whichever is less, if the Company achieved
its net revenue and net income goals.  To be eligible for the  contribution,  an
employee  must have been hired on or before July 15,  1997,  and been an active,
regular employee on December 31, 1997. Since the Company did not achieve its net
revenue or net income goals in 1997 for purposes of the plan,  the amount of the
contribution was reduced to 1.7% of an eligible employee's gross earnings, up to
a maximum of $1,500.  The aggregate amount contributed to the plan was $340,750.
The contributions vest annually,  retroactively from an eligible employee's date
of hire,  at the rate of 25% per year. In addition,  contributions  become fully
vested upon  retirement  from the Company at age 65. There is no  guarantee  the
Company will make any contributions to the plan in the future, regardless of its
financial  performance.  If the Company,  at its  discretion,  chooses to make a
contribution again in the future, the amount could be higher or lower.

9.   Shareholders' Equity

     Stock Option Plans

     The Company has  adopted  stock  option  plans  under  which  officers  and
employees  may be granted  incentive  stock options or  nonqualified  options to
purchase shares of the Company's  common stock. At December 31, 1997,  7,364,533
shares of common stock were  reserved for issuance  under these plans,  of which
521,100  were  available  for grant.  In January  1998,  the Board of  Directors
authorized  the Company to exchange  stock options  granted under these plans to
all employees  (except officers with more than one year seniority) and having an
exercise  price greater than $11.75 for options with an exercise price of $11.75
(the fair market  value of the  Company's  stock on January 26,  1998,  when the
exchange  was  effected).  Under the terms of this stock  option  repricing,  no
portion of any repriced  option was  exercisable  until July 27,  1998.  Options
representing the right to purchase a maximum of 1,777,016 shares of common stock
were repriced.

     The Company has also  adopted a Directors'  Stock Option Plan,  under which
directors  who are not  employees  of the  Company  may be granted  nonqualified
options to purchase shares of the Company's  common stock. At December 31, 1997,
200,000  shares of common stock were  reserved for issuance  under such plan, of
which 70,000 were available for grant.

     The Company  grants stock  options  under its plans at a price equal to the
fair  value of the  Company's  common  stock on the date of  grant.  Subject  to
continued service, options generally vest over a period of four years and expire
ten years from the date of grant.

     The following  table  summarizes  the Company's  stock option  activity and
related information for the three years ended December 31, 1997:

<TABLE>
<CAPTION>
                                             1997                        1996                        1995
                                  --------------------------  --------------------------  --------------------------
                                                   Weighted                    Weighted                    Weighted
                                                    Average                     Average                     Average
                                    Number of      Exercise      Number of     Exercise      Number of     Exercise
                                     Shares          Price         Shares        Price         Shares        Price
                                  -------------  -----------  --------------  ----------  --------------  ----------
<S>                                  <C>         <C>              <C>        <C>              <C>        <C>       
Outstanding at January 1......        3,542,836  $     12.38       2,506,331  $    10.17       1,588,565  $     6.42
Granted.......................        1,252,895        17.39       2,633,911       14.24       1,315,860       12.96
Exercised.....................         (214,821)        8.29        (204,344)       6.60        (270,365)       2.25
Cancelled.....................         (328,795)       13.40      (1,393,062)      12.79        (127,729)       8.99
                                  -------------               --------------              --------------            
Outstanding at December 31....        4,252,115        13.98       3,542,836       12.38       2,506,331       10.17
                                  =============               ==============              ==============            
</TABLE>
 
     The following table summarizes  information about stock options outstanding
at December 31, 1997:

 <TABLE>
<CAPTION>
                                                                         December 31, 1997
                                                --------------------------------------------------------------------
                                                          Options Outstanding                 Options Exercisable
                                                ----------------------------------------   -------------------------
                                                                 Weighted
                                                                 Average      Weighted                    Weighted
                                                                Remaining     Average                     Average
                                                  Number of      Contract     Exercise      Number of     Exercise
           Range of Exercise Prices                 Shares         Life        Price          Shares       Price
- ---------------------------------------------    -----------   ----------   ------------   -----------  ------------
<S>                                                <C>         <C>          <C>                <C>      <C>         
$    1.80    -  $   8.00....................         588,679   5.69 years    $      6.77       406,441  $       6.38
     8.13    -     10.50....................         241,275   7.13                 9.35        82,619          9.40
                   10.63....................         842,625   8.01                10.63       375,099         10.63
    12.25    -     13.56....................         222,850   8.37                13.24        52,624         13.21
                   14.88....................         548,225   8.55                14.88        56,107         14.88
    15.00    -     16.25....................         121,625   8.54                15.30        31,416         15.16
                   16.38....................         737,116   9.51                16.38         8,065         16.38
    17.00    -     20.88....................         557,670   8.62                19.06        51,643         18.34
    21.00    -     22.50....................         327,400   9.14                21.78        35,045         22.34
                   22.69....................          64,650   9.69                22.69             0             0
                                                 -----------                               -----------              
     1.80    -     22.69....................       4,252,115   8.19                13.98     1,099,059         10.21
                                                 ===========                               ===========               
</TABLE>

691,944 and 564,195  outstanding  options were  exercisable at December 31, 1996
and 1995,  respectively.  The weighted-average  grant-date fair value of options
granted during 1997, 1996, and 1995 were $7.38, $4.92, and $6.11, respectively.

     Employee Stock Purchase Plan

     The Company has adopted an Employee Stock Purchase Plan (the "ESPP"), under
which  eligible  employees  may  designate  not  more  than  15% of  their  cash
compensation to be deducted each pay period for the purchase of common stock (up
to a maximum of $25,000  worth of common  stock in any year).  At  December  31,
1997,  1,150,000  shares of common stock were  reserved  for issuance  under the
ESPP. The ESPP is  administered  over offering  periods of up to 24 months each,
with each  offering  period  divided into four  consecutive  six-month  purchase
periods beginning August 1 and February 1 of each year. On the last business day
of each purchase  period,  shares of common stock are purchased with  employees'
payroll deductions  accumulated during the six months at a price per share equal
to 85%  of  the  market  price  of the  common  stock  on the  first  day of the
applicable offering period or the last day of the purchase period,  whichever is
lower.  There were 208,992 and 225,401  shares issued under the ESPP in 1997 and
1996, respectively,  and 387,292 remained available for issuance at December 31,
1997.

     Pro Forma Disclosures

     Pro forma information regarding net income/(loss) and net income/(loss) per
share is required  by SFAS 123,  which also  requires  that the  information  be
determined  as if the Company  had  accounted  for its  employee  stock  options
granted  subsequent to December 31, 1994 under the fair value  method.  The fair
value  for  these  options  was  estimated  at  the  date  of  grant  using  the
Black-Scholes pricing model with the following weighted-average  assumptions for
1997,  1996,  and 1995:  risk-free  interest rates of 5.95%,  5.84%,  and 6.55%,
respectively;  no dividend yield; volatility factor of the expected market price
of the Company's common stock of 48%, 50%, and 50%, respectively; and a weighted
average expected life of the options of four years.

     The  Black-Scholes   option  valuation  model  was  developed  for  use  in
estimating the fair value of traded options,  which have no vesting restrictions
and are fully  transferable.  In addition,  option  valuation models require the
input of highly  subjective  assumptions,  including  the  expected  stock price
volatility.  Because the Company's  employee stock options have  characteristics
significantly different from those of traded options, and because changes in the
subjective input assumptions can materially  affect the fair value estimate,  in
management's  opinion the existing models do not necessarily  provide a reliable
single measure of the fair value of its employee stock options.

     For  purposes of pro forma  disclosures,  the  estimated  fair value of the
options is amortized to expense over the options' vesting period.  The Company's
pro forma information is as follows:
<TABLE>
<CAPTION>

                                                                                   Year Ended December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
                                                                            (in thousands, except per share amounts)
<S>                                                                         <C>           <C>           <C>         
Pro forma net income (loss).............................................    $     11,405  $     10,452  $     (2,780)
Pro forma earnings (loss) per share:
   Basic................................................................            0.56          0.59        (0.16)
   Diluted..............................................................            0.54          0.50        (0.16)
</TABLE>

Since SFAS 123 is applicable only to options granted  subsequent to December 31,
1994, its pro forma effect will not be fully reflected until  subsequent  years.
The effects on pro forma  disclosures  of applying SFAS 123 are not likely to be
representative of the effects on pro forma disclosures in future years.

10.      Tax Provision (Benefit)

     The tax provision (benefit) consists of:
<TABLE>
<CAPTION>

                                                                                          December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
                                                                                         (in thousands)
<S>                                                                         <C>           <C>           <C>         
Federal - current.......................................................    $     11,585  $     12,150  $      4,113
Federal - deferred......................................................          (4,544)       (5,571)       (8,977)
State - current.........................................................           2,304         2,460         1,149
State - deferred........................................................            (506)       (1,089)       (3,044)
Foreign - current.......................................................             190           197           119
                                                                            ------------  ------------  ------------
                                                                            $      9,029  $      8,147  $     (6,640)
                                                                            ============  ============  ============
</TABLE>

     The  tax  provision   (benefit)   reconciles  to  the  amount  computed  by
multiplying  income  (loss)  before tax by the U.S.  statutory  rate as follows:
<TABLE>
<CAPTION>
                                                                                          December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
                                                                                         (in thousands)
<S>                                                                         <C>           <C>           <C>         
Provision (benefit) at statutory rate...................................    $      9,029  $      8,079  $     (2,719)
Change in valuation allowance...........................................            (440)         (432)       (2,396)
Federal research credits................................................            (772)         (425)         (937)
State taxes, net of federal benefit.....................................           1,169           891          (813)
Other...................................................................              43            34           225
                                                                            ------------  ------------  ------------
Tax provision (benefit).................................................    $      9,029  $      8,147  $     (6,640)
                                                                            ============  ============  ============
</TABLE>

     Significant components of the Company's deferred tax assets and liabilities
for     federal     and    state     income     taxes     are    as     follows:

<TABLE>
<CAPTION>
                                                                                                 December 31,
                                                                                          --------------------------
                                                                                              1997          1996
                                                                                          ------------  ------------
                                                                                                (in thousands)
<S>                                                                                       <C>           <C>         
Deferred tax assets:
        Depreciation...................................................................   $        219  $         --
        Distributor reserve............................................................         12,350        11,033
        Charge for in-process research expenses........................................          5,450         5,962
        Inventories....................................................................          5,323         3,293
        Other, net.....................................................................          3,905         2,453
                                                                                          ------------  ------------
                                                                                                27,247        22,741
        Valuation allowance............................................................         (2,606)       (3,046)
                                                                                          ------------  ------------
                                                                                                24,641        19,695
                                                                                          ============  ============
Deferred tax liabilities:
        Depreciation...................................................................             --          (104)
                                                                                          ------------  ------------
                                                                                                    --          (104)
                                                                                          ------------  ------------
                Net deferred tax assets................................................   $     24,641  $     19,591
                                                                                          ============  ============
</TABLE>

The valuation allowance declined by approximately $432,000 during 1996.

11.  Industry and Geographic Information

     The Company operates in a single industry segment.  The Company markets its
products  in the  United  States  and in  foreign  countries  through  its sales
personnel,  independent sales representatives,  and distributors.  The Company's
geographic sales are as follows:

<TABLE>
<CAPTION>
                                                               Year Ended December 31,
                                  ----------------------------------------------------------------------------------
                                             1997                        1996                        1995
                                  --------------------------  --------------------------  --------------------------
                                                          (in thousands, except percentages)

<S>                               <C>               <C>       <C>               <C>       <C>               <C>
United States.................    $    107,308       69%      $     99,131       67%      $     67,156       62%
Export:
     Europe...................          26,239       17             26,105       18             18,706       17
     Japan....................          13,328        8             15,340       10             13,238       12
     Other international......           8,983        6              8,203        5              9,416        9
                                  ------------  ------------  ------------  ------------  ------------  ------------
                                  $    155,858      100%      $    148,779      100%      $    108,516      100%
                                  ============  ============  ============  ============  ============  ============
</TABLE>

12.  Patent Infringement

     In January 1994, the Company brought a patent infringement  lawsuit against
QuickLogic   Corporation   ("QuickLogic"),   which  in  turn  brought  a  patent
infringement  counterclaim  against  the  Company in May 1995.  The  parties are
currently  engaged in  discovery  and motion  proceedings.  Although the Company
believes that it has  meritorious  claims and defenses in this matter,  and that
its  resolution  will not have a  materially  adverse  effect  on the  Company's
business,  financial  position,  or results of  operations,  no assurance can be
given to that effect.

     As is typical  in the  semiconductor  industry,  the  Company  has been and
expects to be from time to time  notified  of claims  that it may be  infringing
patents owned by others.  As it has in the past, the Company may obtain licenses
under patents that it is alleged to infringe.  Although the Company is unable to
estimate with any degree of confidence the cost of such  licenses,  no assurance
can be given that they  would  not,  individually  or in the  aggregate,  have a
materially adverse effect on the Company's financial  condition,  and/or results
of operations.  In addition,  no assurance can be given that such claims against
the  Company  will not  result in  litigation.  All  litigation,  whether or not
determined  in favor of the Company,  can result in  significant  expense to the
Company and can divert the efforts of the  Company's  technical  and  management
personnel from productive tasks.

     Although the Company has obtained patents covering  elements of its circuit
architecture and certain techniques for manufacturing its antifuse, no assurance
can be given that the  Company's  patents will be determined to be valid or that
the claims of QuickLogic or any assertions of  infringement by other parties (or
claims for indemnity from customers resulting from any infringement claims) will
not succeed.  In the event of an adverse  ruling in the  QuickLogic  case or any
other  litigation  involving  intellectual  property,  the Company  could suffer
significant  (and possibly  treble)  monetary  damages.  The Company may also be
required to discontinue  the use of certain  processes;  cease the  manufacture,
use, and sale of infringing  products;  expend significant  resources to develop
non-infringing   technology;  or  obtain  licenses  under  patents  that  it  is
infringing.  Any of these outcomes could have a materially adverse effect on the
Company's business, financial condition, and/or results of operations.

13.  Earnings Per Share

     Under SFAS 128, the Company is required to change the method it has used to
compute  earnings  per  share  and  to  restate  all  prior  periods.   The  new
requirements  include a calculation  of basic earning per share,  from which the
dilutive effect of stock options,  warrants,  and convertible debt are excluded;
and a  calculation  of diluted  earnings  per  share,  which will not change the
primary  earnings  per share  previously  reported.  For the  fiscal  year ended
December  31,  1995,  the  dilutive  effect  of  stock  options,  warrants,  and
convertible  preferred  stock was excluded from the calculation of common shares
used  in  the  denominator  for  diluted   earnings  per  share  because  it  is
anti-dilutive.

     The  following  table  sets  forth the  computation  of basic  and  diluted
earnings per share:
<TABLE>
<CAPTION>
                                                                                   Year Ended December 31,
                                                                            ----------------------------------------
                                                                                1997          1996          1995
                                                                            ------------  ------------  ------------
<S>                                                                         <C>           <C>           <C>         
                                                                            (in thousands, except per share amounts)
Basic:
Average common shares outstanding.......................................          20,370        17,826        17,367
                                                                            ------------  ------------  ------------
Shares used in computing net income (loss) per share....................          20,370        17,836        17,367
                                                                            ============  ============  ============
Net income (loss).......................................................    $     16,768  $     14,938  $     (1,132)
                                                                            ============  ============  ============
Net income (loss) per share.............................................    $       0.82  $       0.84  $     (0.07)
                                                                            ============  ============  ============

Diluted:
Average common shares outstanding.......................................          20,370        17,826        17,367
Net effect of dilutive stock options,  warrants, and convertible preferred
   stock - based on the treasury stock method...........................           1,598         3,659            --
                                                                            ------------  ------------  ------------
Shares used in computing net income (loss) per share....................          21,968        21,485        17,367
                                                                            ============  ============  ============
Net income (loss).......................................................    $     16,768  $     14,938  $     (1,132)
                                                                            ============  ============  ============
Net income (loss) per share.............................................    $       0.76  $       0.70  $     (0.07)
                                                                            ============  ============  ============
</TABLE>


<PAGE>


                REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS



THE BOARD OF DIRECTORS AND SHAREHOLDERS

ACTEL CORPORATION



     We have  audited  the  accompanying  consolidated  balance  sheets of Actel
Corporation  as of  December  31, 1997 and 1996,  and the  related  consolidated
statements of operations,  cash flows, and shareholders'  equity for each of the
three years in the period ended December 31, 1997.  These  financial  statements
are the  responsibility of the Company's  management.  Our  responsibility is to
express an opinion on these financial statements based on our audits.

     We conducted  our audits in accordance  with  generally  accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

     In our opinion,  the financial statements referred to above present fairly,
in  all  material  respects,   the  consolidated  financial  position  of  Actel
Corporation  at December 31, 1997 and 1996 and the  consolidated  results of its
operations  and its cash flows for each of the three  years in the period  ended
December 31, 1997, in conformity with generally accepted accounting principles.



/s/ ERNST & YOUNG LLP

San Jose, California
January 21, 1998


                                  STOCK LISTING

     Actel's common stock has been traded on the  over-the-counter  market since
the Company's  initial public offering (IPO) on August 2, 1993, and is quoted on
the NASDAQ National Market System under the symbol "ACTL." The Company has never
paid cash dividends on its common stock and has no present plans to do so.

     On March 25,  1998,  there  were 304  shareholders  of  record.  Since many
shareholders  have their  shares  held of record in the name of their  brokerage
firm, the actual number of  shareholders is estimated by the Company to be about
5,000.

     During the last two years,  the quarterly  high and low sale prices for the
common stock were:

                       1997                                High          Low
- ---------------------------------------------------   ------------  ------------
First Quarter......................................   $     29.125  $     17.875
Second Quarter.....................................         22.125        15.375
Third Quarter......................................         24.125        15.75
Fourth Quarter.....................................         19.25         11.25

                       1996                                High          Low
- ---------------------------------------------------   ------------  ------------
First Quarter......................................   $     17.125  $      9.00
Second Quarter.....................................         21.875        14.50
Third Quarter......................................         20.25         12.375
Fourth Quarter.....................................         24.625        16.25



                                                                      EXHIBIT 21

                                ACTEL CORPORATION

                     --------------------------------------

                                  Subsidiaries


                     Actel Europe, Ltd., a U.K. corporation

                     Actel Europe SARL, a French corporation

                        Actel GmbH, a German corporation

                Actel Pan-Asia Corporation, a Nevada corporation




                                                                      EXHIBIT 21

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

     We consent to the  incorporation  by reference in this Annual  Report (Form
10-K) of Actel Corporation of our report dated January 21, 1998, included in the
1997 Annual Report to Shareholders of Actel Corporation.

     Our  audits  also  included  the  financial  statement  schedule  of  Actel
Corporation  listed in Item 14(a).  This schedule is the  responsibility  of the
Company's  management.  Our responsibility is to express an opinion based on our
audits. In our opinion, the financial statement schedule referred to above, when
considered in relation to the basic  financial  statements as a whole,  presents
fairly in all material respects the information set forth therein.

     We also  consent to the  incorporation  by  reference  in the  Registration
Statement (Form S-8 No. 33-74492)  pertaining to the 1986 Incentive Stock Option
Plan,  the 1993 Employee Stock  Purchase  Plan,  and the 1993  Directors'  Stock
Option  Plan,  and  in  the  Registration  Statement  (Form  S-8  No.  333-3398)
pertaining to the 1986  Incentive  Stock Option Plan,  the 1993  Employee  Stock
Purchase Plan, and the 1995  Consultant  Stock Plan, of our report dated January
21,  1998,  with  respect  to the  consolidated  financial  statements  of Actel
Corporation  incorporated  by reference in its Annual Report (Form 10-K) for the
year ended December 31, 1997, and our report included in the preceding paragraph
with respect to the financial  statement schedule included in this Annual Report
(Form 10-K) of Actel Corporation.

/s/ Ernst & Young LLP

San Jose, California
March 27, 1998


                                                                      EXHIBIT 24

                                POWER OF ATTORNEY

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears below hereby constitutes and appoints John C. East, Henry L. Perret, and
David  L.  Van  De  Hey,   and  each  of  them  acting   individually,   as  his
attorney-in-fact,  each with full power of substitution,  for him in any and all
capacities,  to sign any and all  amendments  to this Annual Report on Form 10-K
and to file the same,  with exhibits  thereto and other  documents in connection
therewith,  with the Securities and Exchange  Commission,  hereby  ratifying and
confirming  all  that  each  of said  attorneys-in-fact,  or his  substitute  or
substitutes, may do or cause to be done by virtue thereof.

     Pursuant to the  requirements of the Securities  Exchange Act of 1934, this
Annual  Report on Form 10-K has been signed  below by the  following  persons on
behalf of the Registrant and in the capacities and on the dates indicated.

<TABLE>
<CAPTION>
                Signature                                          Title                                Date
- ------------------------------------------  ---------------------------------------------------   ----------------
<S>                                         <C>                                                    <C> 
              /s/ John C. East              President and Chief  Executive  Officer  (Principal    March 27, 1998
              (John C. East)                Executive Officer) and Director

             /s/ Henry L. Perret            Vice  President  of  Finance  and  Chief  Financial    March 27, 1998
            (Henry L. Perret)               Officer   (Principal   Financial   and   Accounting
                                            Officer)

                                            Director
            (Keith B. Geeslin)

             /s/ Jos C. Henkens             Director                                               March 27, 1998
             (Jos C. Henkens)

         /s/ Frederic N. Schwettmann        Director                                               March 27, 1998
        (Frederic N. Schwettmann)

            /s/ Robert G. Spencer           Director                                               March 27, 1998
           (Robert G. Spencer)
</TABLE>

<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-28-1997
<PERIOD-START>                                 DEC-30-1997
<PERIOD-END>                                   DEC-28-1997
<CASH>                                         7,763
<SECURITIES>                                   51,272
<RECEIVABLES>                                  26,767
<ALLOWANCES>                                   1,632
<INVENTORY>                                    20,472
<CURRENT-ASSETS>                               127,263
<PP&E>                                         40,311
<DEPRECIATION>                                 25,230
<TOTAL-ASSETS>                                 159,994
<CURRENT-LIABILITIES>                          50,984
<BONDS>                                        0
<COMMON>                                       85,965
                          0
                                    0
<OTHER-SE>                                     23,024
<TOTAL-LIABILITY-AND-EQUITY>                   159,994
<SALES>                                        155,858
<TOTAL-REVENUES>                               155,858
<CGS>                                          64,244
<TOTAL-COSTS>                                  131,903
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                25,797
<INCOME-TAX>                                   9,029
<INCOME-CONTINUING>                            16,768
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   16,768
<EPS-PRIMARY>                                  .82
<EPS-DILUTED>                                  .76
        

</TABLE>

<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-29-1996
<PERIOD-START>                                 JAN-1-1996
<PERIOD-END>                                   DEC-29-1996
<CASH>                                         3,543
<SECURITIES>                                   25,626
<RECEIVABLES>                                  30,917
<ALLOWANCES>                                   1,422
<INVENTORY>                                    26,848
<CURRENT-ASSETS>                               104,605
<PP&E>                                         33,837
<DEPRECIATION>                                 17,864
<TOTAL-ASSETS>                                 136,712
<CURRENT-LIABILITIES>                          49,208
<BONDS>                                        0
<COMMON>                                       63,151
                          0
                                    18,147
<OTHER-SE>                                     6,206
<TOTAL-LIABILITY-AND-EQUITY>                   136,712
<SALES>                                        148,779
<TOTAL-REVENUES>                               148,779
<CGS>                                          64,420
<TOTAL-COSTS>                                  126,749
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,055
<INCOME-PRETAX>                                23,085
<INCOME-TAX>                                   8,147
<INCOME-CONTINUING>                            14,938
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   14,938
<EPS-PRIMARY>                                  .84
<EPS-DILUTED>                                  .70
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission